sd
session
chair
orring
e
north
carolina
chapel
hill
chapel
hill
nc
usa
panel
nih
ahrq
program
offic
discuss
institut
institut
role
program
offic
extramur
grant
support
panel
member
discuss
opportun
traine
interact
program
offic
facilit
career
develop
research
focu
area
emphasi
extramur
grant
career
develop
award
discuss
panel
take
question
audienc
sd
session
chair
seeli
ew
gelato
women
hospit
boston
usa
brook
univers
stoni
brook
ny
usa
career
develop
award
also
call
k
award
provid
import
step
evolut
independ
grant
fund
interact
workshop
review
purpos
k
award
vari
option
k
award
fund
provid
tip
success
k
applic
receiv
perspect
advic
senior
investig
current
k
recipi
well
nih
help
achiev
success
k
applic
specif
review
choos
k
award
right
defin
research
question
write
research
plan
craft
career
develop
plan
role
mentor
k
award
k
award
review
process
revis
k
award
applic
associ
patient
orient
research
sd
session
chair
harri
pa
univers
nasvhil
tn
usa
redcap
research
electron
data
captur
softwar
program
design
assist
research
team
data
plan
captur
storag
dissemin
program
creat
provid
research
easi
way
right
thing
plan
implement
studi
data
collect
strategi
redcap
softwar
avail
financi
charg
academ
nonprofit
institut
consortium
network
http
within
grow
network
institut
partner
redcap
support
approxim
project
softwar
fill
common
need
research
institut
provid
secur
central
web
base
data
collect
servic
divers
research
portfolio
central
data
collect
model
protect
stakehold
institut
research
research
particip
offer
secur
altern
spreadsheet
nonsecur
databas
program
panel
present
includ
expert
vanderbilt
univers
paul
harri
mayo
clinic
michael
lin
cleveland
clinic
john
sharp
medic
univers
south
carolina
jihad
obeid
panel
topic
includ
redcap
project
overview
support
data
captur
manag
dissemin
b
redcap
consortium
overview
support
divers
environ
c
redcap
permut
support
divers
studi
design
research
project
support
divers
research
team
sd
session
chair
pichert
jw
medic
school
nashvil
tn
usa
critic
commun
studi
go
awri
dr
one
investig
heard
yell
angrili
meet
research
team
academ
member
time
careless
colleagu
lazi
research
assist
screw
hard
work
turn
leav
bark
peopl
better
eat
sleep
fix
problem
call
back
particip
rerun
studi
although
mani
featur
distinguish
profess
one
import
respons
member
conduct
unfortun
clinic
translat
c
research
profession
may
train
deal
disrupt
behavior
aka
bulli
later
violenc
commonli
resist
compromis
research
ethic
qualiti
undermin
trust
commun
hinder
transmiss
find
wors
much
written
fabric
fraud
plagiar
deviat
consent
session
howev
address
disrupt
behavior
threaten
c
research
qualiti
without
proper
tool
commit
c
research
seem
toler
disrupt
behavior
despit
potenti
threaten
patient
safeti
harm
team
moral
increas
cost
address
unprofession
behavior
c
research
begin
commit
reduc
toler
behavior
requir
organiz
infrastructur
b
tier
disrupt
behavior
pyramid
guid
intervent
train
element
resourc
adapt
organ
conduct
high
qualiti
c
research
hickson
gb
pichert
jw
webb
le
gabb
sg
complementari
approach
promot
profession
identifi
measur
address
unprofession
behavior
acad
med
sd
session
chair
mitchel
p
washington
seattl
wa
usa
purpos
concurr
session
highlight
interdisciplinari
research
span
spectrum
translat
research
bench
scienc
commun
practic
panelist
illustr
current
find
differ
translat
perspect
interdisciplinari
collabor
repres
medicin
molecular
biolog
nurs
social
work
disciplin
demonstr
strength
approach
research
exampl
showcas
research
genom
women
health
health
dispar
moder
pamela
mitchel
univers
washington
panelist
elain
larson
columbia
univers
deborah
lyon
virginia
commonwealth
univers
loretta
univers
pennsylvania
sd
session
chair
strong
r
bernard
texa
health
scienc
center
san
antonio
san
antonio
tx
usa
institut
health
bethesda
md
usa
increas
longev
present
result
larg
improv
prenat
neonat
care
public
health
treatment
infecti
diseas
three
lead
caus
death
infecti
diseas
today
three
lead
caus
death
diseas
includ
heart
diseas
cancer
stroke
grow
consensu
addit
increas
longev
may
come
target
age
process
therebi
simultan
target
multipl
diseas
preclin
studi
reveal
wealth
therapeut
target
least
one
compound
slow
age
increas
longev
mice
speaker
session
discuss
barrier
translat
preclin
research
pitfal
encount
clinic
trial
antiag
intervent
implic
health
care
public
polici
sd
session
chair
smoyer
ingelfing
ohio
state
univers
columbu
oh
usa
gener
hospit
boston
usa
medic
school
boston
usa
session
present
pediatr
clinic
translat
research
focus
fetal
origin
major
adult
diseas
includ
heart
diseas
obes
diabet
session
begin
overview
earli
observ
subsequ
research
lead
develop
understand
earli
life
event
includ
prenat
period
major
impact
subsequ
health
individu
throughout
live
overview
follow
three
present
focus
specif
spectrum
preclin
research
fetal
origin
three
common
import
human
diseas
heart
diseas
obes
diabet
improv
understand
origin
potenti
intervent
human
diseas
sd
session
chair
moor
c
begg
pittsburgh
pittsburgh
pa
usa
school
public
health
columbia
univers
new
york
ny
usa
scholar
learn
compet
success
next
nih
grant
applic
independ
k
award
grant
discuss
specif
scenario
scholar
compet
success
next
nih
grant
scholar
learn
strategi
work
common
mistak
avoid
exampl
scholar
current
award
would
benefit
addit
mentor
k
award
learn
develop
argument
justifi
need
nih
includ
chang
addit
plan
would
need
scholar
also
learn
key
differ
small
grant
exploratorydevelopment
grant
benefit
risk
associ
mechan
circumst
mechan
use
final
scholar
learn
maxim
chanc
compet
success
support
includ
avoid
common
mistak
made
new
investig
well
specif
scenario
recruit
senior
investig
serv
investig
consid
exampl
success
applic
discuss
audienc
particip
encourag
sd
session
chair
fleme
wisconsin
madison
wi
usa
purpos
seminar
present
initi
find
site
nation
mentor
train
trial
led
research
team
univers
wisconsin
madison
institut
clinic
translat
research
total
pair
across
site
random
control
experiment
group
mente
primarili
k
scholar
mentor
assign
intervent
arm
trial
particip
hour
train
program
deliv
four
session
train
deliv
site
two
local
facilit
partcip
two
day
trainer
trainer
workshop
measur
focus
chang
activ
mentor
mentor
activ
mentor
report
mente
mentor
session
present
baselin
data
mentor
train
experi
across
site
interview
complet
summer
first
larg
scale
educ
trial
test
effect
mentor
train
program
mentor
conduct
clinic
translat
scienc
site
consortium
particip
trial
expect
train
curriculum
test
studi
provid
framework
mentor
train
across
ctsa
sd
session
chair
k
california
san
francisco
san
francisco
ca
usa
research
health
healthcar
dispar
import
compon
clinic
translat
research
train
program
prepar
scholar
conduct
research
health
healthcar
dispar
must
consid
multifacet
natur
research
session
bring
togeth
leader
across
ctsa
rcmi
activ
engag
develop
network
train
program
health
healthcar
dispar
aim
panel
discuss
discuss
compon
success
train
program
dispar
research
challeng
develop
program
b
highlight
current
effort
develop
network
across
institut
engag
train
dispar
research
sd
session
chair
rich
e
center
health
care
effect
princeton
nj
usa
educ
session
health
care
reform
necess
translat
scienc
led
eugen
rich
md
senior
fellow
director
mathematica
center
health
care
effect
chce
five
main
object
session
summar
evidentiari
question
pose
current
health
system
problem
review
type
scientif
inquiri
relev
answer
question
outlin
opportun
support
approach
health
care
reform
summar
barrier
success
use
translat
scienc
guid
health
care
reform
identifi
next
step
evid
base
health
care
reform
introduct
main
present
scientif
foundat
health
care
reform
given
eugen
rich
follow
main
present
ann
bonham
phd
chief
scientif
offic
aamc
lisa
rubenstein
md
msph
professor
medicin
va
greater
lo
angel
ucla
senior
natur
scientist
rand
hoangmai
mai
pham
md
mph
senior
advisor
center
medicar
medicaid
innov
provid
reaction
main
present
person
comment
topic
appropri
develop
applic
translat
scienc
play
critic
role
improv
qualiti
effici
us
health
care
sd
session
chair
atkinson
rl
allison
commonwealth
univers
richmond
va
usa
alabama
birmingham
birmingham
al
usa
symposium
examin
current
statu
knowledg
caus
obes
identifi
thought
new
etiolog
well
consid
previous
suggest
potenti
solut
identifi
research
area
need
address
understand
complex
diseas
dr
richard
atkinson
talk
old
new
thought
caus
obes
dr
nikhil
dhurandhar
discuss
infecti
agent
shown
caus
obes
implic
portion
obes
infecti
diseas
dr
giovanni
cizza
discuss
environ
affect
bodi
weight
bodi
fat
includ
effect
stress
amount
sleep
exposur
light
circadian
rhythm
dr
david
allison
address
state
knowledg
obes
current
qualiti
quantiti
prior
research
obes
thing
know
obes
suspect
novel
idea
caus
obes
fit
whole
pictur
go
research
potenti
treatment
sd
session
chair
pollock
bh
sullivan
texa
health
scienc
center
san
antonio
san
antonio
tx
usa
univers
durham
nc
usa
use
databas
clinic
translat
research
emphasi
databas
design
consider
support
futur
unanticip
need
discuss
imag
measur
serv
end
point
clinic
outcom
new
imag
biomark
develop
appli
critic
way
imag
collect
way
measur
person
algorithm
softwar
revis
observ
condit
etc
record
secur
standard
fashion
discuss
databas
design
requir
research
imag
share
support
futur
need
administr
health
care
databas
develop
track
qualiti
volum
bill
health
servic
plan
public
health
surveil
repurpos
offer
extrem
use
research
resourc
rigor
innov
studi
design
typic
make
use
wealth
inform
provid
meaning
answer
signific
health
care
question
present
exampl
administr
databas
repurpos
estim
preval
undiagnos
diseas
select
appropri
administr
databas
flaw
strength
innov
use
discuss
data
alreadi
collect
variou
clinic
epidemiolog
studi
often
contain
subset
could
aggreg
secondari
analys
includ
use
compar
effect
research
howev
lack
suffici
meta
data
describ
studi
often
prevent
subset
identifi
util
present
graphic
user
interfac
represent
meta
data
facilit
acquisit
storag
primari
analysi
particular
studi
data
also
enabl
data
share
novel
queri
tool
unplan
analys
across
studi
differ
design
popul
sd
session
chair
vollmer
sh
alabama
birmingham
birmingham
al
usa
nation
experienc
respons
conduct
research
rcr
educ
resourc
develop
explain
new
nih
requir
teach
rcr
includ
train
speaker
offer
method
curricula
prove
success
meet
requir
differ
context
emphasi
place
teach
effect
collabor
skill
resourc
present
includ
knowledg
base
wisdom
techniqu
educ
resourc
ctspedia
offer
use
advic
face
specif
question
topic
rang
biostatist
reproduc
result
resid
train
narr
tool
teach
decis
make
face
ethic
choic
sd
session
chair
mcdonald
univers
school
medicin
durham
nc
usa
key
compon
clinic
translat
scienc
award
ctsa
develop
train
educ
program
translat
scientist
build
nationwid
educ
program
core
compet
translat
scienc
need
identifi
defin
educ
career
develop
key
function
committe
kfc
nation
ctsa
develop
core
compet
themat
area
comprehens
collect
core
compet
translat
scienc
bench
research
clinic
patient
care
includ
commun
engag
research
cenr
cover
wide
divers
rang
knowledg
skill
concept
principl
given
breadth
may
realist
expect
everi
translat
scientist
must
gain
full
compet
themat
area
therefor
core
share
compet
anyon
identifi
translat
scientist
answer
implic
design
creation
train
graduat
program
throughout
ctsa
beyond
session
address
question
serv
forum
discuss
particip
attend
panel
member
includ
bench
scientist
research
commun
engag
research
involv
develop
compet
base
educ
train
program
translat
scientist
sd
session
chair
vukotich
cj
pittsburgh
pittsburgh
pa
usa
commun
engag
research
cenr
includ
commun
equal
partner
research
process
import
compon
translat
scienc
cenr
provid
differ
method
research
commun
want
benefit
commun
commun
base
participatori
research
cbpr
engag
commun
organ
part
entir
research
process
conceptu
format
protocol
design
implement
use
data
translat
polici
practic
school
base
research
sbr
special
part
cbpr
work
import
interest
popul
school
part
commun
also
small
commun
research
pbr
conduct
medic
health
care
set
emphasi
rapid
translat
research
evid
practic
engag
commun
organ
client
cenr
may
use
commun
health
worker
chw
part
research
intervent
team
panel
provid
look
cenr
inform
cenr
import
provid
exampl
success
lesson
learn
success
commun
engag
research
provid
insight
research
may
engag
commun
sd
session
chair
galey
w
hugh
medic
institut
chevi
case
md
usa
recogn
need
help
graduat
program
creat
implement
curricula
train
phd
scientist
understand
medicin
pathobiolog
howard
hugh
medic
institut
hhmi
establish
institut
grant
program
initi
known
med
grad
provid
institut
fund
integr
learn
medicin
pathobiolog
new
exist
phd
graduat
program
goal
effort
train
cadr
basic
biomed
scientist
prepar
particip
translat
emerg
biolog
knowledg
medic
public
health
practic
assur
scientist
awar
problem
challeng
face
practition
diagnosi
treatment
prevent
diseas
hhmi
support
program
last
five
year
program
uniqu
featur
vari
implement
program
strategi
sever
element
emerg
common
success
program
uniqu
featur
common
element
discuss
program
director
hhmi
administr
sd
session
chair
sullivan
dc
mcclain
univers
durham
nc
usa
univers
utah
health
scienc
center
salt
lake
citi
ut
usa
consider
interest
develop
biomark
use
faster
strategi
evalu
drug
better
definit
patient
benefit
treatment
session
select
lung
cancer
alzheim
diseas
exampl
illustr
specimen
imag
biomark
develop
evalu
valid
use
either
therapi
develop
clinic
practic
term
biomark
includ
wide
rang
vitro
vivo
test
vitro
analysi
specimen
yield
enorm
amount
molecular
inform
small
sampl
howev
inform
reflect
singl
locu
space
time
mani
physiolog
paramet
eg
ph
oxygen
may
lost
sampl
prepar
imag
test
provid
less
molecular
inform
provid
anatom
andor
tempor
local
inform
may
provid
accur
reflect
integr
physiolog
statu
thu
test
provid
differ
sometim
complementari
inform
valid
biomark
complic
variabl
within
patient
human
observ
compon
variabl
across
devic
differ
manufactur
need
standard
method
across
institut
center
return
invest
diagnost
test
low
compar
therapeut
drug
potenti
import
opportun
academ
group
particip
biomark
evalu
speaker
session
address
issu
associ
test
biomark
risk
screen
test
lung
cancer
research
question
follow
recent
identifi
benefit
ct
screen
much
work
also
go
evalu
composit
biomark
match
lung
cancer
patient
effect
therapi
tumor
molecular
signatur
alzheim
diseas
larg
longitudin
natur
histori
studi
adni
accumul
wealth
data
evalu
imag
specimen
biomark
risk
assess
diagnosi
treatment
monitor
speaker
address
current
statu
alzheim
biomark
research
paradigm
biomark
work
chronic
diseas
sd
session
chair
kaitin
white
univers
boston
usa
alabama
mobil
al
usa
drug
tomorrow
come
clear
extant
model
drug
develop
yield
new
product
sustain
growth
pharmaceut
industri
long
domin
sourc
medicin
new
model
drug
develop
need
ensur
newer
better
medicin
continu
develop
treat
host
diseas
inadequ
treatment
current
exist
session
explor
current
restructur
effort
within
commerci
sector
growth
impact
partnership
role
food
drug
administr
critic
path
initi
support
new
drug
develop
sd
session
chair
desmond
nl
ulan
bethesda
md
usa
nih
ahrq
program
offic
meet
small
group
scholar
discuss
individu
career
develop
plan
includ
grant
applic
strategi
program
offic
differ
institut
avail
hour
block
scholar
util
direct
discuss
nih
ahrq
staff
research
train
career
develop
grant
clinic
translat
research
sd
session
chair
schoenbaum
e
einstein
colleg
medicin
bronx
ny
usa
today
world
earli
investig
face
compet
demand
aid
abet
success
research
career
career
various
affect
medic
subspecialti
institut
resourc
student
loan
famili
life
etc
one
navig
opportun
demand
make
differ
satisfact
success
clinic
research
session
offer
career
stori
three
clinic
research
differ
path
success
session
target
clinic
research
scholar
earli
investig
present
question
taken
sd
session
chair
myer
duke
charit
foundat
new
york
ny
usa
mani
privat
foundat
support
career
develop
program
biomed
research
session
hear
three
foundat
program
earli
career
stage
focu
basic
translat
clinic
health
servic
research
career
award
medic
scientist
burrough
wellcom
fund
support
advanc
postdoctoralfellowship
train
award
extend
earli
year
faculti
servic
project
basic
biomed
translat
molecular
genet
pharmacolog
epidemiolog
research
clinic
scientist
develop
award
dori
duke
charit
foundat
award
instructor
assist
professor
facilit
transit
independ
clinic
research
career
project
cover
rang
research
area
mechan
diseas
health
outcom
dori
duke
charit
foundat
also
program
support
one
year
mentor
clinic
research
medic
student
nearli
year
robert
wood
johnson
foundat
clinic
scholar
program
foster
develop
physician
leader
research
area
problem
health
care
deliveri
financ
clinic
decis
make
biomed
ethic
medic
histori
health
care
polici
graduat
program
becom
critic
mass
guid
chang
us
health
care
system
session
three
program
describ
includ
programmat
goal
elig
select
criteria
inform
outcom
program
alumni
avail
sd
session
chair
gleason
veteran
affair
washington
dc
usa
depart
veteran
affair
va
offic
research
develop
rich
research
train
histori
clinician
nonclinician
scientist
interest
advanc
knowledg
issu
relat
veteran
health
session
opportun
hear
va
research
career
develop
career
path
especi
interest
pursu
clinic
research
fund
opportun
real
life
exampl
present
sd
session
chair
trikalino
khouri
medic
center
boston
usa
diseas
control
prevent
atlanta
ga
usa
past
year
technolog
advanc
allow
rapid
gener
torrent
genet
genom
data
therebi
present
opportun
improv
patient
care
public
health
numer
genom
applic
time
translat
data
knowledg
action
sever
lag
evid
relationship
genom
factor
clinic
outcom
cost
benefit
harm
genom
applic
set
take
long
gener
risk
obsolet
time
publish
equal
import
exist
framework
evalu
clinic
util
genom
applic
optim
complic
translat
process
realiz
promis
genom
treat
prevent
diseas
improv
health
reduc
health
dispar
major
challeng
face
compar
effect
research
first
talk
provid
introduct
translat
research
genom
applic
practic
prevent
outlin
expect
realist
second
talk
discuss
current
think
recommend
toward
facilit
discoveri
valid
pharmacogenet
marker
speed
thought
translat
integr
clinic
practic
emphasi
cancer
condit
third
talk
describ
approach
evalu
interpret
evid
pharmacogenet
test
virtu
appli
exampl
fourth
talk
discuss
lesson
learnt
studi
pharmacogenet
test
noncanc
condit
use
wide
spectrum
methodolog
conduct
primari
studi
decis
econom
analys
sd
session
chair
athey
b
michigan
ann
arbor
mi
usa
past
year
associ
studi
conduct
common
diseas
studi
led
identif
hundr
genet
variant
identif
specif
gene
proven
daunt
challeng
need
comprehens
analysi
patient
dna
sequenc
level
goal
feasibl
sequenc
technolog
inde
recent
advanc
dna
sequenc
machin
hold
promis
reduc
cost
sequenc
singl
human
genom
less
genet
data
investig
effect
posit
defin
diseas
pathway
valid
drug
target
develop
diagnost
lead
target
person
therapi
well
prevent
strategi
reduc
howev
mani
pitfal
potenti
person
medicin
paradigm
achiev
includ
reduc
cost
increas
speed
sequenc
technolog
convinc
medicar
privat
insur
reimburs
cost
pharmacogenet
test
encourag
pharmaceut
compani
integr
genet
biomark
inform
design
clinic
trial
facilit
develop
implement
diagnost
base
genet
inform
symposium
examin
promis
pitfal
polici
implic
sequenc
revolutionari
new
tool
person
medicin
iennaco
jd
fenni
bower
dixon
whittemor
busch
scahil
univers
school
nurs
new
ct
usa
univers
london
london
unit
kingdom
univers
school
public
health
new
ct
usa
objectivesspecif
aim
compar
feasibl
agreement
three
method
count
worker
exposur
verbal
physic
aggress
use
standard
method
incid
report
restraint
log
questionnair
event
counter
inpati
psychiatr
set
methodsstudi
popul
pilot
studi
determin
feasibl
use
event
counter
measur
aggress
exposur
handheld
counter
use
clinic
staff
randomli
select
adult
unit
consecut
period
data
collect
standard
method
questionnair
inpati
unit
resultsanticip
result
use
counter
end
shift
log
clinician
aggress
exposur
identifi
anticip
counter
method
provid
accur
count
actual
verbal
physic
aggress
exposur
method
questionnair
expect
specifi
event
standard
method
given
standard
method
use
injuri
actual
physic
restraint
patient
occur
questionnair
document
broader
rang
behavior
provid
method
identifi
individu
worker
exposur
aggress
counter
use
counter
also
compar
self
report
perceiv
aggress
exposur
via
survey
discussionsignific
impact
rate
aggress
exposur
current
measur
sever
event
underestim
actual
exposur
worker
aggress
event
never
count
abil
identifi
actual
aggress
exposur
level
evalu
effect
vari
exposur
may
lead
identif
health
work
outcom
addit
measur
current
state
exposur
provid
effort
reduc
aggress
exposur
monitor
effect
araya
h
bahiru
harri
school
medicin
palo
alto
ca
usa
einstein
colleg
medicin
new
york
ny
usa
objectivesspecif
aim
object
studi
character
hivaid
inpati
popul
african
leprosi
tuberculosi
rehabilit
research
train
center
alert
one
facil
ethiopia
provid
long
term
care
hivaid
patient
aim
studi
mortal
rate
preval
opportunist
infect
adher
treatment
character
hivaid
patient
popul
alert
instrument
hospit
attempt
improv
standard
care
patient
advoc
fund
augment
inpati
servic
diagnost
capabl
methodsstudi
popul
retrospect
chart
review
patient
admit
inpati
hivaid
treatment
servic
alert
stratifi
data
age
gender
count
stage
art
treatment
resultsanticip
result
preliminari
data
analysi
show
top
four
preval
opportunist
infect
tuberculosi
pneumonia
crypotcocc
mening
cn
toxoplasmosi
found
patient
cohort
never
start
treatment
even
though
close
patient
count
less
cutoff
count
start
treatment
close
patient
art
treatment
good
adher
approxim
adher
base
discussionsignific
impact
observ
hospit
mortal
rate
approxim
higher
overal
hivaid
mortal
rate
countri
current
conduct
statist
analysi
assess
effect
top
four
opportunist
infect
adher
well
variabl
count
stage
mortal
use
regress
model
hope
discov
explan
make
deduct
analysi
data
babcock
cimpello
l
byczkowski
bazarian
children
hospit
medic
center
cincinnati
oh
usa
rochest
medic
center
rochest
ny
usa
objectivesspecif
aim
object
determin
incid
pc
acut
clinic
variabl
associ
pc
children
mild
traumat
brain
injuri
mtbi
methodsstudi
popul
subanalysi
children
year
previous
establish
mtbi
cohort
variabl
collect
prospect
emerg
depart
ed
month
call
includ
rivermead
post
concuss
symptom
questionnair
rpq
pc
defin
symptom
rpq
wors
bivari
multivari
analys
conduct
examin
associ
variabl
pc
resultsanticip
result
children
enrol
complet
pc
children
pc
similar
without
pc
term
gender
race
mechan
sever
prior
tbi
gc
amnesia
abnorm
brain
ct
receipt
pc
instruct
howev
older
vs
yr
significantli
like
present
loss
conscious
loc
vs
headach
ha
vs
nauseavomit
nv
vs
undergon
brain
ct
imag
vs
receiv
analges
ed
vs
admit
vs
longer
school
absente
vs
day
pursu
lawsuit
vs
without
pc
multivari
analysi
show
age
ci
ha
ci
associ
pc
howev
gender
gc
amnesia
nv
loc
like
develop
pc
associ
ns
ci
ha
remov
model
nv
becam
associ
pc
ci
discussionsignific
impact
children
mtbi
seen
ed
develop
pc
older
children
loc
plu
headach
nauseavomit
consid
risk
develop
pc
boyc
rd
visweswaran
day
handler
pittsburgh
pittsburgh
pa
pa
usa
objectivesspecif
aim
causal
assess
questionnair
caq
psychometr
scale
often
use
help
drug
expert
make
transpar
assess
potenti
causal
relationship
drug
advers
event
ae
maintain
reliabl
caq
score
threshold
usual
chosen
distinguish
plausibl
causal
associ
implaus
one
hypothes
score
produc
caq
often
discord
actual
probabl
associ
methodsstudi
popul
use
two
weight
scheme
deriv
koh
caq
one
probabilist
test
score
produc
version
scale
ever
discord
actual
probabl
associ
resultsanticip
result
found
probabl
score
produc
two
evalu
would
discord
actual
probabl
associ
increas
monoton
major
possibl
score
threshold
discussionsignific
impact
result
indic
score
produc
koh
caq
often
discord
actual
probabl
associ
anticip
properti
caq
deriv
score
respons
implic
use
score
threshold
consid
plausibl
might
case
irrat
point
view
caq
similarli
might
situat
compar
score
produc
caq
identifi
like
causal
drug
ae
would
irrat
dusing
j
anasto
hoover
shi
kief
colleg
medicin
bronx
ny
usa
univers
piscataway
nj
usa
medic
colleg
valhalla
ny
usa
objectivesspecif
aim
serum
albumin
often
use
measur
nutrit
statu
assess
associ
albumin
measur
nutrit
statu
rwandan
women
methodsstudi
popul
enrol
women
studi
data
collect
includ
medic
demograph
paramet
count
albumin
anthropometr
measur
result
bioelectr
imped
analysi
bia
perform
train
studi
nurs
mass
index
ffmi
fat
index
fi
calcul
divid
fat
free
fat
mass
height
outcom
bodi
mass
index
bmi
ffmi
fi
sum
thigh
tricep
subscapular
tt
resultsanticip
result
separ
age
adjust
linear
regress
model
outcom
women
serum
albumin
significantli
associ
bmi
p
ffmi
p
fi
p
weak
signific
associ
tt
p
hiv
women
albumin
significantli
associ
outcom
model
adjust
age
cell
count
bmi
ffmi
fi
p
tt
p
interact
term
hiv
statu
serum
albumin
signific
outcom
model
fit
women
discussionsignific
impact
serum
albumin
predict
bmi
ffmi
fi
women
suggest
good
marker
nutrit
statu
associ
measur
women
may
result
known
valu
measur
advanc
ill
suggest
albumin
use
proxi
nutrit
statu
without
studi
associ
valid
measur
lowri
kw
lavign
memori
hospit
chicago
il
usa
univers
chicago
il
usa
objectivesspecif
aim
obes
known
risk
factor
poor
behavior
control
psychiatr
comorbid
exist
research
examin
behavior
observ
psychiatr
diagnos
children
year
age
younger
studi
examin
associ
child
weight
behavior
problem
observ
noncompli
presenc
absenc
psychiatr
diagnos
whether
demograph
variabl
moder
associ
methodsstudi
popul
archiv
review
observ
studi
particip
children
yr
data
collect
home
visit
includ
questionnair
semistructur
parent
interview
standard
play
observ
subsequ
train
mental
health
profession
review
protocol
entireti
assign
psychiatr
diagnos
warrant
resultsanticip
result
extern
behavior
problem
b
se
b
p
observ
noncompli
b
se
b
p
significantli
associ
higher
child
weight
lower
famili
se
b
se
b
p
also
associ
heavier
child
weight
impact
extern
behavior
problem
weight
stronger
girl
b
se
b
p
child
raceethn
associ
child
weight
intern
behavior
problem
psychiatr
diagnos
associ
child
weight
discussionsignific
impact
child
extern
behavior
problem
associ
higher
weight
young
children
find
suggest
parent
may
perceiv
behavior
heavier
children
difficult
manag
famili
may
receiv
intervent
intens
behavior
problem
sever
enough
warrant
psychiatr
diagnos
nave
b
comfort
ferrier
kwon
rom
prezant
weiden
nolan
york
univers
school
medicin
ny
ny
usa
fire
depart
brooklyn
ny
usa
objectivesspecif
aim
first
year
post
fdni
rescu
worker
declin
ml
stabil
mlyr
declin
subsequ
year
airflow
obstruct
predomin
firefight
sought
subspecialti
pulmonari
evalu
treatment
investig
relationship
biomark
metabol
syndrom
ms
declin
lung
function
methodsstudi
popul
treatment
cohort
n
stratifi
obstruct
predict
lln
normal
airflow
pilot
analysi
assay
patient
serum
drawn
month
post
biomark
ms
luminex
obstruct
n
normal
n
patient
normal
lung
function
serum
cholesterol
chol
triglycerid
tg
avail
patient
obstruct
data
present
mean
sd
p
valu
consid
signific
resultsanticip
result
bmi
time
serum
sampl
differ
normal
obstruct
individu
subspecialti
pft
obstruct
patient
higher
bmi
acceler
declin
lung
function
post
increas
airway
reactiv
evid
air
trap
base
elev
rv
compar
normal
obstruct
subject
significantli
greater
chol
cholhdl
ratio
higher
level
trend
toward
elev
level
tg
discussionsignific
impact
blood
drawn
exposur
identifi
subgroup
patient
marker
ms
subgroup
subsequ
increas
weight
gain
declin
lung
function
find
ms
biomark
prior
lung
function
declin
rais
possibl
combin
irrit
exposur
mediat
ms
interact
promot
lung
injuri
marmolejo
v
salazar
buitrago
ramo
kanna
hospit
bronx
ny
usa
new
york
ny
usa
objectivesspecif
aim
rate
obes
increas
rapidli
unit
state
us
make
major
public
health
concern
new
york
citi
bronx
resid
obes
make
highest
among
five
borough
ethnic
dispar
obes
relat
factor
need
identifi
address
among
new
yorker
methodsstudi
popul
conduct
valid
survey
lincoln
medic
mental
health
center
outpati
clinic
survey
differ
compon
respons
demograph
diet
exercis
bodi
mass
index
bmi
subject
divid
obeseoverweight
group
base
bmi
greater
normal
bmi
group
odd
ratio
confid
interv
ci
p
valu
report
resultsanticip
result
respond
hispan
among
hispan
obes
either
obes
overweight
least
high
school
educ
live
us
year
stepwis
multivari
analysi
overweightobes
bmi
group
hispan
signific
greater
odd
matur
adult
age
age
ci
p
male
gender
ci
p
lack
least
high
school
educ
least
high
ci
p
greater
year
resid
us
time
us
ci
p
among
obes
individu
bmi
odd
higher
among
lack
high
school
educ
live
us
year
discussionsignific
impact
studi
find
show
adult
immigr
hispan
lower
educ
statu
greater
time
resid
us
greater
probabl
overweight
obes
immergluck
lh
khizer
chan
brown
farley
jerri
school
medicin
atlanta
ga
usa
univers
atlanta
ga
usa
healthcar
atlanta
atlanta
ga
usa
emerg
infect
program
atlanta
ga
usa
va
medic
center
atlanta
ga
usa
objectivesspecif
aim
determin
preval
rota
posit
stool
impact
rota
vac
diseas
burden
methodsstudi
popul
two
part
project
case
control
studi
children
rota
test
consecut
season
begin
dec
pediatr
hospit
activ
surveil
children
symptom
acut
gastroenter
age
dec
pediatr
hospit
rate
determin
rota
diseas
rota
vac
children
born
april
rota
vac
statu
collect
state
immun
registri
contact
primari
care
provid
resultsanticip
result
case
control
three
season
vac
record
obtain
case
control
rota
rate
highest
compar
p
vac
rate
rota
vac
dose
respect
among
receiv
rota
vac
dose
fewer
case
control
time
rota
test
case
versu
control
case
vs
control
case
versu
trend
seen
rota
vac
dose
p
activ
surveil
children
enrol
stool
sampl
test
rota
rota
discussionsignific
impact
downward
trend
rota
case
among
children
seek
care
pediatr
hospit
atlanta
case
like
control
incomplet
rota
vac
time
rota
test
shanmugam
vk
schill
atting
univers
hospit
washington
dc
usa
objectivesspecif
aim
lower
extrem
ulcer
known
complic
connect
tissu
diseas
ctd
primari
hypothesi
research
delay
wound
heal
ctd
manifest
dysregul
vasculogen
angiogen
pathway
ulcer
associ
ctd
provid
use
compartment
model
studi
pathway
methodsstudi
popul
retrospect
chart
review
complet
consecut
patient
schedul
georgetown
univers
hospit
center
wound
heal
januari
march
exclus
criteria
includ
absenc
open
ulcer
failur
evalu
studi
period
data
collect
includ
demograph
ulcer
locat
durat
ulcer
size
outcom
surgic
intervent
includ
debrid
graft
wound
vacuum
closur
devic
comorbid
condit
includ
ctd
diabet
vascular
diseas
primari
end
point
correl
wound
durat
ctd
secondari
end
point
outcom
includ
heal
time
heal
surgic
intervent
patient
ctd
compar
without
ctd
resultsanticip
result
schedul
patient
open
ulcer
remain
patient
either
attend
visit
ulcer
time
visit
patient
ulcer
underli
ctd
diabet
present
patient
venou
diseas
arteri
diseas
discussionsignific
impact
consecut
cohort
patient
present
tertiari
wound
heal
center
associ
ctd
intend
use
delay
wound
heal
ctd
model
studi
tissu
marker
angiogenesi
vasculogenesi
formalin
fix
paraffin
embed
specimen
orellana
mf
cuba
san
francisco
ca
usa
objectivesspecif
aim
object
studi
identifi
explain
dispar
dental
servic
util
among
latino
adolesc
california
methodsstudi
popul
secondari
analysi
chi
adolesc
questionnair
use
base
random
digit
dial
telephon
survey
odd
ratio
confid
interv
ci
calcul
use
multipl
logist
regress
model
take
account
complex
survey
design
sampl
weight
resultsanticip
result
total
white
latino
adolesc
particip
languag
spoken
home
english
spanish
immigr
statu
race
signific
determin
frequenc
dental
visit
latino
ci
immigr
ci
adolesc
spoke
spanish
home
ci
less
like
dental
visit
past
year
term
prevent
visit
immigr
ci
latino
ci
adolesc
live
spanish
speak
household
ci
less
prevent
visit
although
signific
adolesc
dental
insur
like
dental
visit
discussionsignific
impact
latino
popul
fastest
grow
largest
minor
group
us
latino
popul
younger
year
age
percent
children
younger
year
age
latino
california
popul
state
latino
surpass
white
state
largest
racialethn
group
amongst
children
yet
littl
known
dental
servic
util
associ
factor
among
latino
adolesc
california
studi
help
identifi
explain
dispar
populationwithout
basic
understand
inequ
address
troutman
w
shaheen
pan
drew
univers
lo
angel
ca
usa
objectivesspecif
aim
object
determin
dispar
predictor
etiolog
length
hospit
stay
among
women
admit
california
hospit
diagnosi
chronic
pelvic
pain
cpp
year
studi
test
hypothes
young
uninsur
women
minor
group
like
diagnos
infecti
etiolog
cpp
rel
white
methodsstudi
popul
admiss
data
california
hospit
review
analyz
time
period
elig
includ
women
diagnos
cpp
age
year
older
hospit
due
infect
noninfecti
etiolog
period
analyz
data
use
descript
bivari
multivari
statist
resultsanticip
result
patient
cpp
due
infecti
diseas
due
infecti
diseas
etiolog
cpp
hospit
vari
age
raceethn
insur
statu
p
black
hispan
age
year
medicalmedicar
higher
odd
hospit
due
infecti
type
rel
white
p
percentag
cpp
subject
hospit
due
infect
decreas
overtim
versu
p
subject
infecti
caus
higher
adjust
odd
hospit
rel
admit
due
infecti
caus
p
median
length
stay
day
white
day
other
infecti
cpp
stay
day
non
infecti
one
p
discussionsignific
impact
data
show
increas
hospit
due
infecti
cpp
time
well
dispar
etiolog
length
hospit
stay
sinc
cpp
diagnosi
exclus
broad
implic
societi
attent
need
relat
diagnosi
cpp
among
minor
uninsur
women
barri
el
mourabet
weyant
clark
regueiro
yadav
saul
binion
pittsburgh
pittsburgh
pa
usa
objectivesspecif
aim
eosinophil
implic
pathogenesi
inflammatori
bowel
diseas
ibd
crohn
diseas
cd
ulcer
coliti
uc
natur
histori
ibd
patient
peripher
eosinophilia
undefin
sought
character
preval
clinic
characterist
ibd
patient
eosinophilia
tertiari
referr
cohort
methodsstudi
popul
queri
prospect
consent
registri
ibd
patient
follow
referr
center
peripher
eosinophilia
identifi
electron
medic
record
emr
queri
identifi
patient
absolut
eosinophil
count
eosibd
group
resultsanticip
result
ibd
patient
emr
analysi
identifi
individu
elev
absolut
eosinophil
count
design
eosibd
eosibd
cohort
includ
uc
cd
patient
among
eosibd
patient
uc
major
male
backwash
ileiti
among
eosibd
patient
cd
major
femal
ileocol
eosibd
patient
requir
hospit
ibd
manag
medic
manag
eosibd
patient
includ
corticosteroid
immunomodul
biolog
surgic
intervent
requir
eosibd
patient
cd
uc
primari
scleros
cholang
seen
eosibd
patient
uc
cd
individu
requir
liver
transplant
discussionsignific
impact
eosibd
rare
subgroup
ibd
associ
sever
coliti
refractori
medic
therapi
aggress
psc
eosibd
may
uniqu
immunopathogen
basi
underli
refractori
chronic
inflamm
studi
warrant
character
molecular
mechan
underli
eosibd
determin
optim
approach
therapi
frei
cr
parchman
forcad
du
nyren
mann
mortensen
wick
pollock
jorgensen
texa
austin
tx
usa
texa
health
scienc
center
san
antonio
tx
usa
texa
ambulatori
research
network
starnet
san
antonio
tx
usa
objectivesspecif
aim
quantifi
incid
measur
sever
describ
treatment
pattern
patient
present
medic
clinic
texa
ssti
methodsstudi
popul
twelv
clinic
particip
prospect
studi
clinician
consent
patient
collect
clinic
inform
pictur
wound
swab
data
process
central
use
identif
suscept
determin
five
antibiot
via
resultsanticip
result
overal
patient
male
hispan
diabet
ssti
within
last
month
abscess
abscess
cm
diamet
major
patient
experienc
pain
score
higher
mani
present
erythema
drainag
ulcer
receiv
incis
drainag
plu
antibiot
trimethoprimsulfamethoxazol
tmpsmx
common
monotherapi
prescrib
follow
doxycyclin
clindamycin
mupirocin
percent
suscept
n
vancomycin
doxycyclin
tmpsmx
clindamycin
linezolid
discussionsignific
impact
mani
patient
present
medic
clinic
texa
ssti
patient
receiv
incis
drainag
plu
antibiot
j
martin
maignan
klein
salisburi
occup
therapi
physic
therapi
cincinnati
children
hospit
medic
center
cincinnati
oh
usa
biostatist
epidemiolog
depart
pediatr
cincinnati
children
hospit
medic
center
cincinnati
oh
usa
pediatr
rehabilit
depart
pediatr
cincinnati
children
hospit
medic
center
depart
physic
medicin
rehabilit
univers
cincinnati
school
medicin
cincinnati
oh
usa
objectivesspecif
aim
establish
minim
clinic
import
differ
mcid
three
common
cerebr
palsi
cp
outcom
measur
methodsstudi
popul
children
male
age
year
cp
well
parent
medic
profession
provid
concurr
rate
clinic
statu
sever
domain
gross
motor
social
function
qualiti
life
overal
function
gross
motor
function
gmfm
pediatr
evalu
disabl
inventori
pedi
cerebr
palsi
qualiti
life
questionnair
children
administ
baselin
month
compar
outcom
measur
chang
score
chang
statu
rate
use
establish
methodolog
calcul
mcid
describ
relationship
measur
statu
rate
resultsanticip
result
mcid
could
establish
averag
outcom
measur
chang
score
across
five
categori
improvementworsen
show
pattern
relationship
could
establish
degre
chang
respond
clinic
statu
rate
chang
score
gmfm
pedi
discussionsignific
impact
methodolog
use
establish
mcid
studi
effect
gmfm
pedi
cp
find
highlight
difficulti
defin
document
meaning
chang
evalu
intervent
children
cp
pruett
cs
fivush
flynn
bradi
hopkin
univers
baltimor
md
usa
children
hospit
seattl
wa
usa
objectivesspecif
aim
lvh
shown
preval
among
african
american
aa
children
primari
hypertens
htn
compar
children
primari
htn
unclear
whether
differ
preval
lvh
persist
adjust
variou
clinic
characterist
object
studi
determin
impact
race
lvh
children
phtn
methodsstudi
popul
studi
children
age
seen
tertiari
medic
center
initi
evalu
high
bp
ultim
diagnos
phtn
univari
multivari
logist
regress
analys
util
determin
odd
lvh
among
aa
versu
children
phtn
resultsanticip
result
overal
preval
lvh
among
aa
children
among
children
p
univari
logist
regress
reveal
time
increas
odd
lvh
aa
versu
children
phtn
increas
longer
present
adjust
confound
leav
bmi
signific
predictor
ci
lvh
among
children
phtn
discussionsignific
impact
aa
children
phtn
lvh
initi
present
howev
adjust
bmi
confound
aa
children
like
lvh
children
overweightobes
may
play
larger
role
develop
lvh
race
children
phtn
pruitt
sl
mcqueen
deshpand
jeff
schootman
univers
school
medicin
saint
loui
mo
usa
j
siteman
cancer
center
hospit
washington
univers
school
medicin
saint
loui
mo
usa
objectivesspecif
aim
studi
sought
identifi
mediat
effect
neighborhood
poverti
physic
function
use
longitudin
data
missouri
cancer
sampl
femal
survivor
methodsstudi
popul
survivor
recruit
one
year
diagnosi
complet
two
telephon
interview
one
year
later
associ
poverti
physic
function
rand
test
use
multilevel
priori
path
model
hypothes
mediat
demograph
socioeconom
confound
covari
hypothes
mediat
includ
clinic
treatment
variabl
psychosoci
factor
depress
stress
social
support
perceiv
neighborhood
characterist
behavior
risk
factor
leisur
time
physic
activ
smoke
bodi
mass
index
alcohol
use
comorbid
resultsanticip
result
unadjust
analysi
women
live
neighborhood
higher
poverti
like
report
lower
physic
function
p
adjust
model
fit
data
well
p
cfi
rmsea
effect
neighborhood
poverti
physic
function
fulli
mediat
physic
activ
bodi
mass
index
discussionsignific
impact
breast
cancer
survivor
live
neighborhood
greater
poverti
report
lower
physic
function
effect
fulli
explain
physic
activ
bodi
mass
index
health
promot
intervent
aim
improv
survivor
lifestyl
may
help
amelior
neighborhood
socioeconom
dispar
physic
function
ryan
lm
teach
brandoli
singer
wood
freishtat
wright
tosi
chamberlain
nation
medic
center
washington
dc
usa
objectivesspecif
aim
pediatr
forearm
fractur
increas
incid
modifi
factor
includ
overweight
statu
andor
defici
bone
health
low
dietari
calcium
intak
hypovitaminosi
may
contribut
risk
preval
african
american
aa
children
object
determin
associ
forearm
fractur
weight
bone
health
aa
children
methodsstudi
popul
studi
enrol
aa
children
age
year
without
forearm
fractur
bmi
calcium
intak
serum
vitamin
level
bone
miner
densiti
bmd
measur
bivari
multivari
analys
test
associ
weight
bone
health
fractur
statu
resultsanticip
result
enrol
case
control
mean
age
proport
male
differ
compar
case
control
mean
bmi
percentil
case
significantli
higher
control
p
case
control
bmi
percentil
ci
differ
proport
case
control
meet
recommend
daili
dietari
calcium
intak
age
ci
mean
vitamin
level
case
ngml
similar
control
ngml
p
proport
case
control
ci
vitamin
insuffici
mean
total
bodi
case
versu
control
p
statist
differ
discussionsignific
impact
data
support
associ
overweight
statu
risk
childhood
forearm
fractur
find
also
suggest
vitamin
statu
bmd
may
play
role
increas
rate
childhood
forearm
fractur
gaido
j
sultan
dahl
valentin
florida
gainesvil
fl
usa
objectivesspecif
aim
vitamin
vit
import
adapt
immun
inflamm
defici
preval
inflammatori
bowel
diseas
ibd
gener
popul
identifi
risk
factor
vit
defici
ibd
suggest
nutrit
defici
underli
etiolog
howev
major
sourc
vit
sun
exposur
perform
irb
approv
prospect
cohort
studi
determin
preval
vit
defici
ibd
popul
northern
florida
assess
risk
factor
defici
methodsstudi
popul
aug
oct
adult
ibd
patient
seen
uf
ibd
clinic
consent
enrol
defici
defin
vit
level
ngml
insuffici
level
ngml
data
collect
includ
dietari
intak
vit
sun
exposur
histori
colorimet
read
bmi
medic
small
bowel
resect
diseas
activ
crp
serum
patient
suboptim
vit
level
start
supplement
level
obtain
resultsanticip
result
patient
white
male
cd
uc
mean
age
yr
mean
bmi
mean
crp
biolog
steroid
multivitamin
vit
supplement
mean
vit
level
rang
defici
found
insuffici
found
univari
multivari
analysi
perform
enrol
complet
discussionsignific
impact
preliminari
data
preval
suboptim
vit
level
ibd
patient
despit
locat
geograph
region
adequ
durat
sunlight
appropri
uv
length
still
surprisingli
high
preval
defici
futur
studi
determin
effect
adequ
vit
supplement
cours
ibd
peppon
lj
rickl
rosier
morrow
huston
mustian
skinner
rochest
rochest
ny
usa
objectivesspecif
aim
pauciti
research
examin
vitamin
level
prognost
variabl
breast
cancer
patient
aim
studi
identifi
associ
vitamin
level
demograph
variabl
prognost
patholog
characterist
breast
cancer
methodsstudi
popul
studi
cohort
consist
women
underw
breast
cancer
surgeri
univers
rochest
vitamin
level
obtain
shortli
follow
surgeri
prognost
variabl
includ
age
race
menopaus
statu
oncotyp
dx
score
tnm
stage
er
statu
pr
statu
express
ancova
linear
regress
logist
regress
use
determin
associ
prognost
variabl
vitamin
level
resultsanticip
result
p
premenopaus
p
breast
cancer
patient
significantli
like
suboptim
vitamin
level
caucasian
postmenopaus
patient
respect
signific
correl
p
decreas
vitamin
level
increas
oncotyp
score
note
breast
cancer
patient
breast
tumor
like
suboptim
level
vitamin
p
p
women
invas
breast
tumor
lower
mean
vitamin
level
invas
ngml
vs
situ
ngml
p
women
situ
tumor
discussionsignific
impact
breast
cancer
patient
suboptim
vitamin
level
like
tumor
aggress
tumor
profil
wors
prognost
marker
tumor
high
recurr
risk
oncotyp
score
research
need
elucid
biolog
relationship
vitamin
breast
cancer
patel
ss
burn
kochila
iowa
iowa
citi
ia
usa
minnesota
minneapoli
mn
usa
objectivesspecif
aim
develop
signific
left
atrioventricular
valv
lavv
regurgit
occur
patient
follow
atrioventricular
septal
defect
avsd
repair
necessit
addit
surgic
intervent
includ
valv
replac
descript
medic
cours
patient
spars
consist
prognost
factor
lavv
replac
yet
identifi
methodsstudi
popul
experi
pediatr
cardiac
care
consortium
review
identifi
earli
outcom
prognost
factor
lavv
replac
follow
primari
avsd
repair
resultsanticip
result
three
hundr
seventi
patient
previous
repair
avsd
underw
reoper
lavv
includ
underw
lavv
repair
lavv
replac
median
time
first
reoper
follow
primari
repair
year
repair
subgroup
year
replac
subgroup
p
multivari
avsd
repair
predictor
earlier
time
valv
replac
includ
presenc
syndrom
postop
mitral
valv
stenosi
surviv
significantli
poorer
replac
subgroup
compar
repair
subgroup
p
multivari
avsd
repair
predictor
death
follow
valv
replac
includ
presenc
syndrom
hazard
ratio
ci
larger
prosthet
valv
sizeweight
ratio
hazard
ratio
per
mmkg
ci
discussionsignific
impact
earlier
mortal
lavv
replac
patient
previous
repair
avsd
predict
presenc
syndrom
prosthet
valv
sizeweight
ratio
abil
predict
outcom
may
use
choos
valv
repair
replac
strategi
westergaard
r
kirk
richesson
mehta
hopkin
univers
baltimor
md
usa
hopkin
bloomberg
school
public
health
baltimor
md
usa
objectivesspecif
aim
inject
drug
user
idu
frequent
incarcer
period
immedi
follow
incarcer
associ
increas
sexual
activ
increas
frequenc
illicit
drug
use
purpos
studi
describ
pattern
behavior
idu
follow
incarcer
assess
whether
risk
behavior
differ
among
idu
without
success
virolog
suppress
respons
antiretrovir
therapi
methodsstudi
popul
assess
shoot
galleri
attend
among
inject
drug
user
follow
cohort
studi
compar
frequenc
behavior
visit
particp
report
recent
incarcer
incarcer
report
proport
idu
report
risk
behavior
compar
receiv
receiv
effect
antiretrovir
therapi
resultsanticip
result
idu
contribut
studi
visit
dataset
incarcer
report
studi
visit
visit
follow
report
incarcer
particip
like
report
needl
share
vs
shoot
galleri
attend
vs
incarcer
occur
idu
elev
hiv
rna
equal
like
engag
high
risk
behavior
idu
undetect
hiv
rna
discussionsignific
impact
among
idu
hiv
transmiss
risk
behavior
particularli
common
period
follow
incarcer
idu
effect
treat
art
result
infecti
less
like
engag
high
risk
behavior
erdembileg
byambaa
ozturk
zhang
traci
kim
beckett
berglund
davi
davi
ca
usa
istanbul
istanbul
turkey
vermont
colchest
vt
usa
northern
california
health
care
system
sacramento
ca
usa
objectivesspecif
aim
studi
two
set
inflammatori
marker
repres
system
crp
fibrinogen
b
vascular
inflamm
associ
age
gender
methodsstudi
popul
determin
crp
fibrinogen
activ
level
cvd
risk
factor
caucasian
african
american
undergo
coronari
angiographi
resultsanticip
result
trend
pattern
vascular
inflammatori
marker
chang
age
either
gender
although
signific
ethnic
differ
observ
contrast
differ
trend
seen
system
inflammatori
marker
men
women
crp
level
increas
significantli
age
pattern
chang
age
differ
caucasian
african
american
p
suggest
ethnic
differ
specif
less
substanti
chang
crp
level
associ
age
caucasian
men
compar
african
american
men
fibrinogen
level
show
signific
increas
age
genderethn
group
found
signific
contribut
obes
measur
bmi
magnitud
associ
marker
system
inflamm
crp
fibrinogen
age
ethnic
gender
group
howev
trend
pattern
vascular
inflammatori
marker
chang
age
even
adjust
obes
discussionsignific
impact
find
suggest
increas
system
vascular
inflammatori
burden
age
result
unveil
import
assess
pattern
inflammatori
marker
age
gender
promot
phenotyp
across
ethnic
holtzer
mahoney
wang
raghavan
verghes
einstein
colleg
medicin
bronx
ny
usa
school
psycholog
yeshiva
univers
bronx
ny
usa
york
univers
school
medicin
new
york
ny
usa
objectivesspecif
aim
mani
activ
daili
live
involv
simultan
perform
upper
lower
limb
howev
effect
age
subtask
perform
specif
task
priorit
well
studi
investig
effect
age
upper
lower
limb
perform
walk
carri
tray
specif
task
priorit
methodsstudi
popul
sixteen
old
year
young
year
adult
perform
two
singl
task
walk
prefer
pace
hold
tray
stand
two
dual
task
walk
hold
tray
focus
attent
keep
tray
walk
hold
tray
focus
attent
four
gait
paramet
maximum
rang
tray
tilt
measur
resultsanticip
result
wtat
compar
singl
task
age
group
show
signific
chang
upper
lower
limb
perform
old
individu
show
increas
tray
tilt
less
chang
gait
perform
compar
young
individu
wtaw
signific
chang
either
tray
stabil
gait
perform
except
reduc
stride
length
group
wtat
larger
proport
older
group
show
higher
dual
task
cost
chang
compar
singl
task
tray
stabil
lower
cost
gait
compar
young
group
versu
p
discussionsignific
impact
task
priorit
dual
task
differenti
affect
perform
upper
lower
limb
old
young
individu
find
may
ramif
develop
train
strategi
learn
relearn
complex
motor
activ
senior
morcuend
sadler
torner
iowa
iowa
citi
ia
usa
citi
va
medic
center
iowa
citi
ia
usa
objectivesspecif
aim
studi
associ
type
time
traumat
event
diagnosi
ptsdbpd
methodsstudi
popul
studi
midwestern
cohort
va
enrol
women
veteran
particip
n
complet
telephon
interview
assess
demograph
childhood
adult
rape
histori
combat
civilian
trauma
lifetim
diagnos
depress
ptsd
bpd
subject
mental
health
diagnos
exclud
analys
conduct
use
conting
tabl
test
resultsanticip
result
depress
diagnos
particip
ptsd
bpd
bpdptsd
women
ptsdbpd
like
report
rape
two
time
compar
women
depress
ptsd
bpd
p
particip
ptsdbpd
bpd
first
rape
childhood
compar
depress
ptsd
p
women
ptsdbpd
like
report
rape
two
time
period
childhood
adult
civilian
life
militari
life
compar
depress
ptsd
bpd
p
women
bpdptsd
like
report
three
type
trauma
childhood
rape
adult
rape
combat
trauma
civilian
trauma
compar
depress
ptsd
bpd
p
discussionsignific
impact
find
support
previou
research
indic
extens
exposur
lifetim
trauma
women
veteran
women
histori
childhood
rape
exposur
differ
type
trauma
time
elev
risk
diagnosi
ptsdbpd
current
treatment
model
focus
ptsd
ignor
necessari
intervent
bpd
geraghti
em
california
davi
sacramento
ca
usa
objectivesspecif
aim
us
youth
death
rate
higher
mani
peer
nation
teen
birth
put
individu
adolesc
girl
reproduct
health
risk
also
pose
threat
commun
health
state
vital
statist
data
use
better
understand
geographi
youth
death
teen
birth
local
level
research
examin
geograph
pocket
excess
youth
death
teen
birth
california
seek
understand
environment
determin
risk
methodsstudi
popul
geograph
inform
system
use
develop
age
gender
adjust
standard
mortal
rate
smr
among
youth
age
year
zip
code
level
teen
birth
percentag
birth
teen
compar
teen
birth
rate
zip
code
result
map
subject
hot
spot
analysi
find
statist
signific
cluster
excess
youth
death
smr
greater
crude
death
rate
teen
birth
statist
analysi
use
stata
statacorp
colleg
station
tx
perform
avail
variabl
better
understand
factor
associ
youth
death
teen
birth
resultsanticip
result
map
show
distribut
hot
spot
teen
birth
youth
death
california
statist
analysi
show
exist
racial
ethnic
dispar
teen
birth
attain
earli
prenat
care
young
women
young
men
age
highest
risk
prematur
death
particularli
weekend
summer
month
discussionsignific
impact
geograph
statist
analysi
youth
death
teen
birth
help
develop
target
prevent
strategi
vulner
youth
result
work
intend
support
strateg
effort
reduc
youth
dispar
improv
youth
california
kor
dj
warner
alsara
li
gajic
clinic
rochest
mn
usa
objectivesspecif
aim
delay
identif
patient
risk
acut
lung
injuri
ali
may
prevent
implement
ali
prevent
earli
treatment
strategi
object
studi
develop
valid
autom
electron
strategi
identifi
preoper
risk
factor
postop
ali
methodsstudi
popul
follow
irb
approv
electron
medic
record
patient
undergo
surgeri
evalu
two
independ
data
extract
strategi
compar
first
util
manual
chart
review
second
tool
search
deriv
refin
deriv
cohort
patient
subsequ
valid
independ
cohort
patient
agreement
two
strategi
assess
resultsanticip
result
kappa
statist
rang
ci
amiodaron
cirrhosi
ci
agreement
manual
autom
electron
data
extract
almost
perfect
variabl
diabet
mellitu
cirrhosi
antagonist
substanti
chronic
obstruct
pulmonari
diseas
ppi
statin
moder
gastroesophag
reflux
diseas
fair
variabl
restrict
lung
diseas
amiodaron
queri
outperform
manual
data
collect
term
sensit
rang
median
autom
queri
vs
median
manual
data
extract
specif
uniformli
high
strategi
discussionsignific
impact
autom
electron
free
text
queri
build
iter
process
ultim
result
accur
highli
effici
data
extract
strategi
may
use
determin
risk
condit
postop
ali
j
pyle
miller
patel
loeffelholz
casola
garofalo
chonmaitre
texa
medic
branch
galveston
tx
usa
objectivesspecif
aim
compar
rate
aom
complic
uri
caus
hmpv
respiratori
virus
determin
hmpv
viral
load
associ
aom
complic
methodsstudi
popul
nasopharyng
aspir
npa
collect
within
uri
onset
part
prospect
studi
healthi
children
yr
follow
occurr
aom
viral
studi
perform
cultur
respiratori
syncyti
viru
rsv
eia
microarray
pcr
rsv
parainfluenza
influenza
b
coronaviru
archiv
npa
use
hmpv
quantit
pcr
resultsanticip
result
archiv
npa
episod
uri
episod
children
evalu
median
age
mo
mo
uri
episod
posit
hmpv
hmpv
sole
viru
altogeth
uri
episod
complic
aom
uri
episod
hmpv
singl
viru
complic
aom
rate
uri
complic
aom
virus
highest
rsv
follow
rhinovirus
respect
children
aom
complic
uri
hmpv
viral
load
lower
median
copiesml
without
aom
differ
signific
p
hmpv
viral
load
significantli
higher
median
children
fever
compar
without
p
discussionsignific
impact
hmpv
detect
uri
episod
viru
rate
aom
complic
uri
viral
load
associ
presenc
fever
aom
develop
arguel
lm
liu
van
horn
ariza
wang
liu
hong
langman
wang
pediatr
northwestern
univers
feinberg
school
medicin
chicago
il
usa
mari
ann
j
milburn
smith
child
health
research
program
children
memori
hospit
chicago
il
usa
prevent
medicin
northwestern
univers
feinberg
school
medicin
chicago
il
usa
kidney
diseas
northwestern
univers
feinberg
school
medicin
chicago
il
usa
biomedicin
anhui
medic
univers
hefei
china
objectivesspecif
aim
examin
relationship
oh
level
fast
glucos
fast
insulin
insulin
resist
ir
rural
chines
adolesc
monozygot
mz
dizygot
dz
twin
use
control
analysi
methodsstudi
popul
report
includ
adolesc
twin
anq
region
china
age
year
adipos
measur
includ
bodi
mass
index
bmi
total
bodi
fat
bf
percent
bodi
fat
bf
measur
absorptiometri
dexa
resultsanticip
result
linear
model
associ
show
signific
invers
associ
log
oh
log
fast
insulin
log
fast
mz
twin
se
p
se
p
respect
associ
found
dz
twin
discussionsignific
impact
control
analysi
demonstr
invers
relationship
vitamin
fast
insulin
ir
mz
twin
dz
twin
indic
import
take
consider
individu
genet
variat
cortes
godbold
cunningham
gabrilov
sinai
school
medicin
new
york
ny
usa
objectivesspecif
aim
primari
object
determin
safeti
toler
lamivudin
vorinostat
adult
leukemialymphoma
atll
secondari
object
determin
overal
diseas
free
overal
surviv
assess
symptom
burden
measur
mdasi
measur
chang
histon
acetyl
cell
cycl
induct
apoptosi
evalu
chang
dna
rna
assess
chang
cytotox
effector
frequenc
determin
chang
level
plasma
vascular
endotheli
cell
basic
fibroblast
growth
factor
methodsstudi
popul
patient
initi
treatment
lamivudin
mg
bid
prior
receiv
chemotherapi
patient
receiv
two
cycl
chemotherapi
chop
eshap
ice
respons
follow
complet
two
cycl
chemotherapi
lamivudin
evalu
patient
achiev
respons
stabl
diseas
better
assign
success
cohort
lamivudin
alon
combin
vorinostat
mg
mg
mg
po
qd
x
day
follow
day
rest
dose
escal
util
success
cohort
conduct
determin
maximum
toler
biolog
activ
dose
vorinostat
maximum
patient
recruit
resultsanticip
result
context
studi
expect
lamivudin
mg
bid
combin
vorinostat
safe
toler
atll
patient
addit
anticip
improv
surviv
decreas
symptom
burden
regimen
discussionsignific
impact
patient
diagnos
atll
limit
therapeut
option
outcom
univers
fatal
regimen
util
initi
reduc
tumor
burden
howev
initi
reduct
usual
extrem
short
live
rapid
recurr
diseas
clinic
research
need
improv
patient
surviv
rl
butler
quarshi
ofili
school
medicin
atlanta
ga
usa
school
medicin
atlanta
ga
usa
objectivesspecif
aim
determin
sensit
specif
chang
cystatin
c
potenti
diagnost
marker
worsen
renal
function
wrf
patient
acut
heart
failur
ahf
determin
predict
valu
cystatin
c
short
term
outcom
length
hospit
readmiss
hospit
methodsstudi
popul
ancillari
studi
diuret
optim
strategi
evalu
dose
studi
multicent
random
control
trial
patient
admit
ahf
diures
moder
high
dose
loop
diuret
follow
day
explor
develop
wrf
use
serum
creatinin
cystatin
c
level
perform
cystatin
c
marker
wrf
evalu
receiv
oper
characterist
curv
analysi
determin
best
cutoff
associ
chang
cystatin
c
length
hospit
readmiss
determin
resultsanticip
result
mean
age
dose
cohort
year
women
african
american
patient
develop
wrf
use
definit
increas
creatinin
mgdl
median
length
stay
index
hospit
day
patient
experienc
death
rehospit
emerg
room
visit
within
day
discussionsignific
impact
cystatin
c
emerg
novel
marker
renal
function
independ
age
gender
diet
lean
muscl
mass
lead
suggest
may
prefer
creatinin
endogen
serum
marker
assess
renal
function
anticip
result
studi
contribut
scientif
literatur
optim
serum
biomark
earli
detect
clinic
signific
wrf
stangl
b
vatsalya
cook
zametkin
ramchandani
bethesda
md
usa
objectivesspecif
aim
object
studi
examin
influenc
subject
measur
alcohol
effect
person
measur
intraven
iv
alcohol
social
drinker
methodsstudi
popul
healthi
social
drinker
n
underw
two
session
consist
prime
phase
subject
prompt
push
button
receiv
individu
standard
alcohol
infus
follow
phase
ad
lib
access
alcohol
infus
measur
includ
number
button
press
nbp
peak
peak
averag
avg
breath
alcohol
concentr
brac
time
peak
brac
tp
subject
measur
includ
drug
effect
questionnair
deq
alcohol
urg
questionnair
auq
alcohol
effect
questionnair
aefq
person
measur
includ
impuls
behavior
scale
barratt
impuls
scale
bi
sensit
punish
sensit
reward
questionnair
spsrq
resultsanticip
result
result
indic
signific
posit
correl
motor
attent
impuls
measur
avg
peak
sensit
reward
posit
correl
avg
peak
nbp
aefq
measur
also
posit
correl
tp
nbp
correl
measur
deq
measur
drug
like
drug
want
auq
total
score
follow
prime
significantli
associ
avg
nbp
peak
discussionsignific
impact
iv
alcohol
measur
significantli
associ
measur
impuls
reward
sensit
well
measur
drug
like
urg
prime
result
support
relationship
impuls
prime
effect
alcohol
alcohol
intak
behavior
cengiz
e
tamborlan
weinzim
school
medicin
new
ct
usa
objectivesspecif
aim
acceler
rate
insulin
absorpt
action
may
improv
perform
system
reli
subcutan
insulin
pump
studi
undertaken
investig
effect
novel
insulin
infus
site
warm
devic
insupatch
insulin
action
methodsstudi
popul
glucos
clamp
techniqu
use
examin
effect
insupatch
pharmacodynam
ukg
bolu
aspart
insulin
subject
studi
perform
separ
morn
without
activ
insupatch
devic
day
basal
infus
suspend
glucos
level
maintain
mgdl
variabl
rate
dextros
infus
hour
bolu
date
subject
yr
femal
complet
clamp
resultsanticip
result
hypothes
time
peak
insulin
action
tmaxgir
time
earli
half
maxim
activ
tearli
occur
much
earlier
insupatch
without
insupatch
tmaxgir
min
min
p
tearli
min
vs
min
p
area
time
action
profil
first
nineti
minut
clamp
aucgir
significantli
greater
insupatch
without
insupatch
vs
p
wherea
bioavail
vs
p
differ
without
infus
site
warm
discussionsignific
impact
preliminari
data
suggest
warm
infus
site
effect
mean
acceler
time
peak
action
insulin
analog
patient
improv
time
action
respons
may
provid
mean
obtain
better
control
postmeal
glucos
excurs
open
insulin
deliveri
je
torr
romaguera
san
juan
usa
objectivesspecif
aim
mani
inflammatori
bowel
diseas
patient
receiv
immunosuppress
agent
diseas
well
document
patient
receiv
immunosuppressor
increas
risk
malign
includ
cervic
cancer
goal
studi
establish
safeti
efficaci
hpv
quadrival
vaccin
prevent
cervic
neoplasia
ibd
patient
specif
aim
studi
determin
seroconvers
serotyp
vaccin
quadrival
hpv
vaccin
puerto
rican
ibd
patient
use
immunosuppress
agent
also
want
determin
preval
abnorm
cervic
histolog
puerto
rican
ibd
patient
methodsstudi
popul
quadrival
hpv
vaccin
administ
particip
cytolog
neg
seroneg
elisa
pcr
least
one
hpv
serotyp
day
studi
entri
vaccin
month
collect
serum
studi
particip
month
assess
antibodi
titer
inclus
criteria
studi
particip
diagnosi
ibd
age
year
previou
diagnosi
malign
immunolog
relat
condit
subject
recruit
univers
puerto
rico
center
ibd
clinic
resultsanticip
result
hypothesi
patient
ibd
immunosuppresor
therapi
develop
seroconvers
hpv
vaccin
similar
way
healthi
control
discussionsignific
impact
develop
adequ
immunorespons
immun
hpv
qaudrival
vaccin
patient
ibd
unknown
research
puerto
rican
immunosupress
popul
warrant
establish
effect
hpv
vaccin
develop
guidelin
screen
eack
sm
hogarti
cho
prasad
greenwald
hogarti
keshavan
pittsburgh
pittsburgh
pa
usa
medic
school
boston
usa
objectivesspecif
aim
examin
effect
cognit
enhanc
therapi
cet
comprehens
cognit
rehabilit
program
gray
matter
chang
patient
earli
cours
schizophrenia
methodsstudi
popul
outpati
earli
cours
schizophrenia
schizoaffect
disord
randomli
assign
treat
trial
cet
n
activ
enrich
support
therapi
est
control
n
assess
annual
use
structur
mri
comprehens
cognit
batteri
cet
integr
approach
remedi
social
nonsoci
cognit
deficit
schizophrenia
util
cognit
train
secondari
social
techniqu
est
focus
ill
manag
stress
reduct
individu
psychotherapeut
approach
resultsanticip
result
morphometri
analys
gray
matter
chang
indic
signific
differenti
pattern
densiti
chang
treatment
group
left
hemispher
network
cluster
includ
amygdala
fusiform
parahippocamp
gyru
subsequ
volumetr
analys
reveal
individu
receiv
est
show
loss
gray
matter
volum
network
two
year
studi
patient
receiv
cet
exhibit
preserv
time
signific
increas
gray
matter
volum
region
mediat
analys
indic
cet
effect
social
cognit
partial
mediat
protect
gray
matter
loss
network
discussionsignific
impact
cet
effect
approach
remedi
social
nonsoci
cognit
deficit
schizophrenia
may
achiev
efficaci
act
social
cognit
brain
network
geisberg
ca
dickey
silverstein
smith
sawyer
nashvil
tn
usa
california
lo
angl
lo
angl
ca
usa
objectivesspecif
aim
women
treat
breast
cancer
anthracyclin
ac
risk
develop
heart
failur
cardiotox
monitor
eject
fraction
ef
insensit
marker
earli
cardiac
dysfunct
current
biomark
exist
predict
earli
cardiotox
neuregulin
nrg
essenti
cardiac
growth
factor
activ
physiolog
stress
exercis
signal
erbb
receptor
nrg
critic
maintain
cardiac
function
detect
serum
therefor
hypothes
women
treat
ac
would
exhibit
chang
nrg
chang
would
detect
earli
cardiac
dysfunct
methodsstudi
popul
prospect
studi
enrol
breast
cancer
women
receiv
ac
prior
follow
ac
treatment
particip
complet
exercis
questionnair
echocardiogram
gave
serum
sampl
subclin
cardiac
dysfunct
defin
decreas
ef
baselin
develop
diastol
dysfunct
resultsanticip
result
women
treat
ac
patient
experienc
subclin
cardiac
dysfunct
develop
subclin
cardiac
dysfunct
statist
signific
chang
baselin
nrg
level
mean
ngml
ngml
p
versu
women
chang
ef
mean
ngml
ngml
p
respect
although
statist
signific
women
subclin
cardiac
dysfunct
also
lower
report
baselin
physic
exercis
vs
methrswk
respect
discussionsignific
impact
conclus
nrg
level
drop
ac
treatment
drop
may
prognost
potenti
detect
earli
cardiac
dysfunct
futur
studi
may
investig
effect
activ
intervent
prior
ac
treatment
determin
physic
exercis
prevent
declin
nrg
level
ac
tasneem
ananth
bolt
chakraborti
chiswel
mccourt
zarin
califf
durham
nc
usa
durham
nc
usa
nih
bethesda
md
usa
objectivesspecif
aim
develop
relat
databas
purpos
analyz
aggreg
data
clinicaltrialsgov
methodolog
regroup
clinic
trial
clinic
specialti
use
mesh
thesauru
methodsstudi
popul
relat
databas
develop
analyz
entir
studi
dataset
download
sep
clinicaltrialsgov
xml
file
studi
regroup
clinic
specialti
use
mesh
thesauru
develop
methodolog
creat
valid
implement
subset
mesh
thesauru
use
specialti
group
mesh
descriptor
within
subset
review
annot
domain
expert
within
clinic
disciplin
duke
univers
resultsanticip
result
databas
studi
clinicaltrialsgov
readi
analys
annot
mesh
descriptor
domain
expert
near
complet
use
creat
studi
dataset
correspond
specialti
group
data
qualiti
review
inform
prepar
extract
analysi
dataset
discussionsignific
impact
data
accumul
clinicaltrialsgov
abil
aggreg
descript
character
overal
portfolio
clinic
research
enterpris
increasingli
desir
analys
content
databas
develop
relat
dataset
critic
purpos
studi
data
analysi
within
specialti
group
well
compar
analys
group
desir
subset
studi
clinic
specialti
use
method
meet
need
may
applic
purpos
conclud
discuss
opportun
challeng
analyz
clinicaltrialsgov
databas
fund
fda
sponsor
clinic
trial
transform
initi
stroustrup
holzman
newborn
medicin
depart
pediatr
depart
prevent
medicin
new
york
ny
usa
newborn
medicin
depart
pediatr
new
york
ny
usa
sinai
school
medicin
new
york
ny
usa
objectivesspecif
aim
determin
whether
fluid
restrict
speed
resolut
respiratori
distress
neonat
transient
tachypnea
newborn
ttn
methodsstudi
popul
late
preterm
neonat
diagnos
ttn
random
either
standard
fluid
manag
restrict
fluid
manag
neonat
restrict
fluid
group
receiv
mlkgday
total
fluid
less
daili
neonat
standard
fluid
group
first
day
life
primari
studi
outcom
durat
respiratori
support
secondari
outcom
length
time
first
enter
feed
time
discharg
nicu
resultsanticip
result
patient
complet
studi
protocol
advers
event
due
fluid
restrict
occur
surviv
analysi
demonstr
differ
durat
respiratori
support
two
group
whole
p
subpopul
patient
requir
respiratori
support
hour
signific
reduct
durat
respiratori
support
among
fluid
restrict
patient
p
discussionsignific
impact
transient
tachypnea
newborn
respiratori
distress
syndrom
caus
delay
pulmonari
salt
channel
switch
fluid
clearanc
although
ttn
common
diagnosi
littl
data
underli
fluid
manag
diseas
studi
mild
fluid
restrict
safe
otherwis
healthi
term
late
preterm
neonat
ttn
fluid
restrict
reduc
durat
respiratori
distress
neonat
sever
ttn
first
studi
demonstr
benefit
treatment
ttn
beyond
support
care
recommend
mild
fluid
restrict
patient
ttn
requir
respiratori
support
finnerti
cc
ju
spratt
victor
jeschk
hegd
bhavnani
luxon
brasier
herndon
surgeri
utmbshc
galveston
tx
usa
translat
sciencesseali
center
molecular
medicin
utmb
galveston
tx
usa
utmb
galveston
tx
usa
objectivesspecif
aim
reliabl
predict
mortal
sever
burn
patient
remain
elus
investig
effect
combin
proteom
variabl
clinic
covari
inhal
injuri
burn
size
age
earli
identif
burn
patient
die
methodsstudi
popul
children
total
burn
surfac
area
tbsa
exceed
admit
consent
experiment
protocol
serum
hormon
acut
phase
protein
cytokin
measur
time
admiss
mathemat
model
use
determin
associ
analyt
patient
outcom
resultsanticip
result
princip
compon
analysi
demonstr
serum
protein
abund
clinic
covari
provid
independ
inform
regard
patient
surviv
analys
use
gener
addit
model
demonstr
relationship
analyt
mortal
linear
perform
nonlinear
model
use
multivari
adapt
regress
spline
mar
combin
serum
analyt
clinic
assess
model
increas
overal
outcom
predict
accuraci
increas
area
receiv
oper
characterist
curv
discussionsignific
impact
result
show
accuraci
mar
classifi
substanti
improv
combin
protein
abund
inform
clinic
covari
robb
sl
haas
univers
indianapoli
usa
objectivesspecif
aim
investig
seek
enhanc
posit
health
model
guid
select
target
variabl
purpos
present
describ
link
two
theoret
model
address
psychosoci
adjust
adolescentsyoung
adult
aya
undergo
stem
cell
transplant
methodsstudi
popul
compon
haas
resili
ill
model
rim
also
call
adolesc
resili
model
includ
protect
factor
deriv
mean
hope
spiritu
perspect
perceiv
social
support
friend
health
care
provid
famili
environ
commun
adapt
cohes
posit
cope
confront
optimist
support
risk
factor
distress
defens
cope
rim
compon
target
therapeut
music
video
tmv
intervent
base
robb
contextu
support
model
music
therapi
robb
theori
hypothes
effect
music
therapi
intervent
contain
element
structur
autonomi
support
support
relationship
resultsanticip
result
contextu
support
element
tmv
intervent
influenc
rim
outcom
resili
via
multipl
path
exampl
focu
develop
music
video
support
aya
transit
defens
posit
cope
offer
mean
commun
traumat
event
unspoken
thought
emot
experienc
diagnosistreat
encourag
famili
provid
support
turn
foster
resili
outcom
masteryconfid
discussionsignific
impact
theoret
synergi
describ
present
use
test
tmv
multisit
random
clinic
trial
provid
model
synergist
use
theori
inform
intervent
studi
design
jm
st
john
child
pavlet
wu
cozzarelli
schroeder
gordon
nih
bethesda
md
usa
nih
bethesda
md
usa
nih
bethesda
md
usa
nih
bethesda
md
usa
maryland
dental
school
baltimor
md
usa
objectivesspecif
aim
oral
cgvhd
affect
patient
cgvhd
optim
therapi
exist
parallel
group
random
pilot
studi
test
topic
thalidomid
gel
mg
ind
versu
placebo
plain
product
oral
ulcer
cgvhd
methodsstudi
popul
protocol
approv
irb
written
inform
consent
obtain
patient
year
age
oral
biopsi
confirm
cgvhd
elig
exclus
criteria
includ
contraind
thalidomid
use
inabl
stop
topic
treatment
oral
cgvhd
primari
efficaci
end
point
least
decreas
ulcer
total
baselin
week
investig
gel
use
timesday
week
oral
ulcer
resultsanticip
result
thalidomid
group
n
target
ulcer
mean
oral
ulcer
reduct
vs
placebo
group
n
target
ulcer
four
ulcer
resolv
thalidomid
group
versu
placebo
group
seriou
advers
event
advers
event
possibl
relat
thalidomid
moder
mild
mild
placebo
variabl
baselin
pain
score
mean
rang
mild
moder
thalidomid
group
oral
pain
week
sensori
affect
pain
increas
week
stay
baselin
placebo
group
decreas
pain
score
week
except
sensori
pain
swallow
discussionsignific
impact
preliminari
data
suggest
topic
thalidomid
may
singl
agent
activ
oral
cgvhd
test
topic
thalidomid
oral
cgvhd
warrant
newlin
k
arbauh
sewer
burgess
new
york
ny
usa
objectivesspecif
aim
test
lifestyl
intervent
set
combin
diabet
prevent
educ
strategi
explicit
incorpor
participatori
research
examin
effect
intens
lifestyl
intervent
physiolog
bodi
mass
index
bmi
psychosoci
qualiti
life
qol
depress
diabet
risk
percept
outcom
black
women
prediabet
examin
effect
intens
lifestyl
intervent
physiolog
bmi
psychosoci
qol
depress
outcom
black
women
type
diabet
methodsstudi
popul
studi
design
design
sampl
conveni
sampl
ongo
inclus
criteria
includ
follow
black
american
femal
gender
year
age
prediabet
diabet
usual
primari
care
sourc
exclus
criteria
includ
pregnanc
lactat
seriou
mental
ill
comorbid
eg
cancer
may
preclud
complet
studi
measur
physiolog
bmi
psychosoci
center
epidemiolog
studi
depress
scale
medic
outcom
survey
mo
risk
percept
survey
develop
diabet
measur
collect
analyt
strategi
univari
statist
describ
sampl
pair
evalu
distal
proxim
chang
outcom
measur
resultsanticip
result
intervent
ongo
preliminari
result
anticip
report
april
acrtsct
joint
annual
meet
discussionsignific
impact
find
contribut
scienc
translat
diabet
prevent
educ
strategi
commun
set
effect
address
diabet
epidem
burden
black
american
navaneethan
sd
feali
schauer
sehgal
kirwan
clinic
cleveland
oh
usa
clinic
pathobiolog
cleveland
oh
usa
clinic
bariatr
metabol
institut
cleveland
oh
usa
medic
center
case
western
reserv
univers
cleveland
oh
usa
objectivesspecif
aim
obes
independ
risk
factor
develop
cardiovascular
diseas
chronic
kidney
diseas
ckd
propos
ascertain
effect
lifestyl
modif
bariatr
surgeri
renal
outcom
among
obes
ckd
patient
methodsstudi
popul
prospect
cohort
studi
data
collect
postintervent
month
examin
impact
weight
loss
attain
lifestyl
modif
week
hypocalor
diet
supervis
exercis
bariatr
surgeri
adipokin
includ
plasma
adiponectin
leptin
marker
inflamm
insulin
resist
urinari
protein
excret
glomerular
filtrat
rate
gfr
obes
bodi
mass
index
ckd
patient
gfr
resultsanticip
result
weight
loss
attain
either
intervent
result
lower
urinari
protein
excret
stabil
renal
function
among
obes
ckd
patient
intent
weight
loss
result
amelior
endotheli
dysfunct
inflamm
insulin
resist
increas
hmw
adiponectin
level
mediat
renal
outcom
discussionsignific
impact
weight
loss
ckd
patient
result
stabil
gfr
increas
plasma
adiponectin
level
studi
present
opportun
studi
analyz
sustain
renal
benefit
retard
progress
renal
diseas
b
studi
mechan
increas
plasma
adiponectin
level
urinari
protein
excret
c
clinic
trial
compar
efficaci
benefit
differ
weight
loss
intervent
ckd
patient
heitman
e
lane
univers
medic
center
nashvil
tn
usa
objectivesspecif
aim
promot
practic
understand
asa
standard
ethic
core
concept
research
integr
rcr
enhanc
profession
identifi
solidar
among
vumc
biostatistician
leverag
biostatistician
role
victr
studi
increas
ethic
qualiti
studi
design
data
manag
promot
research
ethic
consult
complex
issu
widen
scope
victr
educ
offer
research
ethic
rcr
methodsstudi
popul
member
vanderbilt
center
biomed
ethic
societi
offer
regular
case
confer
ethic
biostatist
part
educ
program
vanderbilt
institut
clincal
translat
research
victr
particip
includ
faculti
staff
traine
biostatist
across
victr
use
american
statist
associ
asa
ethic
guidelin
statist
practic
framework
confer
examin
current
ethic
challeng
aris
research
resultsanticip
result
asa
guidelin
parallel
ori
core
area
rcr
provid
good
gound
requir
rcr
instruct
case
studi
develop
jointli
biostatist
faculti
real
deidentifi
event
allow
particip
develop
practic
skill
ethic
analysi
decis
make
research
discussionsignific
impact
emphasi
link
statist
method
statistician
profession
integr
research
place
biostatistician
leadership
role
ethic
victr
research
capac
build
among
biostatistician
improv
awar
ethic
issu
increas
appropri
use
research
ethic
consult
servic
address
complex
unusu
issu
farroni
js
carter
texa
medic
branch
galveston
galveston
tx
usa
objectivesspecif
aim
goal
promot
cultur
shift
within
institut
translat
scienc
univers
texa
medic
branch
galveston
utmb
toward
make
research
integr
fundament
element
activ
translat
research
enterpris
object
studi
develop
tool
process
infrastructur
research
ethic
consult
servic
evalu
qualiti
outcom
methodsstudi
popul
tool
develop
provid
greater
consist
captur
research
ethic
servic
stakehold
feedback
sever
work
group
conven
harmon
research
ethic
consult
form
pilot
retrospect
analysi
conduct
assess
tool
prospect
studi
conduct
measur
substant
element
research
ethic
consult
feedback
evalu
servic
outcom
resultsanticip
result
expect
determin
need
institut
stakehold
develop
robust
mechan
evalu
ass
qualiti
research
ethic
consult
servic
implement
procedur
document
tool
increas
effici
satisfact
consult
servic
discussionsignific
impact
uniqu
environ
along
expertis
ethic
support
personnel
enabl
us
make
signific
contribut
toward
measur
intrins
valu
translat
research
ethic
project
promot
continu
excel
translat
research
improv
ethic
educ
develop
ethic
polici
best
practic
foster
continu
collabor
translat
research
brother
kb
wright
clayton
univers
medic
center
nashvil
tn
usa
objectivesspecif
aim
identifi
barrier
clinic
implement
pharmacogenom
clarifi
patient
perspect
especi
concern
multiplex
clinic
pharmacogenom
test
explor
patient
want
notifi
clinic
pharmacogenom
test
avail
patient
prefer
give
consent
test
methodsstudi
popul
conduct
five
focu
group
session
particip
particip
ask
respond
case
stori
patient
underw
prospect
multiplex
genet
test
pharmacogenom
purpos
particip
ask
identifi
posit
neg
aspect
test
inform
consent
procedur
would
prefer
undergo
test
transcrib
discuss
code
two
investig
third
investig
negoti
discrep
code
resultsanticip
result
particip
gener
support
pharmacogenom
test
way
avoid
advers
drug
reaction
prescrib
tool
prepared
event
health
crisi
wari
possibl
test
might
gener
diseas
suscept
result
concern
privaci
inform
gener
test
discussionsignific
impact
uptak
accept
pharmacogenom
test
patient
depend
qualiti
convers
patient
abl
physician
prior
test
sinc
patient
comfort
much
higher
target
pharmacogenom
test
compar
diseas
suscept
test
polici
tool
capabl
ensur
target
scope
help
eas
translat
effort
research
assist
design
storag
data
access
polici
appropri
clinic
pharmacogenom
test
result
lane
kb
heitman
univers
med
school
nashvil
tn
usa
biomed
ethic
societi
nashvil
tn
usa
objectivesspecif
aim
provid
streamlin
method
allow
research
ethic
input
prior
initi
clinic
studi
without
ad
layer
review
methodsstudi
popul
vanderbilt
institut
clinic
translat
research
victr
administ
vanderbilt
ctsa
award
provid
opportun
design
implement
human
translat
research
propos
go
review
assur
appropri
use
grant
institut
support
request
process
includ
biostatist
human
subject
protect
facil
review
design
identifi
possibl
enhanc
endeavor
start
scientif
review
committe
src
compos
faculti
divers
research
experi
review
propos
use
nih
score
system
rate
merit
propos
administr
review
focus
complianc
regulatori
requir
human
research
victr
src
also
allow
ethic
review
issu
beyond
human
subject
protect
biostatist
review
address
util
power
guard
enrol
subject
trial
unlik
provid
measur
effect
src
includ
member
center
biomed
ethic
societi
whose
particip
provid
earli
input
ethic
expertis
without
addit
step
ethic
consult
might
requir
resultsanticip
result
src
provid
ethic
review
yr
period
way
issu
address
includ
anticip
incident
find
unintend
consequ
appropri
studi
personnel
studi
design
collabor
data
manag
discussionsignific
impact
method
allow
earli
feedback
provid
abil
recogn
detail
ethic
discuss
consult
may
warrant
stamataki
ka
leatherdal
marx
yan
colditz
brownson
univers
st
loui
school
medicin
st
loui
mo
usa
univers
st
loui
brown
school
social
work
st
loui
mo
usa
care
ontario
toronto
canada
objectivesspecif
aim
system
local
health
depart
lhd
us
potenti
advanc
local
orient
public
health
respons
obes
control
reduc
geograph
dispar
howev
extent
obes
prevent
program
correspond
local
obes
level
unknown
studi
assess
extent
lhd
across
us
respond
local
level
obes
examin
associ
jurisdict
level
obes
preval
exist
obes
prevent
program
methodsstudi
popul
data
lhd
organiz
characterist
profil
studi
local
health
depart
estim
obes
behavior
risk
factor
surveil
system
analyz
n
sinc
local
public
health
system
nest
within
state
infrastructur
multilevel
model
use
examin
relationship
obes
preval
lhd
obes
prevent
program
assess
impact
cluster
resultsanticip
result
associ
area
obes
preval
lhd
activ
substanti
portion
varianc
lhd
activ
explain
cluster
discussionsignific
impact
paper
identifi
gap
local
public
health
respons
obes
epidem
result
underscor
import
take
account
multipl
level
infrastructur
examin
predictor
lhd
perform
design
intervent
strategi
improv
implement
practic
local
set
snyder
pater
lennox
hudmon
doebbel
smith
univers
colleg
pharmaci
indianapoli
usa
clinic
translat
scienc
institut
indianapoli
usa
pittsburgh
school
pharmaci
pittsburgh
pa
usa
global
partner
bloomington
il
usa
univers
school
medicin
indianapoli
usa
institut
inc
indianapoli
usa
objectivesspecif
aim
develop
brief
questionnair
identifi
patient
experienc
problem
determin
whether
incorpor
questionnair
commun
pharmaci
practic
affect
incid
type
advers
drug
event
report
patient
six
month
character
treatment
plan
creat
pharmacist
patient
respons
risk
inform
methodsstudi
popul
item
compris
origin
drug
therapi
concern
dtc
scale
item
pool
administ
patient
use
clinic
judgment
factor
analysi
reduc
item
pool
psychometr
test
addit
patient
patient
complet
abbrevi
dtc
meet
pharmacist
determin
presenc
problem
characterist
curv
aid
identifi
score
use
problem
predictor
addit
patient
random
either
complet
abbrevi
dtc
discuss
result
pharmacist
usual
care
group
follow
month
resultsanticip
result
particip
median
age
year
rang
femal
caucasian
least
high
school
educ
report
take
median
medic
rang
next
step
final
abbrevi
dtc
estim
agreement
problem
identif
among
studi
pharmacist
n
prior
initi
prospect
data
collect
discussionsignific
impact
na
parikh
k
hyun
hoffner
rassbach
debiasi
nation
medic
center
washington
dc
md
usa
objectivesspecif
aim
clinic
pathway
develop
cnmc
standard
care
osteomyel
evalu
aho
pathway
implement
prepathway
postpathway
comparison
specif
focus
percentag
blood
cultur
obtain
mri
use
time
mri
compar
clinic
outcom
specif
length
stay
rate
pathogen
identif
pre
postpathway
group
methodsstudi
popul
retrospect
cohort
studi
review
patient
chart
princip
discharg
diagnosi
osteomyel
januari
march
postpathway
april
octob
period
origin
medic
record
review
resultsanticip
result
chart
review
patient
prepathway
group
patient
postpathway
group
demograph
factor
two
cohort
similar
includ
age
yr
vs
yr
sex
male
vs
male
well
sever
level
vs
sinc
pathway
initi
patient
receiv
blood
cultur
compar
prepathway
patient
mri
studi
diagnosi
compar
prepathway
clinic
signific
decreas
time
mri
note
hour
prepathway
hour
postpathway
howev
mean
length
stay
day
cohort
pathogen
identif
prepathway
group
postpathway
group
discussionsignific
impact
implement
aho
pathway
cnmc
success
notabl
increas
blood
cultur
rate
increas
mri
use
diagnosi
decreas
time
admiss
mri
howev
clinic
outcom
like
lo
pathogen
identif
improv
investig
need
determin
clinic
outcom
improv
stefan
ms
rothberg
priya
pekow
lindenau
medic
center
springfield
usa
univers
school
medicin
boston
usa
massachusett
school
public
health
amherst
usa
objectivesspecif
aim
background
bb
benefici
patient
ischem
heart
diseas
ihd
heart
failur
hf
howev
limit
evid
benefit
risk
continu
bb
therapi
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
among
patient
object
compar
outcom
patient
hospit
aecopd
coexist
ihd
andor
hf
treat
inhal
agonist
combin
cardioselect
csbb
treat
alon
methodsstudi
popul
retrospect
cohort
studi
hospit
patient
hospit
aecopd
coexist
ihd
hf
multivari
logist
regress
propens
score
adjust
match
use
treatment
csbb
first
hospit
day
outcom
inpati
mortal
mechan
ventil
start
day
readmiss
aecopd
hf
ihd
within
day
resultsanticip
result
preliminari
result
patient
meet
inclus
criteria
treat
csbb
first
hospit
day
includ
patient
ihd
patient
hf
compar
untreat
patient
receiv
bb
older
median
age
vs
lower
inpati
mortal
vs
p
lower
aecopd
readmiss
vs
p
discussionsignific
impact
among
patient
hospit
aecopd
coexist
hf
ihd
csbb
associ
decreas
risk
death
current
focu
develop
multivari
model
associ
bb
use
outcom
smith
c
wisniveski
sinai
school
medicin
new
york
ny
usa
objectivesspecif
aim
outcom
patient
lung
cancer
remain
poor
particularli
among
individu
ethnic
racial
minor
potenti
sourc
dispar
suggest
includ
patient
system
factor
studi
survey
physician
determin
belief
regard
treatment
prefer
minor
nonminor
patient
lung
cancer
methodsstudi
popul
provid
questionnair
physician
care
lung
cancer
patient
medic
center
new
york
citi
questionnair
ask
physician
view
respect
belief
prefer
minor
nonminor
lung
cancer
patient
resultsanticip
result
elig
physician
return
survey
respons
provid
like
think
minor
patient
higher
view
fatal
lung
cancer
meant
diagnos
lung
cancer
late
anyth
everyth
part
god
plan
p
comparison
although
provid
feel
gener
comfort
discuss
belief
report
less
like
minor
patient
p
compar
white
patient
provid
believ
hispan
black
patient
less
like
accept
surgeri
well
cancer
treatment
chemotherapi
radiat
therapi
similarli
provid
consid
minor
like
want
involv
famili
prognosi
discuss
treatment
decis
final
provid
report
minor
less
recept
dnr
direct
palli
care
referr
discussionsignific
impact
signific
differ
among
provid
regard
minor
prefer
belief
lung
cancer
care
understand
influenc
rel
import
factor
import
step
toward
develop
intervent
improv
outcom
minor
patient
lung
cancer
kuo
robbin
burn
casey
arkansa
medic
scienc
littl
rock
ar
usa
objectivesspecif
aim
object
studi
examin
physician
characterist
associ
recommend
care
practic
cshcn
willing
care
cshcn
methodsstudi
popul
statewid
survey
pcp
arkansa
pcp
medicaid
caseload
children
mail
paper
survey
four
time
month
survey
content
inform
prior
literatur
defin
recommend
practic
cshcn
predictor
variabl
includ
physician
specialti
field
demograph
practic
type
patient
public
insur
descript
multivari
regress
analys
describ
characterist
pcp
associ
recommend
care
practic
willing
care
cshcn
resultsanticip
result
mail
survey
return
half
practic
group
set
practic
person
practic
pediatrician
like
see
cshcn
practic
person
practic
associ
written
care
plan
aor
ci
provid
extra
time
aor
ci
provid
commun
referr
aor
ci
femal
gender
associ
extra
time
aor
ci
provid
commun
referr
aor
ci
physician
children
medicaid
like
will
care
cshcn
aor
ci
discussionsignific
impact
femal
physician
physician
smaller
practic
like
deliv
recommend
practic
cshcn
physician
higher
publicli
insur
children
will
care
cshcn
futur
research
identifi
barrier
optim
cshcn
care
pcp
work
larger
practic
practic
higher
proport
privat
insur
patient
strope
sa
univers
st
loui
mo
usa
objectivesspecif
aim
assess
publish
surveil
protocol
design
detect
asymptomat
cancer
recurr
definit
treatment
renal
cancer
methodsstudi
popul
use
markov
simul
model
estim
cost
benefit
compet
publish
algorithm
surveil
imag
radic
nephrectomi
partial
nephrectomi
low
stage
kidney
cancer
perform
sensit
analysi
around
assumpt
cancer
detect
differ
screen
protocol
resultsanticip
result
willing
pay
per
cancer
recurr
detect
surveil
regimen
highest
cost
appear
warrant
howev
sensit
analysi
small
chang
assumpt
sensit
differ
imag
modal
caus
lower
cost
strategi
effect
greatli
reduc
cost
discussionsignific
impact
surveil
kidney
cancer
patient
survivorship
period
abl
detect
recurr
diseas
asymptomat
state
propos
screen
protocol
vari
extens
cost
may
significantli
differ
result
popul
level
low
risk
diseas
yona
marsland
gu
moor
wenzel
pittsburgh
pittsburgh
pa
usa
objectivesspecif
aim
epidemiolog
evid
show
higher
rate
major
depress
disord
mdd
among
individu
asthma
understand
associ
examin
whether
increas
asthma
sever
associ
symptom
depress
rate
mdd
methodsstudi
popul
purpos
assess
symptom
depress
among
individu
mildmoder
asthma
n
sever
asthma
n
healthi
control
n
recruit
sever
asthma
research
network
sarp
depress
measur
beck
depress
inventori
bdi
addit
full
score
creat
modifi
bdi
score
drop
item
assess
somat
symptom
may
result
asthma
eg
sleep
disturb
resultsanticip
result
sampl
consist
individu
mean
age
year
femal
caucasian
african
american
ethnic
comparison
mean
show
symptom
depress
assess
full
modifi
scale
score
among
individu
asthma
control
ps
addit
compar
individu
mildmoder
asthma
sever
asthmat
report
symptom
depress
modifi
scale
p
similar
trend
use
full
bdi
p
individu
asthma
met
clinic
cutoff
mdd
compar
control
higher
depress
symptom
trend
observ
sever
asthma
group
versu
mildmoder
asthma
p
discussionsignific
impact
find
provid
support
higher
rate
depress
symptom
among
individu
sever
asthma
compar
mildmoder
asthma
counterpart
research
warrant
determin
direct
associ
felix
hc
may
littl
rock
ar
usa
objectivesspecif
aim
studi
aim
assess
differ
hospit
length
stay
obes
individu
hospit
stroke
match
individu
hospit
stroke
methodsstudi
popul
person
respond
medic
expenditur
panel
survey
mep
hospit
stroke
propens
score
use
construct
comparison
group
nonobes
person
n
hospit
stroke
similar
group
obes
person
n
hospit
stoke
multivari
regress
model
use
account
residu
differ
two
group
assess
differ
hospit
length
stay
group
resultsanticip
result
obes
person
shorter
hospit
length
stay
stroke
nonobes
person
although
differ
statist
signific
discussionsignific
impact
research
warrant
account
potenti
bia
introduc
exclus
mep
respond
due
death
institution
reason
includ
clinic
measur
assess
sever
stroke
tong
e
patern
tsoh
chen
california
davi
sacramento
ca
usa
california
san
francisco
san
francisco
ca
usa
objectivesspecif
aim
tobacco
lead
prevent
caus
morbid
mortal
polici
base
fact
secondhand
smoke
harm
other
encourag
smoker
quit
protect
nonsmok
exposur
howev
public
health
polici
yet
fulli
translat
clinic
intervent
methodsstudi
popul
conduct
focu
group
potenti
counsel
intervent
use
adult
dyad
smoker
household
nonsmok
intervent
involv
group
educ
secondhand
smoke
concern
motiv
interview
individu
lab
result
smoke
exposur
besid
particip
questionnair
focu
group
transcript
analyz
theme
relat
accept
intervent
resultsanticip
result
total
particip
recruit
focu
group
separ
smoke
statu
dyad
spousalpartn
friend
smoker
least
contempl
quit
almost
nonsmok
tri
elimin
home
exposur
past
year
tri
support
smoker
quit
respect
rate
smoker
nonsmok
intervent
compon
use
includ
group
educ
counsel
lab
result
theme
emerg
includ
conduct
group
educ
fellow
smokersnonsmok
build
support
reduc
conflict
increas
intens
contact
explain
lab
address
concern
sampl
hair
discussionsignific
impact
propos
counsel
intervent
accept
particip
educ
materi
protocol
pilot
intervent
revis
accord
theme
elicit
smith
ak
king
yourman
ahalt
eng
knight
covinski
california
san
francisco
san
francisco
ca
usa
objectivesspecif
aim
conduct
studi
qualiti
life
divers
popul
elder
late
life
disabl
methodsstudi
popul
use
qualit
methodolog
subject
recruit
san
francisco
lok
program
first
program
care
elderli
pace
lok
enrolle
disabl
meet
medicaid
criteria
nurs
home
placement
interview
elder
english
spanish
cantones
statu
respond
ask
rate
overal
qualiti
life
scale
excel
poor
open
end
question
explor
reason
rate
specif
probe
disabl
depend
resultsanticip
result
interview
older
adult
mean
age
women
european
american
african
american
latino
chines
american
mean
adl
depend
respond
rate
qualiti
life
good
better
six
domain
emerg
depend
elder
felt
import
qualiti
life
physic
disabl
pain
nonpain
symptom
psycholog
depress
anxieti
resili
cognit
cognit
impair
ethic
autonomi
digniti
spiritualreligi
hope
religi
cope
social
isolationsupport
exampl
quot
unfortun
lot
famili
peopl
feel
old
know
anyth
anymor
kind
way
digniti
discussionsignific
impact
divers
group
disabl
elder
rate
qualiti
life
least
good
mani
factor
influenc
qualiti
life
includ
resili
religi
cope
respect
digniti
miss
standard
assess
qualiti
life
eg
summerfelt
w
sulo
sack
powder
rakowski
london
chess
robinson
health
care
park
ridg
il
usa
bridgeport
ct
usa
group
int
l
toronto
canada
objectivesspecif
aim
background
provid
servic
patient
home
hospit
home
model
care
select
diagnos
proven
clinic
safe
prefer
patient
caregiv
provid
howev
scale
model
limit
challeng
provid
physician
resourc
home
object
evalu
feasibl
safeti
efficaci
scalabl
substitut
hospit
home
model
advoc
home
hospit
program
power
clinic
home
ahhp
use
virtual
physician
via
enhanc
video
methodsstudi
popul
design
prospect
nonrandom
design
compar
patient
requir
hospit
admiss
copd
chf
dvt
pneumonia
patient
treat
ahhp
compar
patient
clinic
elig
ahhp
present
care
outsid
ahhp
admit
hour
intervent
hospit
home
model
enhanc
use
wireless
biometr
measur
real
time
biometr
enhanc
physician
home
visit
measur
patient
caregiv
provid
satisfact
qualiti
clinic
measur
function
statu
advers
event
servic
util
cost
resultsanticip
result
treatment
group
satisfi
p
lower
readmiss
rate
p
equival
qualiti
anticip
lower
cost
lower
advers
event
similar
clincial
qualiti
discussionsignific
impact
ahhp
feasibl
efficaci
patient
famili
improv
scalabl
hospit
home
model
prove
use
health
system
adapt
new
paradigm
health
servic
deliveri
larson
j
dosrei
frosch
solomon
hopkin
takoma
park
md
usa
maryland
baltimor
md
usa
objectivesspecif
aim
evalu
gender
differ
mental
health
servic
use
referr
pediatr
clinic
explor
differ
way
parent
describ
mental
health
need
girl
boy
methodsstudi
popul
one
hundr
children
age
refer
urban
pediatr
primari
care
clinic
commun
children
mental
health
clinic
refer
provid
complet
form
document
reason
referr
demograph
mental
health
servic
use
obtain
mental
health
clinic
interview
famili
explor
factor
impact
parent
decis
attend
mental
health
evalu
univari
analys
use
examin
group
differ
regress
analys
use
examin
likelihood
attend
initi
mental
health
evalu
interview
analyz
use
ground
theori
examin
differ
gender
parent
discuss
mental
health
problem
resultsanticip
result
boy
frequent
refer
girl
vs
percent
refer
children
attend
initi
mental
health
evalu
attend
initi
evalu
differ
gender
logist
regress
show
girl
ci
greater
odd
mental
health
visit
compar
boy
girl
attend
visit
versu
boy
p
qualit
analys
enrich
find
current
underway
discussionsignific
impact
gender
differ
attend
initi
mental
health
evalu
girl
like
continu
treatment
qualit
analysi
underway
explor
famili
describ
mental
health
need
boy
girl
may
influenc
servic
use
waseem
leber
medic
mental
health
center
bronx
ny
usa
medic
colleg
cornel
unvers
new
york
ny
usa
objectivesspecif
aim
determin
length
stay
lo
patient
psychiatr
diagnos
emerg
depart
methodsstudi
popul
retrospect
cohort
studi
review
children
year
age
present
urban
ed
psychiatr
symptom
januari
decemb
control
group
nonpsychiatr
diagnos
select
random
period
ed
length
stay
minut
compar
patient
psychiatr
diagnos
lo
determin
time
triag
disposit
discharg
admiss
patient
psychiatr
diagnos
classifi
one
two
categori
major
psychiatr
diagnos
bipolar
disord
psychos
major
depress
suicid
attempt
ideat
homicid
ideat
hallucin
minor
psychiatr
diagnos
adhd
adjust
disord
anxieti
panic
attack
behavior
issu
resultsanticip
result
total
patient
psychiatr
diagnos
visit
ed
control
group
patient
patient
major
psychiatr
diagnos
group
patient
minor
psychiatr
diagnos
group
mean
lo
nonpsychiatr
patient
minut
ci
lo
minor
psychiatr
patient
minut
ci
minut
major
psychiatr
patient
ci
median
lo
nonpsychiatr
patient
minut
minor
psychiatr
patient
minut
major
psychiatr
patient
minut
test
show
signific
differ
group
p
discussionsignific
impact
describ
step
durat
time
take
treat
discharg
pediatr
psychiatr
patient
discuss
nation
task
forc
meetingguidelin
could
provid
help
reliev
ed
increas
burden
yona
burk
rak
kelli
moor
marsland
wenzel
pittsburgh
pittsburgh
pa
usa
pittsburgh
pa
usa
institut
pittsburgh
pa
usa
healthi
commun
pittsburgh
pa
usa
colleg
allegheni
counti
pittsburgh
pa
usa
objectivesspecif
aim
disproportion
high
asthma
morbid
mortal
persist
among
socioeconom
disadvantag
children
known
environment
risk
factor
partial
explain
persist
dispar
evid
show
exposur
chronic
stress
predict
asthma
exacerb
impact
factor
stress
asthma
morbid
remain
poorli
understood
methodsstudi
popul
studi
util
concept
map
engag
resid
adult
youth
identifi
neighborhood
factor
may
influenc
posit
neg
childhood
asthma
studi
activ
includ
systemat
brainstorm
sort
rate
cluster
map
activ
character
percept
factor
influenc
care
control
childhood
asthma
resultsanticip
result
particip
identifi
discret
item
relat
asthma
pollut
stress
shoot
teas
health
insur
smoke
item
organ
priorit
group
cluster
environment
trigger
stressor
item
relat
stressor
visual
depict
creat
illustr
pathway
stressor
impact
lung
function
feel
anxieti
acut
panic
respons
discussionsignific
impact
util
engag
research
approach
led
contextu
rang
uniqu
neighborhood
relat
stressor
result
inform
testabl
hypothes
regard
neighborhood
influenc
childhood
asthma
care
control
futur
quantit
research
inform
design
behavior
public
health
asthma
care
control
program
youth
seligman
bj
cullen
horwitz
univers
school
medicin
stanford
ca
usa
objectivesspecif
aim
world
health
organ
global
burden
diseas
gbd
report
import
tool
global
health
polici
maker
howev
accuraci
estim
countri
undergo
epidemiolog
transit
unclear
attempt
valid
life
tabl
model
use
gener
estim
mortal
develop
countri
methodsstudi
popul
data
obtain
male
femal
human
mortal
databas
countri
avail
data
everi
ten
year
provid
input
gbd
life
tabl
model
serv
comparison
observ
data
resultsanticip
result
age
sixti
model
estim
surviv
sex
differ
substanti
observ
prior
year
male
femal
estim
surviv
tend
greater
observ
follow
male
femal
estim
surviv
tend
less
observ
view
observ
estim
surviv
separ
observ
surviv
past
sixti
increas
year
consid
male
increas
mean
sd
probabl
femal
increas
contrast
estim
surviv
past
sixti
decreas
period
among
male
estim
surviv
probabl
declin
among
femal
declin
discussionsignific
impact
result
show
gbd
mortal
model
accur
estim
surviv
past
sixti
develop
countri
transit
twentieth
centuri
may
similarli
flaw
develop
countri
undergo
transit
estim
popul
attribut
diseas
burden
reconsid
huddleston
j
gabriel
fowler
clinic
rochest
mn
usa
state
univers
teme
az
usa
objectivesspecif
aim
determin
reliabl
inpati
health
care
deliveri
congest
heart
failur
patient
hospit
free
advers
event
ae
methodsstudi
popul
patient
hospit
congest
heart
failur
januari
decemb
includ
clinic
record
administr
data
ae
data
repositori
util
abstract
inform
global
trigger
tool
methodolog
identifi
ae
unplan
ill
result
evalu
treatment
medic
condit
multivari
regress
analys
determin
patient
characterist
relat
occurr
time
ae
analys
perform
determin
cumul
densiti
hazard
probabl
densiti
function
recur
condit
compet
caus
ae
analyz
resultsanticip
result
one
thousand
seven
hundr
eleven
patient
hospit
chf
mean
age
year
men
mean
charlson
index
sd
least
one
ae
requir
addit
monitor
higher
spontan
hazard
rate
time
first
ae
event
per
hour
none
characterist
collect
statist
influenc
probabl
ae
occur
howev
age
charlson
index
relat
time
first
ae
ae
least
one
event
occur
within
hour
admiss
r
event
recurr
markedli
influenc
patient
characterist
medic
relat
advers
event
occur
frequent
sooner
hospit
discussionsignific
impact
nation
report
indic
care
get
safer
major
work
date
focus
patient
state
analysi
method
assess
ae
must
begin
includ
aspect
care
deliveri
system
offer
highest
potenti
mitig
ae
mcneeli
j
wright
rotrosen
shelley
matthew
buccholz
curro
school
medicin
new
york
ny
usa
colleg
dentistri
new
york
ny
usa
ny
harbor
healthcar
system
new
york
ny
usa
corpor
rockvil
md
usa
objectivesspecif
aim
substanc
use
substanti
effect
oral
health
dental
visit
provid
opportun
address
substanc
use
disord
survey
dentist
learn
whether
might
play
role
substanc
use
screen
intervent
methodsstudi
popul
dentist
activ
pearl
dental
research
network
invit
complet
survey
summer
survey
assess
clinic
polici
dentist
practic
attitud
percept
barrier
regard
screen
counsel
referr
substanc
use
resultsanticip
result
one
hundr
dentist
complet
survey
respons
rate
almost
respond
felt
import
screen
patient
tobacco
alcohol
illicit
drug
use
though
actual
screen
rate
much
lower
counsel
referr
infrequ
provid
user
alcohol
illicit
drug
common
tobacco
frequent
identifi
barrier
address
substanc
use
insuffici
knowledgetrain
barrier
lack
referr
site
staff
resist
time
constraint
reimburs
avail
mani
dentist
said
would
offer
counsel
assist
tobacco
alcohol
illicit
drug
affirm
respons
significantli
like
among
dentist
saw
medicaid
patient
p
discussionsignific
impact
dentist
recogn
import
screen
substanc
use
lack
clinic
train
system
might
allow
interven
barrier
reduc
dentist
could
will
partner
address
substanc
use
disord
sheeran
rabinowitz
reilli
lotterman
bruce
cornel
medic
colleg
white
plain
ny
usa
island
hospit
brown
medic
school
provid
ri
usa
vermont
colleg
medicin
burlington
vt
usa
allen
health
care
burlington
vt
usa
objectivesspecif
aim
telehealth
commonli
use
homecar
manag
ill
elderli
patient
typic
depress
goal
cornel
pilot
studi
test
accept
earli
outcom
depress
care
manag
dcm
program
use
exist
telehealth
equip
methodsstudi
popul
studi
partner
homecar
agenc
vt
ny
fl
use
differ
telehealth
equip
program
protocol
enabl
patient
report
mood
antidepress
request
telehealth
nurs
phone
call
telehealth
nurs
receiv
full
day
dcm
train
pilot
consent
patient
receiv
protocol
elig
patient
age
depress
admit
depress
diagnosi
antidepress
english
spanish
speak
nondement
patient
receiv
telemonitor
collect
data
transmit
agenc
telehealth
nurs
manag
patient
depress
research
assist
conduct
interview
assess
symptom
satisfact
protocol
telehealth
nurs
survey
protocol
resultsanticip
result
recruit
divers
sampl
english
spanish
speak
patient
patient
nurs
report
high
level
satisfact
among
patient
depress
baselin
mean
sever
score
markedli
sever
hamd
mean
score
mild
discussionsignific
impact
result
support
feasibl
use
homecar
exist
telemonitor
provid
dcm
accept
level
high
across
patient
telehealth
nurs
preliminari
find
suggest
symptom
improv
although
outcom
must
verifi
random
trial
thompson
persel
baker
univers
feinberg
school
medicin
chicago
il
usa
objectivesspecif
aim
assess
impact
multifacet
health
inform
technolog
support
qualiti
improv
qi
initi
racial
dispar
qualiti
ambulatori
care
methodsstudi
popul
februari
qi
initi
consist
point
care
remind
clinic
decis
support
regular
audit
feedback
provid
implement
throughout
larg
academ
gener
intern
medicin
practic
qi
initi
target
measur
chronic
diseas
prevent
care
chronic
diseas
measur
includ
process
care
intermedi
outcom
measur
coronari
heart
diseas
heart
failur
hypertens
diabet
prevent
care
measur
includ
cancer
screen
women
health
immun
time
seri
model
use
assess
chang
proport
patient
satisfi
qualiti
measur
stratifi
race
chang
racial
dispar
qualiti
measur
februari
februari
resultsanticip
result
qualiti
care
improv
measur
white
patient
measur
black
patient
qualiti
improv
black
white
patient
process
care
measur
prevent
care
measur
none
intermedi
outcom
measur
measur
racial
dispar
baselin
dispar
declin
remain
stabl
increas
measur
implement
qi
initi
discussionsignific
impact
gener
qi
initi
ie
program
aim
improv
qualiti
care
patient
overal
specif
tailor
address
healthcar
dispar
may
lead
improv
racial
dispar
qualiti
chronic
diseas
prevent
care
suffici
elimin
healthcar
dispar
apollonio
san
francisco
ca
usa
objectivesspecif
aim
although
clinic
research
often
identifi
effect
public
health
intervent
mani
enact
polici
lead
unnecessari
death
diseas
problem
particularli
acut
research
tobacco
use
caus
annual
death
unit
state
lung
cancer
death
approxim
death
occur
alcohol
drug
abus
mental
health
popul
treatment
smoke
rate
time
gener
popul
exist
literatur
report
smoke
cessat
therapi
effect
popul
three
state
mandat
therapi
made
avail
treatment
facil
condit
licensur
methodsstudi
popul
paper
review
public
commentari
background
inform
propos
exist
state
polici
assess
use
clinic
evid
policymak
process
associ
legisl
regulatori
outcom
date
three
state
new
jersey
new
york
virginia
establish
regul
requir
provis
smoke
cessat
therapi
residenti
substanc
abus
treatment
center
andor
psychiatr
hospit
although
state
propos
similar
polici
studi
popul
consist
retroact
review
polici
enact
resultsanticip
result
hypothes
increas
relianc
clinic
research
policymak
process
encourag
adopt
law
provid
disadvantag
popul
treatment
right
tobacco
cessat
treatment
discussionsignific
impact
studi
attempt
identifi
clinic
research
translat
public
health
intervent
encourag
enact
polici
yet
knowledg
critic
ensur
clinic
research
find
use
save
live
kehl
ka
madison
wi
usa
objectivesspecif
aim
hospic
nurs
usual
respons
prepar
famili
death
littl
known
includ
prepar
aim
studi
identifi
content
time
nurs
prepar
famili
death
describ
rn
tailor
messag
differ
hospic
certifi
nurs
concern
prepar
famili
methodsstudi
popul
mail
survey
sent
rn
member
hpna
identifi
hospic
primari
practic
data
extract
survey
use
cardiff
teleform
descript
compar
statist
analysi
conduct
use
r
http
resultsanticip
result
respons
rate
nurs
agre
famili
prepar
physic
chang
care
give
task
preparatori
inform
usual
given
admiss
patient
condit
chang
prepar
usual
done
time
prepar
tailor
factor
affect
tailor
messag
includ
patient
signssymptom
much
famili
want
know
famili
cultur
background
famili
educ
certifi
nurs
like
work
longer
time
hospic
larger
agenc
case
manag
respons
differ
educ
statu
group
certifi
nurs
like
agre
famili
prepar
care
give
task
p
use
written
materi
p
discuss
symptom
dysphagia
p
cold
extrem
p
vital
sign
chang
p
discussionsignific
impact
result
studi
may
use
support
develop
test
educ
nurs
tailor
intervent
famili
caregiv
assist
prepar
patient
death
bardach
n
dudley
san
francisco
ca
usa
objectivesspecif
aim
patient
experi
rate
hospit
post
nation
public
report
consum
gener
content
cgc
websit
use
patient
hospit
choic
sought
assess
hospit
rate
cgc
websit
compar
scientif
gener
rate
nation
public
report
websit
methodsstudi
popul
data
sourc
current
patient
satisfact
rate
hospit
onlin
hospitalcomparehhsgov
oct
limit
sampl
popular
citi
yelpcom
search
remain
hospit
yelpcom
gather
follow
overal
rate
star
number
rate
distribut
rate
time
period
rate
given
compar
overal
distribut
score
correl
pearson
product
moment
individu
hospit
perform
two
sourc
resultsanticip
result
hospit
nation
dataset
n
popular
yelp
citi
rate
yelpcom
rang
rate
mean
rate
per
hospit
rate
date
distribut
rate
two
sourc
similar
high
rate
low
low
rate
rate
correl
hospit
high
rate
site
p
discussionsignific
impact
though
consum
gener
rate
hospit
scientif
gener
numer
similar
scientif
design
measur
patient
satisfact
inform
consum
gener
websit
may
use
addit
resourc
patient
look
choos
hospit
simmon
dn
grubber
bosworth
universitydurham
vamc
durham
nc
usa
objectivesspecif
aim
potenti
explanatori
factor
hypertens
control
may
associ
blood
pressur
bp
control
rang
among
differ
race
methodsstudi
popul
baselin
data
hypertens
patient
obtain
rct
variou
factor
examin
bp
control
statu
sinc
optim
level
bp
control
unclear
may
vari
certain
patient
popul
bp
level
stratifi
logist
regress
use
determin
associ
race
control
bp
mmhg
andor
mmhg
rel
uncontrol
bp
mmhg
andor
mmhg
tightli
control
bp
mmhg
andor
mmhg
without
adjust
potenti
explanatori
factor
racial
differ
bp
control
resultsanticip
result
odd
uncontrol
bp
rel
control
bp
higher
african
american
caucasian
associ
african
american
uncontrol
bp
reduc
least
financi
situat
bmi
includ
associ
decreas
factor
includ
model
simultan
although
statist
signific
odd
tightli
control
bp
rel
control
bp
also
higher
african
american
caucasian
versu
ci
statist
signific
dispar
shown
two
rang
control
bp
categori
discussionsignific
impact
modifi
factor
like
bmi
may
use
reduc
racial
differ
cardiovascular
morbid
subset
particip
whose
bp
control
baselin
signific
racial
dispar
though
african
american
like
tighter
bp
mmhg
may
increas
cardiac
event
risk
patient
year
old
holden
kb
school
medicin
atlanta
ga
usa
objectivesspecif
aim
purpos
studi
foster
greater
understand
relationship
select
biolog
psycholog
factor
depress
symptom
among
african
american
women
methodsstudi
popul
sampl
compris
african
american
women
urban
commun
n
commun
base
primari
healthcar
center
n
small
privat
academ
institut
n
women
particip
health
well
empower
session
includ
complet
batteri
assess
measur
particip
focu
group
involv
educ
present
depress
quantit
data
analys
carri
use
resultsanticip
result
depress
report
highest
among
commun
group
yet
clinic
sampl
women
report
formal
diagnos
depress
total
sampl
depress
score
found
signific
posit
associ
neg
rumin
thinkingautomat
thought
stress
life
event
social
support
depress
stigma
depress
found
signific
neg
associ
resili
spiritu
strongest
predictor
depress
total
sampl
neg
rumin
think
low
discussionsignific
impact
crucial
care
attent
provid
heighten
awar
uniqu
risk
protect
factor
african
american
women
rel
depress
essenti
cultur
relev
strategi
model
prevent
diseas
promot
mental
well
among
african
american
women
divers
sector
commun
discern
nutescu
e
bautista
gao
galant
schumock
lambert
illinoi
chicago
chicago
il
usa
objectivesspecif
aim
evalu
clinic
practic
inr
pattern
outcom
associ
warfarin
use
patient
manag
antithrombosi
clinic
atc
methodsstudi
popul
retrospect
observ
cohort
studi
patient
undergo
total
knee
hip
replac
tkr
thr
receiv
warfarin
prophylaxi
within
hour
surgeri
refer
atc
anticoagul
manag
januari
month
postsurgeri
resultsanticip
result
patient
male
evalu
tkr
thr
mean
age
sd
year
mean
length
hospit
stay
day
mean
length
warfarin
therapi
day
includ
outlier
mean
time
requir
reach
therapeut
inr
rang
day
proport
inr
level
spent
therapeut
rang
proport
extend
therapeut
rang
inr
proport
inr
level
spent
therapeut
rang
inr
inr
major
bleed
occur
patient
symptomat
venou
thromboembol
vte
occur
patient
inpati
outpati
total
event
occur
inr
versu
inr
p
discussionsignific
impact
despit
close
monitor
warfarin
use
associ
signific
time
spent
accept
anticoagul
level
result
high
rate
symptomat
vte
major
event
occur
inr
level
may
indic
need
aggress
anticoagul
acut
postop
phase
kehl
ka
van
veldhuisen
madison
wi
usa
objectivesspecif
aim
limit
inform
publish
last
week
life
home
hospic
examin
period
yield
much
inform
may
improv
care
final
day
purpos
studi
describ
reason
outcom
contact
frequent
symptom
address
last
week
life
methodsstudi
popul
descript
studi
use
six
month
record
provid
midwest
hospic
record
patient
resid
home
receiv
crisi
care
die
januari
june
examin
data
extract
review
train
rn
spss
use
descript
date
analysi
resultsanticip
result
patient
chart
reveal
contact
mean
contact
per
patient
rang
contact
initi
hospic
staff
famili
frequent
reason
includ
symptom
manag
emot
support
person
care
death
frequent
outcom
instruct
famili
rn
notifi
medic
chang
symptom
address
contact
frequent
includ
increas
sleep
fatigu
symptom
document
incontin
pain
breath
chang
coma
discussionsignific
impact
understand
reason
contact
last
week
hospic
patient
live
give
insight
question
problem
famili
care
give
time
futur
research
need
explor
differ
document
symptom
inform
provid
famili
intervent
need
develop
test
provid
inform
need
famili
caregiv
last
week
life
fernandez
garcia
e
kravitz
california
davi
sacramento
ca
usa
objectivesspecif
aim
depress
care
dispar
partli
due
stigma
inhibit
disclosur
patient
symptom
social
market
may
reduc
stigma
nondisclosur
depress
symptom
target
social
market
intervent
reduc
stigma
may
effect
nontarget
intervent
seek
answer
two
question
depress
video
public
servic
announc
psa
design
target
gender
incom
improv
viewer
intent
discuss
depress
profession
compar
nontarget
depress
psa
control
use
theori
plan
behavior
tpb
target
improv
intent
methodsstudi
popul
two
studi
use
factori
design
particip
randomli
assign
view
either
fulli
target
gender
incom
partial
target
nontarget
psa
control
studi
assess
reliabl
studi
instrument
degre
target
measur
identif
psa
studi
provid
estim
intent
disclos
depress
symptom
relationship
use
structur
equat
model
among
intent
target
concord
tpb
construct
particip
characterist
depress
symptom
belief
demograph
resultsanticip
result
expect
target
concord
significantli
posit
associ
identif
depress
psa
intent
disclos
depress
symptom
identif
modifi
effect
view
psa
viewer
intent
subject
norm
attitud
disclos
depress
symptom
salient
construct
tpb
affect
view
psa
discussionsignific
impact
anticip
result
provid
evid
target
social
depress
stigma
reduct
strategi
help
nontarget
strategi
aspect
target
effect
balekian
gould
southern
california
lo
angel
ca
usa
objectivesspecif
aim
develop
valid
mortal
model
esld
patient
use
clinic
paramet
admiss
methodsstudi
popul
retrospect
studi
icu
admiss
admiss
develop
cohort
admiss
valid
cohort
patient
histori
esld
counti
hospit
lo
angel
ca
resultsanticip
result
hospit
mortal
rate
develop
valid
cohort
respect
mayo
liver
diseas
meld
score
better
discrimin
univari
model
area
curv
auc
p
acut
physiolog
chronic
health
evalu
apach
ii
score
auc
multivari
predictor
mortal
meld
apach
ii
mechan
ventil
gender
ad
mechan
ventil
meld
achiev
largest
signific
increas
model
discrimin
auc
p
multivari
adjust
mortal
associ
femal
gender
odd
ratio
confid
interv
ci
p
meld
increas
ci
p
statist
signific
interact
meld
score
gender
p
therefor
final
simplifi
model
includ
meld
score
gender
interact
term
mechan
ventil
retain
signific
associ
mortal
ci
p
model
discrimin
good
develop
cohort
auc
valid
cohort
auc
discussionsignific
impact
esld
patient
simpl
model
incorpor
meld
score
mechan
ventil
superior
discrimin
apach
ii
score
predict
hospit
mortal
gender
dispar
exist
find
must
confirm
popul
contrera
jp
schmid
beshanski
selker
ctsi
boston
usa
medic
center
boston
usa
objectivesspecif
aim
discrimin
patient
acut
heart
failur
syndrom
ahf
among
symptom
suggest
acut
coronari
syndrom
ac
methodsstudi
popul
use
data
adult
patient
symptom
suggest
ac
enrol
clinic
trial
potenti
risk
factor
includ
demograph
present
symptom
past
medic
histori
initi
ecg
use
multinomi
logist
regress
construct
multivari
model
simultan
predict
rel
odd
ahf
acut
myocardi
infarct
ami
angina
nonischem
cardiac
diseas
pulmonari
diseas
noncardiac
diseas
gender
age
pulmonari
rale
chest
pain
short
breath
ecg
variabl
resultsanticip
result
among
patient
men
women
mean
age
year
final
diagnos
ahf
ami
angina
nonischem
cardiac
diseas
pulmonari
diseas
noncardiac
diseas
presenc
rale
strongli
differenti
ahf
diagnos
chief
complaint
short
breath
also
differenti
ahf
cardiac
diagnos
pulmonari
diseas
ischem
ecg
chang
chest
pain
chief
complaint
differenti
ami
angina
ahf
other
diseas
femal
like
nonischem
cardiac
noncardiac
diagnos
older
patient
like
ischem
cardiac
diagnos
less
like
nonischem
noncardiac
pulmonari
diagnos
discussionsignific
impact
age
gender
lead
ecg
three
clinic
histori
variabl
clearli
differenti
cardiac
noncardiac
outcom
patient
suspect
ac
use
inform
easili
avail
within
minut
initi
patient
evalu
gordon
holm
sarli
univers
school
medicin
st
loui
mo
usa
objectivesspecif
aim
object
studi
assess
impact
research
studi
knowledg
base
chang
polici
chang
practic
methodsstudi
popul
assess
impact
ocular
hypertens
treatment
studi
oht
nih
clinic
trial
demonstr
safeti
efficaci
ocular
hypotens
medic
prevent
glaucoma
bibliograph
analysi
perform
journal
articl
result
oht
addit
research
output
activ
also
examin
locat
evid
research
impact
resultsanticip
result
tradit
bibliometr
analysi
suffici
robust
enough
adequ
assess
impact
oht
find
result
synthesi
clinic
practic
health
outcom
discern
via
bibliometr
analysi
includ
practic
guidelin
cpt
code
curriculum
materi
among
other
therefor
develop
framework
reflect
biomed
research
process
includ
contribut
knowledg
base
chang
understand
diseas
chang
polici
chang
practic
chang
commun
health
chang
public
law
polici
framework
assess
impact
biomed
research
implement
site
becker
medic
librari
model
assess
research
impact
discussionsignific
impact
number
resourc
avail
track
diffus
impact
beyond
citat
analysi
order
provid
meaning
assess
polici
practic
health
outcom
becker
medic
librari
model
assess
research
impact
http
beckerwustleduimpactassess
help
biomed
research
quantifi
document
translat
impact
arlow
rl
schulman
michelson
totten
western
reserv
cleveland
oh
usa
hospit
cleveland
oh
usa
objectivesspecif
aim
cadav
trial
serv
initi
proof
concept
mean
optim
two
novel
tracheotomi
product
cadav
trial
estim
key
outcom
two
devic
fda
k
clearanc
academ
public
methodsstudi
popul
eight
nonembalm
cadav
first
use
proof
concept
test
optim
product
design
twelv
nonembalm
cadav
random
tracheostomi
cricothyrotomi
current
standard
care
use
novel
product
one
emerg
medicin
physician
perform
indic
procedur
studi
measur
success
rate
obtain
patent
airway
valid
fiberopt
scope
paramet
measur
includ
speed
success
rate
number
attempt
locat
insert
subject
eas
use
resultsanticip
result
eight
initi
cadav
shown
posit
result
reduc
speed
increas
success
rate
increas
eas
use
devic
modif
current
prototyp
second
trial
discussionsignific
impact
current
emerg
cricothyrotomi
kit
requir
high
level
skill
patient
popul
sustain
debilit
complic
result
improp
procedur
current
airway
protocol
patient
indic
receiv
emerg
cricothyrotomi
temporari
airway
must
repair
within
hour
replac
definit
tracheostomi
procedur
ventil
novel
product
tracheotomi
repres
opportun
safer
efficaci
cricothyrotomi
well
first
devic
indic
perform
emerg
tracheostomi
perform
emerg
tracheostomi
bring
higher
standard
care
prehospit
battlefield
emerg
health
care
provid
reznik
bauman
hospit
montefior
bronx
ny
usa
einstein
colleg
medicin
bronx
ny
usa
objectivesspecif
aim
assess
awar
implement
nyc
depart
health
nyc
dohmh
asthma
manag
initi
manag
asthma
school
ma
bronx
elementari
school
methodsstudi
popul
qualit
semistructur
interview
nurs
teacher
bronx
elementari
school
record
transcrib
independ
code
interview
common
theme
resultsanticip
result
nurs
awar
ma
initi
none
could
describ
ma
recommend
nurs
said
student
asthma
identifi
form
parent
bring
school
administr
howev
nurs
teacher
report
common
way
found
student
asthma
inform
convers
parent
student
nurs
report
use
american
lung
associ
open
airway
school
oa
asthma
educ
curriculum
grade
student
asthma
without
know
part
ma
initi
howev
none
implement
fidel
modifi
content
number
frequenc
lesson
nurs
provid
asthma
educ
teacher
none
teacher
awar
ma
school
procedur
identifi
student
asthma
awar
asthma
educ
provid
student
asthma
report
receiv
formal
instruct
mean
student
asthma
classroom
recommend
nyc
dohmh
discussionsignific
impact
lack
awar
poor
implement
ma
asthma
initi
common
theme
among
nurs
teacher
sever
bronx
elementari
school
increas
awar
ensur
proper
implement
exist
asthma
manag
initi
may
improv
asthma
care
school
cabrera
r
sing
caridi
florida
gainesvil
fl
usa
objectivesspecif
aim
data
limit
transarteri
chemoembolz
tace
plu
sorafenib
combin
hepatocellular
carcinoma
hcc
evalu
safeti
efficaci
tace
plu
sorfenib
tace
combin
cohort
patient
treat
singl
center
methodsstudi
popul
juli
consecut
case
hcc
treat
tace
evalu
baselin
clinic
safeti
toxic
data
well
data
collect
surviv
curv
calcul
resultsanticip
result
forti
three
patient
n
receiv
tace
combin
median
median
time
drug
week
week
respect
major
cohort
experienc
advers
event
ae
common
advers
event
ae
fatigu
skin
reaction
diarrhea
grade
advers
event
includ
fatigu
skin
reaction
dose
reduct
requir
patient
drug
interrupt
need
patient
dose
discontinu
requir
patient
due
drug
relat
ae
mainli
fatigu
hand
foot
skin
reaction
new
worsen
ascit
leukopenia
hypertens
relat
chest
pain
due
radiolog
symptomat
progress
median
surviv
overal
tace
group
month
median
surviv
patient
bclc
stage
b
month
median
surviv
child
month
child
b
month
median
surviv
patient
bclc
stage
c
month
child
month
child
b
month
discussionsignific
impact
combin
tace
gener
unanticip
side
effect
present
challeng
ae
profil
requir
close
monitor
overal
efficaci
decreas
child
b
cirrhosi
studi
use
tace
combin
warrant
monaghan
cogen
streisand
nation
medic
center
washington
dc
usa
washington
univers
school
medicin
washington
dc
usa
objectivesspecif
aim
evalu
preadolesc
diabet
knowledg
relationship
among
knowledg
daili
care
behavior
behavior
adher
methodsstudi
popul
preadolesc
age
age
yr
diagnos
mean
year
yr
complet
diabet
knowledg
test
dkt
behavior
adher
parent
complet
recal
interview
detail
daili
diabet
care
children
adequ
metabol
control
prescrib
convent
insulin
regimen
remaind
prescrib
intens
regimen
multipl
daili
inject
insulin
pump
resultsanticip
result
dkt
preadolesc
averag
correct
commonli
miss
item
involv
nutrit
acut
complic
eg
keton
hypoglycemia
diabet
knowledg
significantli
associ
age
diseas
durat
regimen
type
control
insulin
regimen
greater
diabet
knowledg
associ
frequent
bg
check
f
p
signific
relationship
behavior
adher
emerg
discussionsignific
impact
result
suggest
youth
diabet
knowledg
adequ
yet
knowledg
nutrit
acut
complic
could
improv
although
parent
often
involv
care
preliminari
result
suggest
youth
diabet
knowledg
also
import
associ
frequent
bg
monitor
preadolesc
assum
increas
respons
provid
target
educ
enhanc
parent
youth
knowledg
may
buffer
deterior
diabet
care
common
adolesc
studi
assess
chang
diabet
knowledg
time
relationship
specif
behavior
warrant
ephrem
g
kanei
israel
medic
center
new
york
ny
usa
objectivesspecif
aim
red
blood
cell
distribut
width
rdw
quantit
measur
variabl
size
circul
erythrocyt
higher
level
rdw
associ
increas
mortal
among
patient
heart
failur
myocardi
infarct
coronari
arteri
diseas
cad
undergo
angiographi
aim
studi
examin
role
rdw
indic
sever
cad
patient
unstabl
angina
ua
non
myocardi
infarct
nstemi
methodsstudi
popul
conduct
retrospect
chart
review
adult
patient
admit
institut
diagnosi
ua
nstemi
underw
coronari
angiographi
rdw
admiss
retain
per
lab
index
level
consid
high
clinic
characterist
revascular
strategi
medic
therapi
percutan
coronari
intervent
pci
coronari
arteri
bypass
graft
cabg
compar
high
normal
rdw
group
resultsanticip
result
high
rdw
note
studi
subject
patient
like
femal
vs
p
heart
failur
vs
p
lower
hemoglobin
level
vs
gdl
p
normal
level
high
rdw
associ
higher
recours
cabg
vs
p
suggest
higher
diseas
burden
multivari
logist
regress
analysi
age
sex
hemoglobin
heart
failur
dyslipidemia
famili
histori
cad
addit
covari
high
rdw
found
statist
signific
independ
predictor
need
cabg
ci
discussionsignific
impact
patient
high
rdw
requir
cabg
often
normal
rdw
rdw
addit
tool
risk
stratif
patient
ua
nstemi
atreja
ala
lashner
brzezinski
achkar
kandiel
shen
soll
clinic
cleveland
oh
usa
lo
angel
ca
usa
objectivesspecif
aim
assess
feasibl
accuraci
report
pro
qualiti
indic
qualiti
life
medic
adher
patient
crohn
diseas
cd
determin
impact
captur
pro
decis
support
clinic
decis
make
outcom
patient
cd
methodsstudi
popul
pilot
studi
fund
acg
clinic
research
award
design
prospect
random
clinic
trial
chang
short
inflammatori
bowel
diseas
questionnair
sibdq
primari
outcom
patient
random
receiv
intervent
self
manag
physician
alert
control
web
access
without
alert
resultsanticip
result
first
phase
studi
design
develop
web
portal
complet
second
phase
studi
random
control
trial
ongo
patient
agre
part
studi
crohnspromis
least
enter
detail
cd
median
age
women
white
patient
report
cd
med
consist
document
electron
health
alert
fire
far
median
sibdq
chang
point
discussionsignific
impact
crohnspromis
allow
easi
captur
track
patient
report
outcom
phenotyp
inform
use
routin
clinic
practic
translat
research
major
patient
enter
detail
cd
pro
without
addit
assist
research
need
done
understand
behavior
patient
never
order
crohnspromis
serv
repres
platform
improv
patient
care
facilit
translat
research
ramirez
k
fernandez
elia
blanco
costa
rica
san
jose
costa
rica
puerto
rico
san
juan
puerto
rico
objectivesspecif
aim
purpos
research
observ
clinic
behavior
dentogingiv
complex
dimens
dgcd
facial
aspect
teeth
prepar
receiv
crown
final
placement
specif
aim
studi
determin
dgcd
baselin
determin
posit
crown
margin
line
use
free
gingiv
margin
refer
month
final
crown
placement
determin
periodont
statu
baselin
month
methodsstudi
popul
baselin
tooth
prepar
crown
placement
plaqu
assess
sulcu
probe
depth
bleed
probe
dgcd
taken
tooth
prepar
distanc
osseou
crest
crown
margin
posit
measur
without
prior
recommend
place
margin
locat
given
restor
dentist
questionnair
provid
restor
dentist
prosthodont
paramet
patient
examin
month
crown
placement
plaqu
accumul
sulcu
probe
depth
bleed
probe
measur
well
distanc
free
gingiv
margin
crown
prepar
line
resultsanticip
result
central
hypothesi
neg
effect
gingiv
health
inflamm
aesthet
gingiv
recess
restor
dentist
place
margin
crown
prepar
mm
osseou
crest
discussionsignific
impact
work
propos
determin
dgcd
free
gingiv
margin
respons
provid
inform
achiev
healthi
gingiva
aesthet
identifi
import
measur
help
prevent
occurr
alter
inflamm
recess
abl
achiev
success
treatment
broder
putterman
medic
center
bronx
ny
usa
objectivesspecif
aim
persist
elev
antiphospholipid
antibodi
apl
ab
level
associ
increas
risk
arteri
venou
thrombosi
factor
may
affect
apl
ab
level
well
studi
conduct
studi
explor
factor
associ
high
apl
ab
level
lupu
anticoagul
lac
posit
peopl
without
autoimmun
diseas
hospit
deep
vein
thrombosi
dvt
pulmonari
embol
pe
cerebrovascular
accid
cva
methodsstudi
popul
includ
patient
hospit
larg
urban
tertiari
care
center
primari
discharg
diagnosi
dvt
pe
cva
lupu
anticoagul
lac
anticardiolipin
glycoprotein
antiphosphatidylserin
igg
igm
iga
measur
resultsanticip
result
patient
dvt
pe
patient
cva
includ
statin
use
associ
ci
p
either
lac
posit
least
one
apl
ab
unit
compar
statin
use
multivari
model
furthermor
patient
low
ldl
statin
time
like
least
one
apl
ab
unit
andor
lac
posit
ci
p
compar
peopl
low
ldl
statin
patient
dvt
pe
type
diabet
time
like
ci
p
least
one
low
posit
apl
ab
compar
dvt
pe
patient
without
even
adjust
age
race
ethnic
discussionsignific
impact
high
level
apl
ab
may
reflect
endotheli
damag
caus
hyperlipidemia
cross
ritter
rede
clinic
research
foundat
marshfield
wi
usa
clinic
marshfield
wi
usa
wisconsin
school
medicin
public
health
depart
human
oncolog
madison
wi
usa
objectivesspecif
aim
determin
current
histor
outcom
individu
diagnos
treat
prostat
cancer
singl
institut
compar
outcom
psa
screen
individu
diagnos
without
psa
screen
compar
outcom
differ
treatment
option
select
within
popul
methodsstudi
popul
set
marshfield
clinic
largest
privat
multispecialti
group
practic
wisconsin
provid
health
care
servic
annual
approxim
uniqu
patent
particip
individu
diagnos
prostat
cancer
tumor
registri
method
collect
age
diagnosi
stage
grade
tumor
psa
valu
diagnosi
initi
cancer
treatment
time
subsequ
treatment
evid
metastasi
age
death
caus
death
known
electron
chart
abstract
tumor
registri
electron
medic
record
studi
approv
marshfield
clinic
irb
resultsanticip
result
averag
age
prostat
cancer
diagnosi
decreas
age
decreas
age
occur
increas
psa
screen
current
approxim
diagnos
least
one
psa
test
age
grade
stage
biggest
predictor
prostat
cancer
outcom
detect
surviv
differ
prostat
cancer
treatment
age
stage
grade
control
discussionsignific
impact
individu
diagnos
treat
prostat
cancer
within
marshfield
clinic
follow
nation
trend
decreas
age
diagnosi
advent
psa
screen
treatment
outcom
compar
nation
trend
ahm
sm
kieli
higa
morton
univers
school
medicin
stanford
ca
usa
univeristi
school
medicin
depart
surgeri
stanford
ca
usa
objectivesspecif
aim
studi
examin
patient
motiv
undergo
bariatr
surgeri
aim
determin
effect
readi
chang
postsurg
outcom
methodsstudi
popul
consecut
patient
undergo
bariatr
surgeri
gastric
bypass
rygb
laparoscop
gastric
band
lgb
sleev
gastrectomi
sg
administ
questionnair
preoper
month
postop
visit
assess
motiv
surgeri
readi
chang
univers
rhode
island
chang
assess
urica
data
analyz
anova
pearson
appropri
resultsanticip
result
preoper
rygb
sg
patient
confid
postop
success
lgb
patient
rygb
lgb
sg
p
across
surgeri
subtyp
differ
rtc
score
rygb
lgb
sg
p
trend
posit
correl
preoper
rtc
score
month
excess
weight
loss
ewl
r
p
signific
decreas
rtc
score
preoper
month
post
op
visit
vs
p
signific
posit
correl
differ
ewl
month
r
p
procedur
posit
signific
correl
patient
confid
success
month
post
op
ewl
month
r
p
discussionsignific
impact
first
studi
assess
effect
readi
chang
postop
outcom
across
surgeri
subtyp
rtc
score
may
affect
short
term
weight
loss
signific
chang
rtc
score
postop
chang
correl
increas
weight
loss
month
post
op
identifi
strategi
augment
rtc
may
use
ensur
long
term
weight
loss
thoma
vermund
univers
school
medicin
nashvil
tn
usa
objectivesspecif
aim
major
india
rural
elderli
often
neglect
caregiv
social
support
provid
elderli
popul
sathumadurai
villag
vellor
south
india
studi
previous
identifi
need
problem
elderli
regard
social
support
identifi
need
problem
caregiv
regard
relationship
elderli
determin
suggest
elderli
caregiv
improv
qualiti
life
rural
set
methodsstudi
popul
qualit
studi
conduct
india
analysi
conduct
vanderbilt
school
medicin
focu
group
discuss
conduct
group
femal
caregiv
male
caregiv
femal
elderli
questionnair
administ
elderli
popul
provid
larger
perspect
regard
elderli
social
support
resultsanticip
result
one
hundr
questionnair
return
peopl
age
older
miss
inform
adjust
predictor
averag
social
support
decreas
point
age
increas
increas
point
se
increas
social
support
point
less
individu
incom
compar
incom
discussionsignific
impact
rural
elderli
older
lower
se
incom
decreas
social
support
caregiv
collect
inform
regard
need
elderli
caregiv
vital
determin
servic
provid
group
elderli
daycar
villag
implement
result
studi
chandramohan
g
kermah
norri
medic
center
torranc
ca
usa
angel
bio
medic
research
institut
torranc
ca
usa
drew
univers
medicin
scienc
lo
angel
ca
usa
objectivesspecif
aim
recent
data
reveal
preval
vitamin
defici
higher
expect
children
particularli
among
african
american
ethnic
preval
obes
also
high
popul
thu
look
interrelationship
among
obes
vitamin
defici
variou
cr
risk
factor
independ
cluster
aa
children
methodsstudi
popul
analysi
children
age
year
nation
health
nutrit
survey
conduct
perform
serum
oh
defici
defin
ngml
statist
analysi
done
use
sudaan
softwar
program
resultsanticip
result
aa
children
boy
tall
obes
high
bp
dyslidemia
high
fast
blood
sugar
signific
differ
distribut
mean
vitd
level
accord
age
gender
obes
statu
lipid
profil
odd
ratio
vitd
defici
signific
obes
high
blood
pressur
combin
use
statist
regress
model
howev
associ
note
nonobes
high
bp
combin
obes
normal
bp
combin
signific
associ
note
discussionsignific
impact
signific
increas
risk
vitd
defici
observ
obes
children
risk
fold
higher
control
obes
children
high
bp
therefor
risk
vitd
defici
perhap
nutrit
rather
inherit
effect
find
shed
light
pathophysiolog
cr
risk
factor
popul
ashwel
z
yadav
cowan
wall
genni
washington
dc
usa
med
ctr
bronx
ny
usa
som
new
york
ny
usa
objectivesspecif
aim
prepar
deriv
clinic
decis
rule
cdr
improv
use
ct
diagnos
orbit
fractur
author
sought
estim
annual
incid
orbit
fractur
emerg
depart
ed
usag
comput
tomographi
ct
make
diagnos
author
also
sought
evalu
mandatori
electron
data
collect
instrument
edci
administ
provid
facilit
data
collect
methodsstudi
popul
nation
estim
made
analyz
nhamc
databas
hospit
system
bill
code
data
use
make
local
estim
edci
integr
ct
order
system
provid
complet
form
order
perform
ct
sinc
edci
fill
everi
ct
order
data
collect
effici
measur
complianc
count
number
unrealist
data
collect
instrument
answer
time
conveni
sampl
provid
complet
edci
resultsanticip
result
million
ed
visit
us
million
patient
treat
injuri
eye
face
patient
underw
ct
imag
patient
diagnos
orbit
fractur
local
hospit
system
annual
ed
visit
ct
orbit
perform
suffer
orbit
fractur
edci
complianc
rate
took
less
minut
complet
discussionsignific
impact
nation
local
data
demonstr
low
yield
ct
imag
identifi
orbit
fractur
data
collect
use
mandatori
electron
data
collect
instrument
link
computer
provid
order
entri
provid
prospect
consecut
patient
data
need
develop
cdr
select
use
ct
imag
orbit
trauma
polag
c
chin
lesli
solnick
davi
sacramento
ca
usa
objectivesspecif
aim
clostridium
difficil
cd
import
caus
healthcar
associ
diarrhea
death
symptom
due
injuri
immun
associ
asymptomat
carriag
observ
patient
diarrhea
cd
cultur
pcr
report
rare
patient
sever
diseas
led
call
toxin
test
replac
dna
detect
hypothes
cd
complic
rare
patient
patient
immun
carrier
preliminari
test
retrospect
determin
frequenc
cd
complic
durat
diarrhea
among
inpati
test
cd
toxin
methodsstudi
popul
medic
record
review
inpati
admiss
cd
toxin
test
conveni
sampl
stool
test
cd
pcr
caus
mortal
cd
complic
eg
coliti
megacolon
colectomi
tabul
diarrhea
day
stoolsday
measur
resultsanticip
result
patient
toxin
admiss
cd
complic
document
toxin
patient
p
month
caus
mortal
rate
n
toxin
patient
vs
n
patient
p
toxin
patient
n
ci
diarrhea
day
versu
day
patient
n
among
pcr
test
patient
toxindna
patient
n
diarrhea
day
n
patient
n
diarrhea
day
discussionsignific
impact
cd
complic
rare
patient
may
less
diarrhea
toxin
patient
prospect
observ
studi
plan
measur
outcom
toxindna
inpati
diarrhea
chamber
c
parsi
schupp
armstrong
davi
school
medicin
depart
dermatolog
sacramento
ca
usa
objectivesspecif
aim
previou
research
suggest
healthcar
deliveri
may
improv
patient
satisfact
reduc
cost
improv
access
dermatolog
specialti
care
rigor
outcom
research
util
valid
outcom
measur
scarc
necessari
adopt
novel
healthcar
deliveri
model
purpos
studi
compar
clinic
equival
novel
onlin
healthcar
deliveri
model
standard
care
manag
psoriasi
patient
methodsstudi
popul
particip
psoriasi
random
receiv
care
either
onlin
period
clinic
valid
diseas
sever
qualiti
life
measur
includ
psoriasi
area
sever
index
pasi
investig
global
assess
iga
dermatolog
life
qualiti
index
dlqi
use
assess
effect
care
model
resultsanticip
result
onlin
group
show
improv
psoriasi
diseas
sever
measur
mean
improv
pasi
week
onlin
group
p
p
signific
differ
exist
mean
chang
pasi
two
group
mean
differ
pasi
chang
ci
priori
delta
iga
dlqi
score
also
improv
studi
period
signific
differ
exist
onlin
group
p
discussionsignific
impact
compar
tradit
care
onlin
model
result
similar
improv
psoriasi
diseas
sever
qualiti
life
onlin
care
effect
altern
standard
care
manag
psoriasi
sepelyak
k
dunkin
hong
haa
reiss
interdisciplinari
brain
scienc
research
stanford
ca
usa
school
medicin
stanford
ca
usa
objectivesspecif
aim
patient
william
syndrom
ws
turner
syndrom
ts
characterist
cognit
deficit
select
spare
verbal
abil
howev
studi
suggest
verbal
abil
spare
other
impair
aim
examin
specif
area
verbal
function
determin
disproportion
impair
children
ws
ts
methodsstudi
popul
administ
wechsler
scale
intellig
children
fourth
edit
nepsi
development
neuropsycholog
batteri
subject
age
ws
boy
ws
girl
ts
girl
typic
develop
td
girl
still
recruit
test
ws
td
subject
specif
verbal
abil
test
includ
vocabulari
similar
mean
comprehens
phonolog
process
speed
name
comprehens
instruct
comparison
verbal
subscal
conduct
use
multivari
analys
covari
linear
regress
model
resultsanticip
result
preliminari
analysi
confirm
signific
differ
overal
verbal
abil
group
averag
verbal
iq
ts
ws
td
respect
td
subject
tend
perform
consist
across
verbal
subtest
qualit
girl
ts
slightli
lower
score
phonolog
process
speed
name
compar
subtest
score
children
ws
disproportion
low
score
vocabulari
comprehens
comprehens
instruct
discussionsignific
impact
pattern
impair
specif
verbal
abil
offer
clue
root
caus
overal
verbal
deficit
may
also
help
therapist
util
intervent
approach
tailor
patient
strength
weak
huchko
mj
maloba
cohen
bukusi
california
san
francisco
san
francisco
ca
usa
medic
research
institut
nairobi
kenya
objectivesspecif
aim
visual
method
cervic
cancer
screen
promot
set
albeit
limit
evalu
women
thu
compar
perform
two
visual
inspect
techniqu
among
women
kenya
methodsstudi
popul
women
underw
cervic
cancer
screen
two
hiv
clinic
kisumu
one
site
perform
primari
screen
use
visual
inspect
acet
acid
via
site
perform
visual
inspect
lugol
iodin
vili
posit
result
either
screen
exam
confirm
colposcopi
cervic
histolog
women
via
group
offer
colposcopi
vili
group
women
given
return
appoint
differ
day
order
allow
iodin
stain
fade
resultsanticip
result
octob
may
women
underw
cervic
cancer
screen
differ
averag
age
vs
count
vs
stage
women
underw
via
versu
underw
vili
overal
rate
via
vili
p
posit
predict
valu
via
vili
p
via
group
women
undergo
colposcopi
versu
p
vili
group
discussionsignific
impact
vili
may
superior
method
via
diagnosi
among
women
set
although
referr
colposcopi
led
higher
rate
valid
strategi
use
vili
explor
capit
rel
high
posit
predict
valu
test
castel
ld
hartmann
deppen
mayer
johnson
boomershin
abramson
chakravarthi
mclellan
friedman
cella
univers
medic
center
nashvil
tn
usa
texa
southwestern
medic
center
dalla
tx
usa
univers
feinberg
school
medicin
chicago
il
usa
objectivesspecif
aim
breast
cancer
patient
begin
cours
aromatas
inhibitor
ai
year
prevent
cancer
recurr
joint
pain
like
lead
nonadher
adequ
data
joint
pain
predictor
trajectori
need
studi
joint
pain
patient
first
week
ai
therapi
methodsstudi
popul
postmenopaus
femal
outpati
initi
ai
n
complet
baselin
survey
prior
ai
initi
followup
survey
everi
week
thereaft
week
pain
measur
joint
use
numer
rate
scale
baselin
risk
factor
assess
includ
perform
statu
physic
function
comorbid
menopaus
symptom
time
sinc
menopaus
onset
age
educ
social
support
depress
exploratori
linear
regress
cluster
robust
standard
error
use
analyz
risk
factor
individu
worsen
pain
resultsanticip
result
mean
age
year
sd
women
fulli
activ
n
depress
n
baselin
mean
worst
pain
joint
prior
ai
initi
sd
women
wors
perform
statu
sever
menopaus
symptom
wors
physic
function
exist
musculoskelet
comorbid
baselin
greater
risk
increas
joint
pain
week
discussionsignific
impact
measur
describ
joint
pain
cours
ai
therapi
find
breast
cancer
adjuv
therapi
cohort
expect
help
inform
adher
intervent
toward
ensur
clinic
effect
ai
prevent
cancer
recurr
martinez
sr
mayadev
canter
lara
davi
cancer
center
sacramento
ca
usa
objectivesspecif
aim
previous
report
rural
patient
receiv
lower
rate
postmastectomi
radiat
therapi
rt
rel
urban
counterpart
hypothes
rural
patient
would
poorer
surviv
result
dispar
use
rt
methodsstudi
popul
use
surveil
epidemiolog
end
result
databas
identifi
bca
patient
treat
mastectomi
sacramento
surround
counti
patient
without
distant
metastas
tumor
cm
size
metastat
lymph
node
unit
state
depart
agricultur
scale
design
counti
rural
urban
multivari
cox
proport
hazard
model
predict
mortal
statu
covari
includ
age
raceethn
tumor
size
tumor
grade
hormon
receptor
statu
number
nodal
metastas
use
rt
stratifi
model
use
rt
counti
statu
risk
mortal
report
hazard
ratio
hr
confid
interv
ci
resultsanticip
result
patient
receiv
rt
urban
counti
multivari
analysi
show
rural
statu
influenc
os
hr
ci
p
dss
hr
ci
p
patient
receiv
rt
increas
risk
mortal
hr
ci
p
mortal
hr
ci
p
among
rural
patient
lack
rt
neg
influenc
os
hr
ci
p
dss
hr
ci
p
discussionsignific
impact
rural
statu
appear
independ
predictor
os
dss
data
indic
surviv
dispar
note
among
rural
bca
patient
may
due
part
decreas
use
rt
rural
popul
lotrecchiano
gr
georg
washington
univers
washington
dc
dc
usa
research
institut
washington
dc
dc
usa
objectivesspecif
aim
determin
social
structur
mechan
emerg
cross
disciplinari
team
scienc
methodsstudi
popul
descript
case
studi
identif
theoret
emerg
code
describ
social
interact
actor
part
network
charg
cross
disciplinari
social
boundari
use
sampl
drawn
nation
urea
cycl
disord
consortium
data
collect
ultim
relev
network
macro
polici
team
meso
evalu
individu
micro
experi
five
phase
approach
includ
network
level
survey
compet
complimentari
valu
nation
focu
group
individu
interview
team
observ
local
focu
group
sociogram
creat
use
atlasti
softwar
analysi
use
linguist
inquiri
word
count
liwc
softwar
resultsanticip
result
level
analysi
consid
role
reciproc
shape
ident
td
divers
team
process
allow
micro
level
exchang
actor
agent
respect
disciplin
within
relationship
social
mechan
observ
product
contributor
knowledg
creation
ultim
contribut
macro
level
context
discussionsignific
impact
studi
test
gener
tri
theori
social
dynam
emerg
embed
cdt
provid
empir
inquiri
definit
mechan
cdt
environ
inform
maintain
studi
elucid
role
interact
emerg
new
knowledg
focu
relationship
discoveri
prove
critic
identifi
natur
condit
polici
creation
leadership
characterist
train
necessari
truli
effect
cdt
gri
cj
landsittel
pilewski
pittsburgh
pittsburgh
pa
usa
objectivesspecif
aim
lung
alloc
system
la
model
develop
use
cox
regress
balanc
transplant
urgenc
transplant
benefit
la
poorli
predict
posttranspl
surviv
auc
surviv
tree
may
provid
clinic
use
tool
may
accur
predict
transplant
surviv
yield
interpret
subgroup
includ
interact
nonlinear
associ
purpos
studi
explor
util
surviv
tree
assess
posttranspl
surviv
order
refin
lung
organ
alloc
methodsstudi
popul
lung
transplant
recipi
transplant
identifi
organ
procur
transplant
network
databas
multipl
imput
perform
miss
data
surviv
tree
fit
r
statist
softwar
formul
prognost
model
transplant
surviv
year
resultsanticip
result
surviv
tree
analysi
provid
compar
result
exist
model
highli
signific
result
p
hazard
ratio
best
worst
subgroup
also
offer
clinic
interpret
model
base
specif
patient
subgroup
rather
weight
linear
combin
preliminari
result
reveal
signific
predictor
year
surviv
occur
split
point
wedg
pressur
mmhg
l
age
year
sever
valu
cardiac
output
discussionsignific
impact
subsequ
analys
explor
ensembl
model
resampl
approach
improv
prognost
valu
tree
model
use
approach
consid
refin
la
given
clinic
interpret
potenti
fit
complex
relationship
oranusi
v
shaheen
lo
amigo
nation
rehabilit
center
lo
angel
ca
usa
drew
univers
lo
angel
ca
usa
objectivesspecif
aim
aim
studi
associ
dvt
dehydr
identifi
risk
factor
dvt
patient
admit
rehabilit
follow
acut
stroke
brain
injuri
methodsstudi
popul
retrospect
review
computer
medic
record
patient
discharg
lo
angel
counti
neurorehabilit
center
diagnosi
dvt
acut
stroke
brain
injuri
traumat
intracrani
hemorrhag
hypox
includ
patient
diagnos
dvt
admiss
inpati
rehabilit
patient
receiv
appropri
dvt
prophylaxi
per
recommend
american
stroke
associ
document
fim
score
locomot
physic
therapist
admiss
center
assess
sever
impair
patient
previous
diagnos
dvt
prior
admiss
center
hypercoagul
exclud
presenc
dehydr
assum
patient
laboratori
evid
preren
azothemia
defin
buncr
ratio
greater
one
presenc
hemoconcentr
includ
also
demograph
insur
statu
length
stay
mortal
data
analysi
descript
bivari
analysi
use
multivari
logist
regress
associ
dvt
dehydr
well
risk
factor
debilit
andor
paralyz
stroke
bi
patient
inpati
rehabilit
determin
resultsanticip
result
progress
discussionsignific
impact
dehydr
often
seen
patient
admit
neurorehabilit
stroke
brain
injuri
howev
role
dehydr
major
risk
factor
dvt
patient
receiv
appropri
dvt
prophylaxi
emphas
momeni
kattan
univers
plasticreconstruct
surgeri
stanford
ca
usa
univers
school
medicin
stanford
ca
usa
objectivesspecif
aim
introduct
radiotherapi
xrt
result
increas
surviv
patient
diagnos
head
neck
malign
howev
potenti
deleteri
impact
radiotherapi
reconstruct
effort
continu
subject
intens
debat
present
studi
design
evalu
effect
preoper
radiotherapi
complic
rate
patient
undergo
microsurg
reconstruct
head
neck
defect
oncosurg
resect
methodsstudi
popul
retrospect
cohort
studi
conduct
patient
underw
immedi
microsurg
reconstruct
postabl
defect
period
studi
subject
divid
two
group
group
receiv
xrt
group
receiv
preoper
xrt
paramet
retriev
analyz
includ
age
gender
comorbid
condit
tobacco
histori
presenc
recurr
diseas
ischemia
time
icu
hospit
stay
well
postop
complic
complic
classifi
well
medic
resultsanticip
result
total
patient
includ
studi
group
patient
group
patient
result
similar
studi
group
except
higher
rate
complic
patient
undergo
radiotherapi
total
patient
experienc
complic
patient
group
n
vs
patient
group
n
p
discussionsignific
impact
data
suggest
preoper
radiotherapi
associ
signific
increas
postop
complic
firm
evid
exist
whether
postop
radiotherapi
advantag
propos
postop
radiotherapi
whenev
possibl
cialon
j
augustin
newhous
vierhil
marshal
rothberg
mink
rochest
rochest
ny
usa
objectivesspecif
aim
batten
diseas
inherit
rare
neurodegen
diseas
childhood
unifi
batten
diseas
rate
scale
ubdr
reliabl
research
tool
design
quantifi
diseas
progress
design
administr
object
determin
valid
ubdr
assess
reliabl
feasibl
telemedicin
administr
ubdr
subject
juvenil
batten
diseas
jncl
diseas
hypothes
ubdr
valid
tool
administ
reliabl
telemedicin
methodsstudi
popul
ubdr
valid
assess
subject
jncl
reliabl
ubdr
evalu
subject
resultsanticip
result
physic
r
p
capabl
subscal
r
p
ubdr
correl
strongli
age
physic
subscal
correl
capabl
subscal
p
correl
behavior
subscal
p
result
demonstr
face
converg
discrimin
valid
correl
rater
telemedicin
administr
ubdr
physic
subscal
p
indic
excel
reliabl
discussionsignific
impact
ubdr
valid
instrument
batten
diseas
result
indic
feasibl
administ
ubdr
reliabl
telemedicin
telemedicin
use
research
tool
rare
neurolog
diseas
research
sharp
j
clinic
cleveland
oh
usa
objectivesspecif
aim
increas
use
electron
health
record
ehr
grow
opportun
secondari
use
clinic
rich
data
research
four
use
case
present
challeng
exist
type
data
distinct
advantag
use
data
sever
research
context
methodsstudi
popul
review
recent
literatur
secondari
use
ehr
data
show
four
major
use
case
research
subject
recruit
diseas
registri
compar
effect
research
record
advers
event
postmarket
evalu
drug
devic
resultsanticip
result
studi
repres
earli
pilot
work
full
util
secondari
data
yet
come
particularli
true
research
subject
recruit
research
registri
matur
use
mani
medic
center
activ
maintain
registri
clinic
data
respositori
research
compar
effect
research
newer
phenomenon
import
fund
standpoint
like
produc
secondari
use
drug
devic
safeti
high
prioriti
studi
examin
issu
use
ehr
data
discussionsignific
impact
secondari
use
ehr
data
research
grow
branch
medic
informat
ehr
propag
also
increas
societ
concern
privaci
secur
must
address
feder
incent
adopt
ehr
meaning
use
requir
may
enhanc
potenti
use
ehr
data
research
grushko
nwachukwu
prat
huo
xu
charoenthammaraksa
wei
nanda
perou
olopad
chicago
chicago
il
usa
north
carolina
chapel
hill
nc
usa
objectivesspecif
aim
tripl
neg
tn
breast
cancer
aggress
overrepres
young
patient
women
african
ancestri
bl
tumor
subset
sporad
tn
tumor
share
morpholog
gene
express
featur
tumor
carrier
suggest
similar
aberr
affect
explor
inactiv
associ
tn
bl
subtyp
methodsstudi
popul
use
msp
immunohistochemistri
primari
breast
cancer
includ
african
american
analyz
promot
methyl
express
er
pr
egfr
cytokeratin
intrins
molecular
subtyp
evalu
cdna
microarray
tumor
subtyp
correl
methyl
clinicopatholog
featur
resultsanticip
result
among
breast
cancer
tn
methyl
detect
tn
p
proport
methyl
differ
subtyp
p
highest
bl
tumor
interestingli
tn
tumor
better
outcom
unmethyl
tn
tumor
p
gene
express
data
confirm
case
fall
bl
subtyp
show
lower
higher
mrna
express
compar
tumor
discussionsignific
impact
inactiv
via
promot
methyl
occur
half
sporad
tn
bl
tumor
may
earli
event
develop
subset
tumor
observ
carrier
find
justifi
parp
inhibit
strategi
treatment
andor
prevent
hereditari
sporad
tn
bl
breast
cancer
support
hci
li
desai
calhoun
cook
kuder
tepper
davi
beckett
mack
lara
jr
goodwin
gandara
davi
sacramento
ca
usa
objectivesspecif
aim
novel
trial
strategi
concurr
evalu
patient
xenograft
pdx
immunodefici
nsg
mice
valid
platform
person
cancer
therapi
methodsstudi
popul
util
transdiciplinari
research
collabor
ucd
cancer
center
jackson
laboratori
gener
cell
lung
cancer
nsclc
pdx
nsg
mice
use
correl
tumor
drug
respons
mice
correspond
patient
responsesnonrespons
patient
serial
passag
pdx
tumor
molecularli
character
mutat
microarray
gene
express
compar
resultsanticip
result
august
engraft
nsclc
tumor
engraft
least
month
tumor
enter
log
phase
growth
seven
first
gener
tumor
subject
histomorpholog
genom
analys
passag
first
tumor
six
tumor
discontinu
show
progress
tumor
growth
incub
time
preliminari
data
suggest
nsg
mous
model
provid
superior
engraft
rate
compar
avail
mous
model
good
histomorpholog
correl
pdx
tumor
origin
human
nsclc
tumor
molecular
genom
data
analyz
discussionsignific
impact
knowledg
largest
cohort
nsclc
pdx
model
yet
establish
character
need
defin
role
clinic
relev
research
platform
select
valid
clinic
relev
drug
target
individu
patient
base
molecular
biomark
profil
vivo
drug
test
scheper
weikel
almubarak
zhang
brahim
meiller
maryland
greenebaum
cancer
center
baltimor
md
usa
objectivesspecif
aim
purpos
translat
studi
investig
role
high
calcium
phosphat
therapi
neutral
local
acid
ph
induc
bp
scaveng
inhibit
connect
tissu
fibrosi
reduc
effect
zoledron
acid
za
oral
soft
tissu
methodsstudi
popul
saliva
patient
use
use
bp
without
bon
measur
ph
fibroblast
keratinocyt
cell
line
expos
za
acid
ph
high
solut
use
visual
inspect
tunel
immunohistochemistri
survivin
caspas
cleav
caspas
express
mt
scratch
migrat
flow
cytometri
assay
measur
effect
za
za
plu
resultsanticip
result
result
shown
patient
bon
acid
saliva
take
bp
without
bon
take
bp
addit
immunohistochemistri
western
blot
show
soft
tissu
surround
bon
lesion
overexpress
caspas
dose
depend
respons
effect
apoptosi
cell
prolifer
cell
cycl
observ
increas
za
concentr
final
shown
za
acid
induc
convers
fibroblast
myofibroblast
possibl
induc
local
fibrot
impair
wound
heal
overal
therapi
revers
salivari
acid
vitro
effect
za
convers
myofibroblast
discussionsignific
impact
combin
result
studi
demonstr
effect
za
bon
salivari
acid
soft
tissu
apoptosi
cell
prolifer
convers
myofibroblast
revers
use
supersatur
solut
support
potenti
role
adjunct
therapi
bon
facilit
soft
tissu
heal
hakim
c
duan
missouri
columbia
mo
usa
objectivesspecif
aim
absenc
dystrophin
cytoskelet
protein
caus
duchenn
muscular
dystrophi
dmd
dmd
lethal
muscl
wast
diseas
affect
boy
dystrophin
defici
muscl
sarcolemma
get
damag
contract
forc
subsequ
muscl
undergo
patholog
chang
muscl
cell
replac
fibrot
tissu
littl
known
passiv
properti
muscl
hypothes
chang
muscl
patholog
render
muscl
stiffer
dystrophin
also
highli
express
junction
mtj
thu
hypothes
dystrophin
defici
compromis
mtj
strength
methodsstudi
popul
test
hypothes
examin
respons
extensor
digitorum
longu
edl
muscl
mdx
mous
mous
model
dmd
resultsanticip
result
age
month
mdx
edl
muscl
significantli
stiffer
normal
control
mdx
edl
muscl
show
higher
relax
rate
normal
mdx
mice
muscl
failur
occur
within
muscl
interestingli
mdx
muscl
fail
proxim
mtj
electron
microscopi
reveal
substanti
mtj
degener
age
young
mdx
mice
discussionsignific
impact
summari
result
suggest
passiv
properti
edl
muscl
mtj
strength
compromis
mdx
importantli
increas
muscl
stiff
could
contribut
immobil
observ
dmd
patient
find
open
door
investig
whether
novel
genecellpharmacolog
therapi
halt
deterior
passiv
properti
improv
mechan
function
clerkin
tang
halperin
sinai
school
medicin
new
york
ny
usa
colleg
cuni
flush
ny
usa
objectivesspecif
aim
util
function
magnet
reson
imag
fmri
test
neurodevelopment
model
adhd
posit
deficit
subcort
alertingarous
mechan
contribut
develop
adhd
remain
present
adulthood
regardless
symptom
remiss
methodsstudi
popul
longitudin
sampl
proband
diagnos
adhd
childhood
control
clinic
evalu
scan
use
fmri
util
cu
reaction
time
rt
task
evok
activ
within
subcort
cortic
region
brain
associ
alert
activ
compar
control
proband
proband
divid
adhd
persist
remitt
signific
set
p
uncorrect
k
resultsanticip
result
adult
adhd
control
activ
similar
brain
region
alert
howev
control
demonstr
greater
activ
supplementari
motor
area
sma
anterior
cingul
acc
dorsolater
prefront
cortex
remitt
persist
differ
control
activ
region
howev
activ
remitt
differ
significantli
persist
conclus
differ
observ
sma
acc
dlpfc
suggest
subtl
discrep
alert
system
among
young
adult
without
childhood
diagnosi
adhd
addit
differ
brain
activ
differ
demonstr
symptom
persist
remitt
discussionsignific
impact
data
provid
preliminari
support
test
neurodevelopment
model
adhd
identifi
neural
system
target
treatment
hay
lm
saha
harri
ackermann
univers
school
nurs
indianapoli
usa
univers
school
medicin
indianapoli
usa
objectivesspecif
aim
least
million
american
prediabet
place
high
risk
develop
type
diabet
weight
loss
physic
activ
shown
prevent
delay
type
diabet
studi
describ
baselin
physic
activ
pa
pattern
use
object
measur
pa
accelerometri
adult
prediabet
enrol
ongo
rct
baselin
pa
describ
relationship
demograph
variabl
pa
examin
methodsstudi
popul
particip
recruit
primari
care
clinic
mostli
femal
african
american
mean
age
year
sd
mean
bmi
sd
relationship
race
gender
age
pa
explor
use
wilcoxon
test
spearman
rank
correl
test
resultsanticip
result
particip
ask
wear
monitor
day
wore
monitor
day
day
day
day
percent
subject
valid
day
monitor
wear
n
engag
minut
moder
vigor
pa
remain
median
time
minday
minday
particip
met
pa
recommend
minut
moder
intens
pa
least
day
pa
declin
increas
age
p
signific
differ
daili
pa
male
femal
african
american
white
particip
discussionsignific
impact
although
challeng
implement
trial
acceleromet
demonstr
low
level
pa
among
subseg
underserv
popul
prediabet
given
result
may
tremend
opportun
prevent
diabet
effect
effort
maxim
regular
pa
riz
hawley
translat
scienc
institut
children
nation
georg
washington
univers
medic
center
washington
dc
usa
objectivesspecif
aim
relaps
major
problem
acut
lymphoblast
leukemia
common
cancer
among
children
elev
express
nfkb
target
gene
associ
increas
relaps
nfkb
regul
surviv
migrat
invas
cancer
cell
import
featur
contribut
relaps
thu
nfkb
inhibit
suggest
includ
exist
therapeut
protocol
hand
exampl
indic
intracellular
stress
activ
nfkb
function
anticanc
drug
often
caus
stress
instanc
dna
damag
respons
ask
nfkb
function
alter
intracellular
stress
induc
convent
therapi
whether
inhibit
nfkb
benefit
current
protocol
methodsstudi
popul
fac
sirna
confoc
microscopi
immunoprecipit
mass
spectrometri
cell
cultur
without
stromal
cell
feeder
layer
leukem
mice
resultsanticip
result
data
indic
inhibit
nfkb
development
factor
activ
nfkb
decreas
cell
death
induc
etoposid
bortezomib
vincristin
provid
mechanist
explan
clinic
observ
show
lack
improv
addit
cours
treatment
combin
dexamethason
partial
act
via
inhibit
nfkb
vincristin
induc
stress
associ
mitot
perturb
howev
suggest
still
import
inhibit
cell
migrat
invas
arm
notch
nfkb
activ
therefor
propos
focu
downstream
target
gene
involv
process
discussionsignific
impact
understand
nfkb
respons
chemotherapi
help
design
effect
combin
strategi
prevent
relaps
cozad
bachman
grant
missouri
dept
biolog
engin
columbia
mo
usa
missouri
dept
gener
surgeri
columbia
mo
usa
objectivesspecif
aim
purpos
studi
assess
biocompat
diaphragm
gold
nanomateri
composit
determin
abil
promot
cell
attach
prolifer
wound
heal
methodsstudi
popul
porcin
diaphragm
collect
decellular
gold
nanorod
aunr
nanoparticl
aunp
variou
concentr
scan
electron
microscopi
sem
use
evalu
scaffold
morpholog
confirm
presenc
gold
nanomateri
cell
prolifer
reagent
use
assess
viabil
cell
composit
rel
decellular
scaffold
livedead
viabilitycytotox
kit
use
visual
cell
attach
morpholog
enhanc
prolifer
assess
use
picogreen
dsdna
reagent
abil
composit
reduc
number
free
radic
measur
use
oxiselect
ro
assay
kit
resultsanticip
result
sem
imag
depict
gold
nanomateri
dispers
diaphragm
microstructur
maintain
throughout
process
biocompat
decellular
less
biocompat
crosslink
confoc
microscopi
imag
depict
proper
cell
morpholog
increas
number
attach
cell
show
initi
higher
cell
popul
show
greater
prolifer
increas
aunp
concentr
composit
result
increas
free
radic
level
discussionsignific
impact
diaphragm
gold
nanomateri
composit
use
demonstr
good
biocompat
cell
attach
proper
morpholog
enhanc
cell
prolifer
free
radic
gener
depend
particl
shape
concentr
iz
brown
whalen
tuschl
rockefel
univers
new
york
ny
usa
objectivesspecif
aim
aim
develop
inexpens
method
profil
mirna
urin
biomark
identif
methodsstudi
popul
duplic
ml
urin
sampl
obtain
volunt
rna
extract
cell
exosom
prepar
one
cdna
librari
transcrib
sampl
synthet
rna
includ
calibr
mirna
profil
base
read
frequenc
resultsanticip
result
particip
age
year
medic
histori
physic
examin
laboratori
evalu
normal
cell
urin
scarc
median
rna
recoveri
ng
per
ml
exosom
yield
addit
pg
rna
per
sampl
averag
read
recov
per
sampl
mirna
constitut
mirna
differ
cell
exosom
strike
differ
note
gender
unexpect
find
involv
abund
consid
addit
also
found
neuron
abund
mirna
urin
yet
differ
gender
urin
fraction
variabl
r
lower
variabl
r
exosom
cell
discussionsignific
impact
studi
show
feasibl
multisampl
urin
mirna
profil
sequenc
meaning
profil
observ
despit
minut
amount
rna
observ
variabl
presum
due
differ
cell
popul
suggest
role
urin
mirna
biomark
diseas
progress
respons
treatment
also
diagnost
aid
gupta
mr
kolli
garofalo
galveston
tx
usa
objectivesspecif
aim
dendrit
cell
dc
popul
defin
lineag
express
blood
dendrit
cell
antigen
bdca
express
either
identifi
subset
human
myeloid
dendrit
cell
mdc
genom
array
studi
link
murin
murin
mdc
base
known
function
murin
dc
subset
thought
play
distinct
role
immun
regul
human
mdc
studi
limit
use
fac
sort
analysi
isol
distinct
mdc
subset
peripher
blood
studi
cytokin
respons
vitro
incub
tlr
agonist
methodsstudi
popul
peripher
blood
mononuclear
cell
pbmc
isol
blood
healthi
adult
donor
densiti
centrifug
pbmc
dc
enrich
deplet
lineag
posit
cell
magnet
label
microbead
stain
flourochrom
conjug
antibodi
fac
sort
analysi
cell
sort
express
incub
plate
poli
c
lp
ssrna
media
hr
cell
free
supernat
analyz
cytokin
resultsanticip
result
found
mdc
express
yet
differ
express
similar
dc
gene
express
identifi
rtpcr
dc
dc
demonstr
differenti
cytokin
product
respons
agonist
moreov
incub
poli
c
induc
robust
cytokin
respons
dc
lp
ssrna
induc
greater
respons
dc
discussionsignific
impact
show
express
defin
function
distinct
mdc
subset
data
suggest
role
immun
regul
may
determin
agonist
rather
cell
type
preferenti
respons
cell
type
differ
agonist
also
like
import
immun
respons
pathogen
breinholt
jp
sturek
univers
school
medicin
indianapoli
usa
objectivesspecif
aim
determin
time
cours
sever
pulmonari
arteri
stenosi
pa
elicit
intravascular
injuri
method
determin
histolog
stenot
pulmonari
arteri
dilat
stent
bioabsorpt
evalu
vessel
growth
stent
bioabsorpt
methodsstudi
popul
gener
novel
model
pa
juvenil
pig
use
intravascular
balloon
deliv
vessel
scleros
simul
diseas
stent
implant
lesion
site
monitor
ultrasound
intermitt
angiographi
stent
bioabsorpt
histolog
vessel
chang
dilat
injuri
heal
evalu
one
cohort
monitor
month
dissolut
evalu
somat
growth
diseas
segment
intervent
resultsanticip
result
anticip
bioabsorb
stent
allevi
pa
recoil
may
occur
stent
dissolv
heal
stent
intact
result
larger
vessel
diamet
hypothes
later
somat
growth
inhibit
scar
occur
result
angioplasti
injuri
discussionsignific
impact
balloon
expand
stent
manufactur
adult
use
current
stent
intend
biliari
renal
applic
place
larg
vessel
children
larg
rigid
smaller
patient
coronari
stent
develop
small
arteri
fit
larg
vessel
small
children
dilat
accomod
somat
growth
bioabsorb
coronari
stent
implant
locat
undergo
growth
prior
creat
narrow
surround
somat
growth
stent
dissolv
prevent
need
later
surgic
intervent
sabharw
v
stevenson
figueira
pelton
boston
usa
objectivesspecif
aim
capsular
switch
event
pneumococc
strain
recipi
capsul
operon
donor
strain
differ
capsular
serotyp
describ
increas
frequenc
follow
introduct
capsular
switch
event
enabl
pneumococci
acquir
new
phenotyp
trait
natur
transform
thu
vaccin
serotyp
chassi
acquir
non
vaccin
capsul
creat
new
combin
increas
virul
compar
origin
strain
may
creat
compar
capac
serotyp
wt
wt
capsular
transform
produc
eom
chinchilla
model
methodsstudi
popul
virul
non
virul
strain
use
creat
capsular
transform
chassi
capsul
wt
wt
strain
compar
pfge
complement
bind
use
flow
cytometri
measur
strain
virul
determin
chinchilla
eom
model
employ
initi
nasopharyng
colon
follow
barotrauma
proport
chinchilla
develop
cultur
posit
eom
densiti
middl
ear
infect
proport
chinchilla
bacteremia
compar
resultsanticip
result
wt
ident
pfge
bound
less
complement
compar
wt
eom
found
ear
challeng
transform
compar
p
diseas
due
wt
character
low
densiti
infect
compar
transform
wt
discussionsignific
impact
capsular
transform
demonstr
reduc
bind
increas
virul
proport
ear
infect
densiti
infect
compar
wt
confirm
potenti
capsular
switch
event
result
new
phenotyp
callan
ja
rotondi
siegl
spring
dey
pittsburgh
pittsburgh
pa
usa
mellon
univers
pittsburgh
pa
usa
objectivesspecif
aim
demonstr
use
cbt
mobilework
present
data
evalu
function
usabl
cbt
mobilework
intervent
control
set
unipolar
depress
patient
receiv
cbt
present
data
heurist
interview
experienc
cbt
therapist
examin
therapeut
comprehens
potenti
problem
likelihood
success
depress
popul
methodsstudi
popul
dr
callan
associ
develop
test
cbt
mobilework
provid
solut
barrier
depress
patient
experi
complet
assign
cbt
mobilework
smartphon
applic
complet
common
cbt
homework
assign
go
dr
callan
colleagu
conduct
iter
usabl
test
refin
prototyp
enhanc
usabl
satisfact
applic
depress
patient
cbt
cbt
therapist
resultsanticip
result
rate
icon
indic
lower
rate
monitor
homework
patient
therapist
lower
rate
icon
homework
icon
patient
problem
solv
homework
therapist
revis
may
necessari
improv
identif
lower
rate
therapist
andor
patient
given
cbt
mobilework
featur
homework
assign
monitor
portion
pie
priorit
fire
drill
break
task
step
solv
problem
downward
arrow
advic
would
give
friend
increas
social
support
social
discussionsignific
impact
expand
cbt
homework
menu
offer
therapist
patient
greater
flexibl
individu
assign
work
potenti
improv
potenc
therapi
depress
mallick
bergen
nishita
wei
michel
david
swan
reid
simon
andrew
intern
menlo
park
ca
usa
medic
school
stanford
ca
usa
research
institut
eugen
usa
oregon
eugen
usa
dame
univers
notr
dame
usa
objectivesspecif
aim
seek
understand
correl
chronic
stress
influenc
develop
substanc
use
cohort
oysup
methodsstudi
popul
evalu
clinic
salivari
rna
metric
differenti
express
candid
gene
saliva
sampl
individu
femal
randomli
select
two
group
stratifi
high
versu
low
sever
neg
life
event
measur
life
event
difficulti
schedul
brown
harri
use
multipl
analyt
platform
multipl
refer
gene
replic
gene
express
assay
chose
candid
gene
previous
identifi
differenti
express
scan
rna
caregiv
brain
cancer
patient
control
subject
match
age
gender
ethnic
marit
statu
free
major
stressor
prior
year
resultsanticip
result
observ
signific
differ
smoke
statu
p
rna
integr
score
p
stress
strata
analyz
qpcr
data
use
compar
standard
curv
rel
standard
curv
method
assay
effici
estim
assay
data
show
high
linear
low
variabl
observ
signific
express
assay
high
stress
stratum
use
method
interrog
glucocorticoid
receptor
regul
gene
analys
show
signific
associ
rna
yield
integr
score
gender
andor
stress
result
normal
gene
express
assay
discussionsignific
impact
gene
express
signatur
chronic
stress
previous
observ
hematopoiet
sampl
observ
unfraction
saliva
young
adult
bembea
mcelrath
schwartz
shah
lehmann
kickler
pronovost
strous
hopkin
univers
baltimor
md
usa
objectivesspecif
aim
compar
mean
coagul
monitor
ecmo
methodsstudi
popul
prospect
observ
studi
ecmo
patient
tertiari
picu
antithrombin
factor
viii
fviii
measur
blood
sampl
collect
everi
hour
ecmo
demograph
clinic
data
collect
prospect
resultsanticip
result
patient
age
year
enrol
median
age
day
iqr
year
median
ecmo
durat
day
iqr
day
primari
ecmo
indic
respiratori
failur
cardiac
failur
extracorpor
cardiopulmonari
resuscit
sepsi
median
iuml
median
median
fviii
median
act
sec
median
heparin
infus
rate
ukghour
heparin
infus
rate
increas
day
ecmo
iuml
p
p
ukghour
p
respect
act
decreas
day
ecmo
sec
ci
p
fviii
remain
stabl
throughout
ecmo
cours
patient
high
fviii
appear
develop
heparin
resist
activ
posit
correl
heparin
infus
rate
r
p
r
p
correl
act
heparin
infus
rate
r
p
result
maintain
control
blood
product
administr
discussionsignific
impact
studi
warrant
determin
use
ecmo
anticoagul
monitor
frazier
eng
clinic
cleveland
oh
usa
western
reserv
univers
cleveland
oh
usa
objectivesspecif
aim
primari
aim
studi
character
cognit
structur
imag
profil
macrocephal
individu
autism
germlin
heterozyg
pten
mutat
compar
individu
autism
macrocephali
without
pten
mutat
b
healthi
control
without
macrocephali
methodsstudi
popul
anticip
collect
dna
cognit
phenotyp
data
individu
macrocephali
autism
control
individu
anticip
harbor
mutat
pten
plan
collect
structur
neuroimag
volum
individu
individu
healthi
control
inclus
criteria
includ
age
autism
spectrum
diagnosi
known
genet
condit
phenotyp
evalu
includ
autism
diagnost
interview
collect
histori
autism
symptom
scale
independ
measur
daili
live
skill
cognit
data
collect
includ
verbal
nonverb
abil
attent
work
memori
memori
resultsanticip
result
month
collect
data
patient
male
median
age
rang
addit
patient
schedul
next
month
patient
met
criteria
autism
spectrum
diagnosi
one
patient
pten
mutat
individu
signific
strength
nonverb
abil
otherwis
low
cognit
function
skill
patient
shown
highli
variabl
symptom
cognit
pattern
discussionsignific
impact
key
next
step
continu
recruit
begin
neuroimag
recruit
healthi
control
anticip
complet
recruit
within
propos
time
frame
mian
jame
becton
bhutta
prodhan
arkansa
medic
scienc
littl
rock
ar
usa
objectivesspecif
aim
acut
phase
reactant
present
predict
clinic
outcom
methodsstudi
popul
prospect
studi
children
receiv
chemotherapi
blood
sampl
collect
presentaion
test
protein
crp
solubl
receptor
interleukin
il
tumor
necrosi
tnf
clinic
outcom
data
correl
includ
follow
criteria
prolong
hospit
day
admiss
picu
posit
bacteri
blood
cultur
risk
patient
none
cluster
analysi
perform
variabl
use
pearson
correl
coeffici
multivari
logist
regress
analysi
perform
develop
risk
base
predict
model
valid
use
receiv
oper
characterist
roc
curv
resultsanticip
result
interim
analysi
perform
dataset
includ
event
univari
analysi
show
median
valu
crp
significantli
differ
high
cluster
analysi
show
strong
correl
tnf
logist
regress
analysi
show
present
crp
p
p
biomark
correl
present
increas
crp
mgl
mgl
associ
increas
likelihood
similarli
rise
pgml
pgml
increas
likelihood
risk
stratifi
predict
model
valid
use
receiv
oper
characterist
curv
auc
discussionsignific
impact
crp
fn
present
correl
may
use
screen
tool
mendez
k
romaguera
ortiz
unger
steinau
school
medicin
guaynabo
puerto
rico
diseas
control
prevent
atlanta
ga
usa
school
public
health
san
juan
puerto
rico
objectivesspecif
aim
object
applic
evalu
urin
hpv
test
use
pcr
base
linear
array
system
easier
comfort
effect
screen
method
compar
standard
cervic
test
specif
aim
determin
hpv
detect
urin
compar
cervic
test
determin
hpv
viral
load
correl
cytolog
histolog
result
evalu
accept
urin
self
sampl
methodsstudi
popul
studi
women
attend
obgyn
clinic
upr
evalu
abnorm
cytolog
pilot
studi
popul
includ
women
sexual
activ
nonpregn
age
year
intact
uteru
resid
pr
attend
clinic
evalu
abnorm
pap
smear
women
exclud
cognit
physic
impair
particip
data
demograph
risk
factor
hpv
infect
urin
self
sampl
accept
collect
particip
collect
self
urin
sampl
pelvic
exam
gynecologist
done
collect
cervic
specimen
colposcopi
cervix
biopsi
perform
sampl
sent
cdc
hpv
laboratori
dna
extract
hpv
detect
type
perform
viral
load
obtain
resultsanticip
result
hypothesi
hpv
detect
urin
self
sampl
could
done
use
pcr
base
linear
array
accept
sensit
method
hpv
screen
discussionsignific
impact
rational
studi
urin
specimen
approach
facilit
hpv
detect
women
poor
access
gynecologist
attract
patient
increas
complianc
screen
follow
protocol
pazdrak
k
straub
kuroski
texa
medic
branch
galveston
tx
usa
objectivesspecif
aim
current
valid
test
measur
glucocorticosteroid
gc
sensit
sever
asthma
eosinophil
inflammatori
cell
play
import
role
asthma
respond
glucocorticoid
manner
parallel
respons
steroid
therapi
seen
asthma
patient
use
compar
proteom
select
protein
eosinophil
order
establish
cellular
marker
steroid
resist
asthma
methodsstudi
popul
proteom
data
protein
eosinophil
use
refer
set
seek
biomark
steroid
respons
cell
obtain
patient
steroid
resist
steroid
refractori
steroid
sensit
asthma
resultsanticip
result
studi
show
eosinophil
display
consider
alter
proteom
profil
result
activ
protein
phosphatas
dephosphoryl
gc
receptor
defect
induct
protein
surmis
identifi
compon
gc
signal
pathway
may
serv
potenti
diagnost
marker
steroid
resist
patient
sever
asthma
discussionsignific
impact
absenc
therapeut
altern
sever
asthma
resist
steroid
pose
genuin
health
challeng
also
financi
burden
patient
account
healthcar
cost
result
expect
signific
impact
identifi
mechan
compon
highli
like
provid
new
target
therapeut
intervent
well
potenti
diagnost
marker
steroid
resist
chong
bf
tseng
pazandak
li
olsen
mohan
texa
southwestern
medic
center
dalla
tx
usa
state
colleg
medicin
hershey
pa
usa
objectivesspecif
aim
autoantibodi
uniqu
cutan
lupu
cle
patient
found
system
lupu
sle
yet
identifi
would
aid
diagnosi
classif
autoantigen
array
measur
multipl
autoantibodi
simultan
patient
sera
primari
aim
character
autoantibodi
profil
cle
patient
without
sle
use
array
methodsstudi
popul
dermatoproteom
array
construct
spot
purifi
autoantigen
involv
variou
autoimmun
system
cutan
diseas
onto
whatman
fast
slide
dilut
patient
sera
cle
patient
without
sle
cle
patient
sle
sle
patient
without
cle
normal
healthi
control
incub
array
label
igg
igm
genepix
scanner
detect
fluoresc
antibodi
gener
imag
analysi
resultsanticip
result
autoantibodi
nuclear
antigen
show
increment
rise
normal
control
cle
patient
without
sle
cle
patient
sle
sle
patient
without
cle
p
igg
autoantibodi
heparan
sulfat
proteoglycan
cle
patient
without
sle
versu
group
discussionsignific
impact
stepwis
autoantibodi
nuclear
antigen
cle
without
sle
cle
sle
sle
without
cle
patient
stratifi
cle
sle
patient
given
lymphocyt
congreg
around
junction
cle
skin
heparan
sulfat
proteoglycan
may
repres
potenti
autoantigen
cle
dermatoproteom
array
potenti
serv
use
tool
distinguish
lupu
subtyp
diagnos
sle
cle
understand
diseas
etiolog
awodel
lin
dimitrakov
colleg
medicin
washington
dc
usa
medic
school
boston
usa
objectivesspecif
aim
aim
measur
chang
cerebr
metabolit
patient
diagnos
cpp
methodsstudi
popul
studi
compar
male
patient
n
diagnos
cpp
male
pain
histori
n
also
femal
patient
n
diagnos
cpp
use
proton
mr
spectroscopi
collect
singl
voxel
mr
acquir
two
pain
process
cortic
region
anterior
cingul
gyru
acg
occipit
grey
matter
ocm
proton
mr
spectral
analysi
perform
use
linear
combin
model
provid
absolut
concentr
neurometabolit
ratio
concentr
raw
spectra
correl
spectroscopi
cosi
concaten
cosi
resultsanticip
result
comparison
mr
result
ogm
male
cpp
male
control
show
trend
reduc
concentr
naa
creatin
cr
pcr
male
cpss
p
report
first
time
cosi
data
acquir
patient
cpp
reveal
signific
increas
threoninecr
male
cpp
ogm
femal
patient
cpp
compar
male
cpp
mr
show
signific
chang
acg
concentr
glutam
macromolecul
reduc
male
also
close
trend
toward
signific
p
note
naa
male
cpp
ogm
cosi
result
show
signific
increas
glutam
glutamin
glx
phenylalanin
phe
aspart
asp
male
cpp
discussionsignific
impact
neuron
loss
damag
mayb
associ
cpp
pathophysiolog
gender
bia
pain
process
may
exist
wang
w
colling
weber
schwartz
boning
pittsburgh
pittsburgh
pa
usa
engin
research
laboratori
depart
veteran
affair
pittsburgh
pa
usa
objectivesspecif
aim
interfac
bci
technolog
aim
establish
direct
link
transmit
inform
brain
extern
devic
potenti
offer
natur
rich
control
signal
robot
devic
prosthet
limb
function
electr
stimul
reanim
paralyz
limb
group
clinic
research
interest
translat
basic
bci
research
clinic
viabl
bci
devic
propos
electrocorticographi
ecog
realist
approach
strike
optim
balanc
tradeoff
associ
neural
signal
qualiti
invas
system
complex
mainten
methodsstudi
popul
conduct
preclin
ecog
studi
direct
focu
decod
hand
postur
ecog
signal
implant
miniatur
ecog
grid
hand
area
motor
cortex
neurosurg
patient
undergo
subdur
epilepsi
monitor
particip
perform
variou
hand
movement
task
includ
individu
finger
movement
task
task
resultsanticip
result
band
ecog
signal
record
motor
cortex
show
signific
increas
power
hand
movement
encod
signific
inform
hand
grasp
movement
regress
power
variou
frequenc
band
first
three
princip
compon
hand
movement
band
yield
high
valu
indic
ecog
signal
encod
signific
inform
hand
grasp
movement
accur
predict
hand
flexion
base
ecog
signal
discussionsignific
impact
suggest
may
possibl
restor
basic
hand
function
daili
activ
use
bci
system
krupka
seydel
ye
taylor
daili
einstein
colleg
medicin
bronx
ny
usa
malaria
project
blantyr
malawi
objectivesspecif
aim
malaria
lead
caus
morbid
mortal
worldwid
though
plasmodium
falciparum
account
malari
fatal
infect
p
falciparum
alway
synonym
diseas
larg
percentag
children
endem
area
carri
parasit
without
characterist
fever
furthermor
symptomat
subset
develop
sever
diseas
syndrom
associ
mortal
rate
individu
develop
symptomat
diseas
andor
sever
diseas
clearli
understood
howev
pattern
host
immun
specif
cytokin
associ
differ
clinic
state
aim
explor
role
immun
system
broadli
host
respons
across
differ
clinic
state
methodsstudi
popul
studi
human
whole
genom
transcript
express
profil
children
admit
coma
p
falciparum
parasitemia
blantyr
malawi
malari
season
asymptomat
parasit
burden
found
routin
outpati
visit
follow
hospit
stay
anoth
sampl
drawn
transcript
profil
sever
asymptomat
visit
compar
healthi
control
patient
resultsanticip
result
individu
gene
well
gene
set
obtain
kegg
literatur
associ
cm
vs
clinic
state
identifi
individu
gene
signific
p
valu
fold
chang
gene
set
signific
determin
use
gene
set
enrich
analysi
genepattern
cambridg
softwar
discussionsignific
impact
data
provid
insight
pathophysiolog
clinic
malaria
state
may
contribut
identif
adjunct
therapi
improv
surviv
rate
kim
wang
cui
curran
ward
warner
roayai
shafir
zhang
itzkowitz
sinai
school
medicin
new
york
ny
usa
sinai
school
medicin
new
york
ny
usa
sinai
school
medicin
new
york
ny
usa
objectivesspecif
aim
small
intestin
carcinoid
sic
often
detect
late
clinic
cours
littl
known
molecular
pathway
import
develop
metastasi
recent
develop
protein
pathway
array
screen
chang
protein
phosphoprotein
express
tissu
object
studi
identifi
key
pathway
import
mechan
sic
metastasi
develop
methodsstudi
popul
primari
tumor
liver
metastas
patient
metastat
sic
harvest
extract
protein
separ
sd
gel
western
blot
perform
antibodi
band
densiti
determin
use
biorad
imag
system
signific
analysi
microarray
use
select
protein
differenti
express
differ
group
unsupervis
hierarch
cluster
analysi
perform
resultsanticip
result
protein
analyz
protein
express
sampl
protein
primari
sic
compar
match
normal
small
bowel
mucosa
cyclin
e
primari
sic
tissu
compar
normal
small
bowel
mucosa
compar
normal
liver
tissu
sic
liver
metastas
demonstr
compar
primari
sic
pair
liver
metastas
cyclin
e
demonstr
signific
liver
metastasi
discussionsignific
impact
studi
compar
gene
protein
express
primari
metastat
sic
tumor
resect
simultan
find
use
protein
pathway
array
reveal
chang
limit
number
protein
suggest
may
target
therapi
magno
p
suarez
meltzer
rico
cancer
center
univers
puerto
rico
san
juan
usa
gastroenterolog
depart
medicin
john
hopkin
univers
school
medicin
baltimor
md
usa
biostatist
epidemiolog
univers
puerto
rico
school
public
health
san
juan
usa
objectivesspecif
aim
object
project
establish
dna
methyl
pattern
use
cancer
surveil
barrett
esophagu
patient
object
achiev
two
specif
aim
determin
preval
dna
promot
hypermethyl
mrna
level
express
candid
gene
barrett
esophagu
differ
grade
dysplasia
adenocarcinoma
valid
methyl
profil
barrett
esophagu
predict
esophag
cancer
develop
methodsstudi
popul
sampl
barrett
esophagu
esophag
adenocarcinoma
collect
particip
questionnair
abstract
clinicopatholog
data
environment
exposur
administ
prior
endoscopi
dna
promot
hypermethyl
candid
gene
gdna
assess
use
methylight
assay
epigenet
gene
silenc
confirm
analysi
differ
methyl
pattern
associ
differ
dysplast
barrett
esophagu
esophag
adenocarcinoma
assess
use
multinomi
regress
model
resultsanticip
result
anticip
result
studi
predict
develop
esophag
adenocarcinoma
barrett
esophagu
base
dna
methyl
profil
discussionsignific
impact
barrett
esophagu
major
risk
factor
esophag
adenocarcinoma
identifi
biomark
screen
barrett
esophagu
patient
high
risk
cancer
would
allow
us
earli
intervent
endoscop
therapi
chemoprevent
swaminathan
bose
shah
hiatt
arkansa
medic
scienc
littl
rock
ar
usa
objectivesspecif
aim
nephrogen
system
fibrosi
nsf
character
tissu
accumul
iron
infiltr
fibrocyt
cell
cellular
pathway
particip
iron
dysmetabol
nsf
unknown
pathway
central
iron
metabol
bodi
methodsstudi
popul
evalu
vitro
effect
gadolinium
contrast
omniscan
cultur
human
peripher
blood
mononuclear
cell
pbmc
pbmc
cultur
omniscan
mmolkg
bw
day
adher
cell
isol
evalu
flow
cytometri
immunofluoresc
phenotyp
protein
express
confirm
western
blot
perform
addit
vitro
studi
oral
iron
chelat
deferipron
evalu
effect
chang
immunohistochemistri
perform
nsf
biopsi
specimen
cellular
marker
resultsanticip
result
omniscan
treatment
induc
increas
number
adher
spindl
cell
cell
strongli
express
marker
iron
metabol
iron
export
ferroportin
less
hepcidin
iron
chelat
significantli
decreas
develop
adher
spindl
cell
spindl
cell
nsf
skin
biopsi
express
ferroportin
discussionsignific
impact
omniscan
induc
develop
spindl
cell
vitro
cell
accumul
human
nsf
activ
pathway
inhibit
hepcidin
vitro
omniscan
taken
along
inhibit
spindl
cell
differenti
deferipron
suggest
potent
role
pathway
iron
export
nsf
pathogenesi
empey
pe
miller
melick
kochanek
poloyac
pharmaci
u
pittsburgh
pittsburgh
pa
usa
center
resuscit
research
u
pittsburgh
pittsburgh
pa
usa
objectivesspecif
aim
concern
regard
unknown
drug
relationship
complic
medic
dose
therapeut
hypothermia
cardiac
arrest
ca
cool
known
substanti
decreas
cytochrom
cyp
drug
metabol
vitro
limit
data
suggest
level
drug
substrat
increas
clinic
studi
object
determin
clearanc
clinic
relev
substrat
fentanyl
midazolam
mild
therapeut
hypothermia
follow
ca
methodsstudi
popul
asphyxi
ca
rat
model
use
bodi
temperatur
control
surfac
cool
h
postinsult
mimic
time
target
temperatur
achiev
clinic
fentanyl
ugkgh
midazolam
mgkgh
given
iv
plasma
level
assay
h
ratsgroup
system
clearanc
calcul
noncompartment
pharmacokinet
metabolit
hepat
microsom
format
rate
measur
vitro
paramet
determin
resultsanticip
result
temperatur
group
cool
reduc
system
clearanc
midazolam
mlminkg
fentanyl
mlminkg
microsom
metabolit
format
rate
lower
driven
reduct
maxim
enzym
veloc
rather
affin
discussionsignific
impact
cool
ca
modestli
decreas
midazolam
fentanyl
system
clearanc
rat
given
cool
appli
h
ca
patient
hepat
clearanc
may
compromis
consider
impact
therapeut
hypothermia
concurr
drug
therapi
warrant
support
spornick
n
khaibullina
finkel
quezado
zay
institut
pediatr
surgic
innov
washington
dc
usa
objectivesspecif
aim
ampl
evid
nocicept
opioid
analgesia
impact
sex
women
lower
toler
sever
stimuli
heat
pressur
electr
cold
compar
men
studi
effect
sex
analges
nocicept
use
assay
deliv
electr
stimuli
hz
order
preferenti
stimul
c
sensori
fiber
respect
methodsstudi
popul
stimul
frequenc
deliv
predetermin
increment
audibl
vocal
defin
nocifens
behavior
intens
stimul
elicit
vocal
current
vocal
threshold
cvt
measur
cvt
administr
morphin
intrathec
ugkg
resultsanticip
result
basal
condit
male
significantli
higher
mean
cvt
compar
femal
hz
increas
dose
morphin
cvt
percent
chang
baselin
increas
significantli
higher
respons
hz
compar
hz
current
vocal
threshold
percent
chang
baselin
h
significantli
order
hz
hz
p
hz
hz
p
result
suggest
respons
hz
simul
mostli
affect
morphin
hour
morphin
inject
overal
effect
morphin
cvt
p
discussionsignific
impact
femal
lower
cvt
male
baselin
impact
anim
sex
therefor
use
electr
stimul
frequenc
reportedli
preferenti
stimul
c
sensori
nerv
fiber
nocicept
assay
enabl
evalu
differ
impact
opioid
analgesia
mice
ceglia
l
silva
morai
harri
field
medic
center
boston
usa
univers
boston
usa
zurich
zurich
switzerland
objectivesspecif
aim
histolog
analysi
muscl
biopsi
adult
vitamin
defici
reveal
predomin
type
muscl
fiber
atrophi
sought
determin
whether
supplement
vitamin
older
vitamin
insuffici
women
affect
chang
muscl
fiber
area
csa
month
methodsstudi
popul
random
pilot
studi
healthi
women
assign
receiv
vitamin
iud
placebo
month
serum
level
muscl
biopsi
vastu
laterali
perform
baselin
month
section
probe
myosin
heavi
chain
antibodi
resultsanticip
result
mean
baselin
similar
group
placebo
n
ngml
vitamin
n
ngml
expect
mean
final
differ
group
placebo
ngml
vitamin
ngml
p
mean
baselin
muscl
fiber
csa
differ
significantli
group
placebo
vitamin
howev
trend
toward
greater
percent
chang
muscl
fiber
csa
vitamin
supplement
placebo
vitamin
p
although
statist
signific
posit
linear
associ
note
chang
chang
muscl
fiber
csa
r
p
discussionsignific
impact
find
consist
potenti
benefici
effect
vitamin
muscl
fiber
size
larger
studi
sampl
need
definit
establish
increas
fiber
area
vitamin
supplement
edward
tl
song
li
univers
nashvil
tn
usa
univers
nashvil
tn
usa
objectivesspecif
aim
target
resequenc
associ
genom
region
common
approach
associ
common
allel
howev
prohibit
expens
resequ
subject
gwa
suffici
depth
call
rare
genotyp
mani
studi
may
use
sequenc
snp
discoveri
subset
subject
intent
genotyp
rare
snp
captur
resequenc
approach
reason
may
ineffici
sampl
care
select
resequenc
studi
develop
approach
sampleseq
select
sampl
target
resequenc
studi
increas
yield
rare
diseas
allel
substanti
random
sampl
subject
base
genotyp
associ
snp
gwa
data
methodsstudi
popul
assum
preval
trait
known
genotyp
avail
snp
ld
causal
variant
hwe
popul
snp
let
ga
gd
genotyp
marker
diseas
locu
respect
let
diseas
statu
case
control
goal
calcul
expect
count
allel
e
gd
ga
given
subject
genotyp
snp
affect
statu
select
subject
accordingli
evalu
method
simul
resultsanticip
result
sampleseq
outperform
compet
sampl
strategi
diseas
allel
rare
perform
similar
strategi
diseas
allel
common
discussionsignific
impact
work
describ
sampleseq
method
optim
select
subject
resequenc
associ
genom
region
method
preserv
resourc
subsequ
step
investig
estim
sampl
size
requir
captur
diseas
allel
target
frequenc
arbitrari
number
region
nazarian
j
saratsi
perez
yadavilli
yoon
magg
nation
medic
center
washington
dc
usa
objectivesspecif
aim
diffus
intrins
pontin
glioma
dipg
high
grade
brainstem
glioma
bsg
remain
uniformli
fatal
factor
contribut
lack
progress
includ
tissu
unavail
lack
robust
anim
model
diseas
recent
studi
suggest
bsg
exhibit
molecular
behavior
distinct
high
grade
glioma
could
account
lack
respons
otherwis
effect
treatment
goal
gener
platform
address
two
obstacl
mention
combat
pediatr
brain
tumor
methodsstudi
popul
launch
clinic
studi
clinicaltrialsgov
postmortem
specimen
collect
work
close
variou
institut
foundat
promot
specimen
donat
establish
biobank
bsg
frozen
specimen
recent
publish
first
genet
engin
murin
model
bsg
also
expand
collabor
site
goal
develop
mediat
drug
deliveri
use
bsg
murin
model
resultsanticip
result
show
bsg
mous
pathogen
similar
high
grade
pediatr
bsg
provid
preliminari
data
show
least
protein
show
similar
dysregul
bsg
mous
human
formalin
fix
sampl
also
gener
preliminari
proteom
data
bsg
mous
present
potenti
biomark
discussionsignific
impact
inspir
nih
approach
assembl
dedic
team
includ
oncologist
neurosurgeon
neurologist
clinic
coordin
scientist
success
team
alreadi
led
acquisit
addit
frozen
bsg
sampl
gener
preliminari
data
ultim
goal
defin
biolog
bsg
dipg
develop
effect
therapeut
base
understand
diseas
zemlyak
zakhaleva
pearl
mileva
gelato
mynarcik
mcnurlan
brook
univers
medic
center
stoni
brook
ny
usa
objectivesspecif
aim
compar
level
gene
express
ikb
kinas
cd
leptin
sampl
adipos
tissu
obes
lean
individu
gynecolog
malign
healthi
control
methodsstudi
popul
retrospect
studi
patient
group
stoni
brook
univers
medic
center
patient
control
group
underw
abdomin
oper
benign
condit
obes
defin
bmi
piec
oment
adipos
tissu
collect
surgeri
rel
amount
rna
calcul
ikb
tnfa
leptin
normal
gapdh
age
smoke
statu
cancer
control
group
compar
test
level
ikb
tnfa
leptin
compar
obes
lean
patient
paramet
differ
cancer
control
group
includ
multivari
logist
regress
model
resultsanticip
result
sampl
size
cancer
patient
control
mean
age
cancer
patient
vs
control
group
p
patient
endometri
ovarian
cervic
cancer
major
cancer
patient
stage
diseas
vs
smoker
p
group
signific
differ
found
lean
obes
patient
level
ikb
p
p
express
gene
ikb
tnfa
associ
cancer
statu
patient
leptin
express
weak
neg
associ
cancer
ci
p
discussionsignific
impact
ikb
tnfa
express
adipos
tissu
associ
posit
cancer
statu
leptin
mild
protect
associ
cancer
lanza
zabielski
jakaiti
ali
nair
clinic
rochest
mn
usa
objectivesspecif
aim
fatti
acid
epa
dha
document
health
benefit
includ
protect
develop
insulin
resist
investig
fish
oil
affect
muscl
mitochondri
function
ceramid
content
potenti
mechan
insulin
sensit
effect
methodsstudi
popul
mice
fed
week
normal
fat
diet
nfd
fat
high
fat
diet
hfd
fat
high
fat
diet
fish
oil
fat
kcal
dha
epa
resultsanticip
result
glucos
toler
ogtt
significantli
declin
hfd
quadricep
muscl
oxid
capac
respirometri
significantli
higher
hfd
compar
nfd
respiratori
control
ratio
p
measur
indic
greater
mitochondri
effici
hfd
compar
nfd
product
amplex
red
nadph
oxidas
activ
lucigenin
similarli
elev
hfd
compar
nfd
total
ceramid
content
mass
spectrometri
higher
hfd
group
muscl
homogen
sarcoplasm
myofibrillar
fraction
mitochondri
fraction
analysi
ceramid
composit
reveal
unsatur
index
higher
hfd
similar
nfd
cellular
fraction
discussionsignific
impact
data
indic
dhaepa
protect
glucos
intoler
also
decreas
mitochondri
coupl
possibl
chang
unsatur
ceramid
skelet
muscl
acheson
daw
laird
mathia
dougherti
health
scienc
center
san
antonio
san
antonio
tx
usa
objectivesspecif
aim
purpos
studi
investig
reward
circuitri
adolesc
marijuana
user
increas
risk
futur
substanc
use
disord
possibl
increas
risk
substanc
use
disord
may
relat
alter
reward
circuitri
methodsstudi
popul
compar
frequent
adolesc
use
per
week
nonus
control
perform
task
comput
task
requir
guess
whether
simul
coin
flip
would
head
tail
perform
perceptu
motor
control
task
particip
instruct
would
win
dollar
correct
guess
lose
dollar
incorrect
guess
howev
task
program
win
loss
equal
regardless
choic
resultsanticip
result
across
particip
win
associ
cingul
middl
frontal
superior
frontal
inferior
frontal
gyru
decliv
activ
loss
associ
cingul
middl
frontal
occipit
gyri
decliv
activ
marijuana
user
greater
middl
inferior
frontal
gyri
caudat
claustrum
activ
win
greater
anterior
posterior
cingul
middl
frontal
gryru
insula
clastrum
decliv
activ
next
found
evid
group
differ
function
connect
among
region
follow
condit
discussionsignific
impact
find
provid
evid
adolesc
marijuana
use
associ
alter
regul
reward
although
unclear
alter
consequ
marijuana
use
preexist
trait
result
provid
support
evid
alter
reward
circuitri
may
contribut
increas
risk
futur
substanc
use
disord
adolesc
frequent
marijuana
user
izadmehr
narla
sinai
school
medicin
new
york
ny
usa
objectivesspecif
aim
prostat
cancer
pca
second
lead
caus
death
among
male
unit
state
beyond
burden
live
affect
lost
new
pca
case
project
alon
thu
need
defin
genet
basi
diseas
clear
develop
genet
relev
mous
model
high
prioriti
pca
research
mice
spontan
develop
prostat
cancer
pca
mous
model
involv
transgen
overexpress
oncogen
target
delet
tumor
suppressor
gene
use
knockout
technolog
howev
highli
penetr
model
wide
dispers
metastat
diseas
yet
develop
address
problem
develop
new
murin
model
pca
combin
transgen
overexpress
oncogen
methodsstudi
popul
develop
genet
relev
mous
model
high
prioriti
pca
research
advancedmetastat
murin
model
prostat
cancer
recapitul
human
diseas
address
problem
investig
whether
concurr
overexpress
acceler
prostat
cancer
progress
gener
novel
doubl
transgen
mous
model
overexpress
human
human
resultsanticip
result
histolog
doubl
transgen
mice
prostat
display
advanc
aggress
tumor
evid
stromal
invas
higher
gleason
score
gleason
compar
mice
overexpress
either
adenocarcinoma
gleason
pin
gleason
alon
discussionsignific
impact
find
highlight
potenti
function
cooper
two
prostat
cancer
relev
oncogen
drive
progress
diseas
novel
mous
model
davidson
le
adam
hasstedt
xin
gress
hunt
utah
salt
lake
citi
ut
usa
health
fit
institut
ld
hospit
salt
lake
citi
ut
usa
genet
univers
utah
salt
lake
citi
ut
usa
objectivesspecif
aim
bariatr
surgeri
consid
effect
therapi
weight
loss
sever
obes
patient
howev
even
experienc
extrem
initi
weight
loss
patient
fail
maintain
reduc
weight
hypothes
haplotyp
fto
would
relat
postsurg
weight
regain
methodsstudi
popul
examin
prospect
associ
gene
haplotyp
weight
regain
subject
previous
sever
obes
n
age
year
bmi
femal
underw
gastric
bypass
surgeri
postsurg
bmi
haplotyp
snp
snp
snp
estim
subdivid
risk
versu
nonrisk
haplotyp
carrier
base
baselin
bmi
effect
haplotyp
larger
sampl
subject
resultsanticip
result
weight
regain
year
post
surgeri
bmi
chang
associ
fto
patient
haplotyp
howev
greater
weight
gain
addit
year
p
discussionsignific
impact
gastric
bypass
patient
carrier
haplotyp
may
suscept
weight
gain
long
term
weight
regain
associ
consist
presurg
weight
associ
risk
haplotyp
gene
may
identifi
subject
need
focus
weight
mainten
intervent
ep
ea
mugg
andreasen
wassink
univers
iowa
iowa
citi
ia
usa
objectivesspecif
aim
schizophrenia
psychiatr
disord
worldwid
preval
nearli
one
percent
symptom
consist
delus
hallucin
emot
blunt
cognit
deficit
symptom
develop
earli
adulthood
typic
lead
lifelong
disabl
herit
factor
significantli
contribut
risk
develop
schizophrenia
howev
factor
heterogen
fulli
character
dna
copi
number
variant
cnv
rare
genet
chang
contribut
schizophrenia
risk
individu
like
alter
level
gene
express
object
project
character
phenotyp
brain
structur
cognit
symptom
individu
schizophrenia
cnv
methodsstudi
popul
research
group
sampl
individu
schizophrenia
data
avail
subject
includ
structur
mri
brain
scan
measur
symptom
cognit
test
cnv
ascertain
use
compar
genom
hybrid
individu
novel
cnv
particular
interest
also
abl
character
potenti
relationship
common
cnv
phenotyp
resultsanticip
result
cnv
identifi
chromosom
particular
interest
cnv
region
contain
gene
import
brain
develop
function
phenotyp
inform
individu
subject
present
discussionsignific
impact
project
advanc
knowledg
genet
factor
contribut
schizophrenia
relat
psychiatr
phenotyp
inform
find
new
treatment
base
mechan
ill
kesebir
burk
einstein
colleg
medicin
depart
pediatr
children
hospit
montefior
bronx
ny
usa
objectivesspecif
aim
object
studi
determin
preval
risk
factor
oral
hpv
use
set
broad
spectrum
primer
methodsstudi
popul
part
studi
prostat
cancer
ashkenazim
oral
rins
sampl
collect
sourc
genom
dna
random
conveni
sampl
extract
dna
sampl
test
use
primer
preferenti
amplifi
beta
gamma
alpha
hpv
type
respect
hpv
dna
type
confirm
dot
blot
hybrid
andor
direct
sequenc
analysi
risk
factor
oral
hpv
evalu
logist
regress
fisher
exact
test
resultsanticip
result
test
posit
hpv
alpha
beta
gamma
mix
genera
hpv
compar
hpv
group
mean
age
versu
p
divorcedsepar
p
less
like
histori
prostat
cancer
p
report
etoh
drinkswk
p
signific
associ
smoke
sun
exposur
presenc
tonsil
sti
educ
diet
andor
autoimmun
diseas
age
year
adjust
oral
hpv
militari
servic
signific
risk
beta
hpv
p
discussionsignific
impact
signific
proport
head
neck
squamou
cell
carcinoma
hnscc
includ
oral
cancer
associ
hpv
howev
preval
broad
rang
hpv
type
determin
oral
caviti
predomin
hpv
type
differ
genera
alpha
beta
gamma
requir
special
primer
detect
use
alpha
betagamma
hpv
primer
oral
hpv
preval
predomin
beta
hpv
risk
oral
hpv
increas
age
militari
servic
increas
risk
beta
hpv
ji
hebbr
zhu
jenkin
biernacka
snyder
drew
fiehn
zeng
schaid
mrazek
weinshilboum
clinic
rochest
mn
usa
carolina
state
univers
raleigh
nc
usa
california
davi
ca
usa
univers
durham
nc
usa
objectivesspecif
aim
major
depress
disord
mdd
common
psychiatr
diseas
select
serotonin
reuptak
inhibitor
ssri
import
class
drug
use
treat
mdd
howev
mani
patient
respond
adequ
ssri
therapi
appli
pharmacogenom
research
strategi
identifi
citalopramescitalopram
treatment
outcom
biomark
methodsstudi
popul
metabolom
profil
use
ga
spectrometri
platform
perform
plasma
sampl
escitalopram
remitt
nonremitt
enrol
larg
ssri
pharmacogenom
trial
mayo
pharmacometabolom
signal
pursu
perform
pharmacogenom
investig
possibl
role
inherit
variat
respons
ssri
treatment
mdd
resultsanticip
result
metabolom
analysi
mdd
patient
treat
ssri
show
baselin
plasma
glycin
level
neg
associ
treatment
outcom
p
genotyp
tag
singl
nucleotid
polymorph
snp
gene
encod
glycin
synthesi
degrad
enzym
perform
dna
sampl
mayo
clinic
ssri
studi
snp
glycin
dehydrogenas
gene
associ
treatment
outcom
phenotyp
initi
studi
mdd
patient
star
studi
use
replic
p
discussionsignific
impact
result
highlight
possibl
role
glycin
ssri
respons
use
pharmacometabolom
inform
pharmacogenom
discoveri
drug
respons
biomark
person
medicin
strong
mk
steward
california
irvin
irvin
ca
usa
objectivesspecif
aim
death
specif
neuron
popul
caus
cognit
motor
dysfunct
multipl
disord
sever
neurodegen
diseas
injuri
common
factor
progress
exampl
huntington
diseas
hd
alzheim
diseas
traumat
brain
injuri
multipl
sclerosi
parkinson
diseas
spinal
cord
injuri
thought
get
wors
excitotox
neuron
point
cell
death
hd
specif
distinct
popul
cell
striatum
degener
import
learn
role
excitotox
cell
death
diseas
identifi
factor
help
prevent
excitotox
cell
death
methodsstudi
popul
mice
great
model
studi
human
diseas
well
excitotox
express
human
mutant
protein
investig
direct
effect
excitotoxin
develop
new
line
hd
mous
model
vulner
strain
background
test
suscept
also
use
microarray
analysi
identifi
pattern
gene
express
uniqu
older
mice
carri
human
hd
transgen
resultsanticip
result
studi
reveal
one
mous
model
hd
display
surpris
resist
striatal
neurodegener
age
vulner
excitotox
cell
death
test
small
select
set
gene
activ
group
display
activ
resist
cell
death
discussionsignific
impact
identifi
cellular
mechan
make
neuron
resist
excitotox
may
point
way
power
new
therapi
could
allevi
symptom
hd
mani
neurodegen
disord
reduc
financi
emot
physic
burden
caus
disord
ramirez
ah
delaney
xu
schildcrout
oetjen
jeff
cowan
basford
bowton
pulley
ritchi
crawford
masi
roden
denni
univers
nashvil
tn
usa
objectivesspecif
aim
variabl
warfarin
dose
includ
promin
genet
compon
test
whether
associ
stabl
warfarin
dose
genet
variant
replic
biovu
vanderbilt
dna
databank
link
dna
sampl
patient
emr
implement
publish
iwpc
algorithm
use
genet
clinic
data
improv
dose
predict
methodsstudi
popul
stabl
warfarin
dose
defin
median
weekli
dose
taken
first
window
patient
consist
therapeut
inr
least
week
use
natur
languag
process
nlp
algorithm
verifi
human
review
fifteen
snp
calu
ggcx
analyz
resultsanticip
result
european
american
stabl
dose
warfarin
nlp
posit
predict
valu
identifi
median
warfarin
dosag
associ
seven
snp
includ
three
high
ld
p
p
p
p
ggcx
p
togeth
variant
explain
dose
variabl
implement
iwpc
algorithm
reduc
mean
absolut
error
weekli
dose
mgwk
mgwk
seen
standard
care
fix
mgweek
dose
regimen
discussionsignific
impact
dna
repositori
link
drug
outcom
data
emr
confirm
discov
pharmacogenet
associ
reduc
dose
error
santillan
santillan
pelham
ketsawatsomkron
yang
hunter
sigmund
iowa
carver
colleg
medicin
iowa
citi
ia
usa
objectivesspecif
aim
decreas
human
placent
ido
activ
associ
preeclampsia
pree
addit
low
mous
ido
activ
associ
reject
high
blood
pressur
key
pree
phenotyp
yet
role
ido
pree
unknown
therefor
gener
mous
model
test
hypothesi
result
pree
methodsstudi
popul
wild
type
wt
femal
cross
wt
male
syngen
control
sc
dam
femal
cross
male
syngen
knockout
sk
dam
gestat
day
gd
urin
assay
protein
concentr
vascular
reactiv
aorta
mesenter
arteri
examin
use
wire
pressur
myograph
respect
resultsanticip
result
sk
dam
demonstr
significantli
higher
proteinuria
sc
dam
sk
ugml
vs
sc
ugml
p
vascular
reactiv
aorta
mesenter
arteri
gd
examin
use
wire
pressur
myograph
respect
dose
acetylcholin
ach
aorta
sk
dam
exhibit
decreas
relax
compar
sc
dam
relax
nm
ach
sk
vs
sc
p
mesenter
arteri
vasodilatori
respons
ach
sodium
nitroprussid
similar
group
initi
preliminari
bp
measur
radiotelemetri
suggest
mean
arteri
pressur
end
pregnanc
higher
sk
versu
sc
dam
sk
mmhg
vs
sc
mmhg
discussionsignific
impact
conclud
loss
ido
lead
endotheli
dysfunct
aorta
increas
proteinuria
pregnanc
given
recent
data
place
primari
role
fetal
toler
pathogenesi
preeclampsia
data
support
ido
import
initi
step
preeclampsia
simmon
gh
padilla
laughlin
missouri
columbia
mo
usa
objectivesspecif
aim
purpos
studi
test
hypothesi
coronari
endothelium
express
higher
level
lower
level
antioxid
protein
compar
system
conduit
arteri
exercis
train
decreas
heterogen
endotheli
cell
phenotyp
coronari
system
vessel
methodsstudi
popul
fourteen
male
hypercholesterolem
swine
exercis
train
week
n
remain
sedentari
n
sacrific
endotheli
cell
mechan
scrape
isol
segment
carotid
brachial
femor
renal
right
coronari
arteri
rca
protein
express
evalu
immunoblot
resultsanticip
result
express
marker
rca
differ
compar
carotid
arteri
prediabet
elev
compar
renal
femor
brachial
arteri
sedentari
anim
prediabet
contrast
exercis
train
anim
exhibit
increas
protein
express
rca
compar
system
arteri
prediabet
wherea
differ
detect
either
express
throughout
vasculatur
c
discussionsignific
impact
conclud
exercis
train
associ
decreas
heterogen
antioxid
protein
express
coronari
system
conduit
arteri
endothelium
support
mhl
gh
jp
drummond
timmerman
fri
rasmussen
volpi
galveston
tx
usa
objectivesspecif
aim
healthi
nondiabet
older
adult
resist
anabol
effect
insulin
skelet
muscl
protein
recent
amino
acid
transport
identifi
import
contributor
activ
muscl
protein
synthesi
insulin
stimul
transcript
amino
acid
transport
enhanc
local
amino
acid
transport
cell
membran
increas
transport
activ
therefor
hypothes
age
may
blunt
amino
acid
transport
express
respons
insulin
infus
therebi
reduc
intracellular
amino
acid
avail
methodsstudi
popul
five
younger
older
adult
studi
baselin
local
insulin
infus
one
leg
increas
leg
plasma
insulin
postprandi
level
without
decreas
amino
acid
concentr
muscl
biopsi
taken
h
insulin
infus
biopsi
analyz
mrna
express
cation
amino
acid
transport
util
resultsanticip
result
baselin
differ
amino
acid
transport
mrna
express
young
older
subject
p
insulin
increas
mrna
express
similarli
age
group
h
time
point
p
discussionsignific
impact
data
suggest
abil
insulin
stimul
amino
acid
transport
express
reduc
healthi
older
adult
futur
studi
focu
mechan
lead
insulin
resist
muscl
protein
anabol
healthi
age
page
k
enriquez
romero
buchanan
southern
california
lo
angel
ca
usa
objectivesspecif
aim
aim
determin
whether
intrauterin
exposur
gestat
diabet
mellitu
gdm
associ
increas
bodi
mass
index
bmi
hispan
children
methodsstudi
popul
particip
hispan
offspr
year
old
mother
particip
ongo
studi
genet
type
diabet
offspr
defin
gdm
expos
mother
document
gdm
pregnanc
interest
nonexpos
offspr
children
whose
mother
document
normal
glucos
level
pregnanc
matern
gdm
defin
american
diabet
associ
criteria
children
current
height
weight
gender
data
birth
matern
height
weight
obtain
phone
interview
mother
bmi
age
gender
base
bmi
determin
children
current
height
weight
studi
irb
approv
usc
resultsanticip
result
particip
includ
gdm
expos
offspr
f
age
yr
nonexpos
offspr
f
age
yr
trend
toward
higher
bmi
offspr
expos
matern
gdm
compar
nonexpos
offspr
vs
p
even
adjust
matern
bmi
discussionsignific
impact
base
inform
report
particip
mother
found
trend
toward
greater
bmi
hispan
children
expos
gdm
utero
compar
nonexpos
hispan
children
current
work
underway
directli
measur
height
weight
total
bodi
fat
expand
number
gdm
expos
nonexpos
offspr
work
first
examin
relationship
exposur
matern
diabet
utero
childhood
adipos
hispan
popul
group
fastest
grow
segment
unit
state
popul
niewold
tb
franek
kariuki
mikola
jolli
utset
zervou
boumpa
goulielmo
chicago
chicago
il
usa
univers
chicago
il
usa
crete
heraklion
greec
objectivesspecif
aim
allel
associ
suscept
system
lupu
erythematosu
sle
multipl
sclerosi
ms
interferon
alpha
thought
causal
sle
recombin
type
ifn
use
therapi
ms
investig
whether
allel
associ
two
diseas
associ
differ
serum
serolog
profil
sle
patient
methodsstudi
popul
singl
nucleotid
polymorph
snp
genotyp
taqman
set
studi
sle
patient
cretan
control
match
ancestr
background
patient
serum
serolog
data
avail
resultsanticip
result
observ
consist
background
associ
sle
snp
p
cochran
q
allel
associ
presenc
autoantibodi
sle
patient
ancestr
background
p
allel
also
associ
increas
serum
activ
p
signific
associ
observ
snp
serum
serolog
profil
discussionsignific
impact
g
allel
associ
suscept
ms
associ
sle
antibodi
serum
sle
patient
african
american
european
ancestri
interest
given
therapeut
effect
type
ifn
ms
patient
pathogen
effect
cytokin
sle
tridandapani
su
brand
bhatti
univers
atlanta
ga
usa
institut
technolog
atlanta
ga
usa
objectivesspecif
aim
object
studi
evalu
seismocardiographi
scm
predict
quiescent
phase
within
cardiac
cycl
scm
obtain
linear
acceleromet
place
chest
wall
methodsstudi
popul
built
hardwar
obtain
simultan
ultrasound
us
electrocardiogram
ekg
scm
data
twenti
subject
undergo
us
scan
left
ventricular
wall
us
gold
standard
cardiac
motion
evalu
studi
simultan
ekg
scm
record
obtain
crosscorrel
us
data
perform
use
ekg
interv
refer
period
simultan
correl
scm
data
also
perform
resultsanticip
result
us
data
provid
inform
quiescent
phase
heart
quiescent
phase
determin
scm
data
track
quiescent
phase
determin
us
data
scm
use
track
quiescent
phase
discussionsignific
impact
cardiac
comput
tomographi
cct
prospect
ekg
gate
unreli
heart
move
target
ekg
good
determin
heart
rel
immobil
within
cardiac
cycl
basi
scm
track
strategi
like
ekg
track
motion
directli
rather
electr
activ
heart
scm
shown
reliabl
method
cct
could
lead
reliabl
noninvas
rapid
inexpens
diagnost
tool
evalu
coronari
arteri
eventu
replac
invas
expens
coronari
angiogram
rogalski
ej
cobia
harrison
wienek
weintraub
mesulam
univers
chicago
il
usa
objectivesspecif
aim
aim
examin
longitudin
cours
ppa
period
offer
quantit
rang
expect
chang
could
use
guid
design
evalu
therapeut
intervent
trial
methodsstudi
popul
region
chang
cortic
thick
volum
loss
well
neuropsycholog
perform
assess
baselin
year
later
rigor
character
patient
fulfil
research
criteria
logopen
agrammat
semant
ppa
subtyp
resultsanticip
result
substanti
progress
clinic
deficit
cortic
atrophi
two
year
neuropsycholog
perform
pattern
lost
sharp
distinct
differenti
one
ppa
variant
anoth
nonetheless
differenti
impair
word
comprehens
versu
grammat
process
larg
maintain
peak
atrophi
site
spread
beyond
initi
distinct
locat
character
three
subtyp
display
converg
distribut
encompass
three
major
compon
languag
network
inferior
frontal
gyru
temporopariet
junction
later
tempor
cortex
despit
progress
overal
peak
atrophi
remain
later
left
hemispher
discussionsignific
impact
result
suggest
distinct
featur
sharpli
differenti
ppa
variant
earli
middl
stage
may
lose
distinct
degener
becom
sever
given
substanti
atrophi
two
year
ppa
clinic
trial
may
requir
fewer
patient
shorter
studi
durat
alzheim
diseas
trial
detect
signific
therapeut
effect
lemair
cheong
ji
park
chung
shin
lifton
school
medicin
new
ct
usa
nation
univers
children
hospit
seoul
republ
korea
nation
univers
bundang
hospit
seongnam
citi
republ
korea
univers
sever
children
hospit
seoul
republ
korea
objectivesspecif
aim
clarifi
genet
basi
patient
unusu
constel
clinic
find
methodsstudi
popul
subject
studi
male
clinic
featur
partial
consist
diagnosi
low
syndrom
ls
low
molecular
weight
proteinuria
hypercalciuria
nephrocalcinosi
development
delay
recurr
seizur
cryptorchid
stunt
growth
howev
hypopituitar
partial
tsh
complet
gh
defici
micropeni
cleft
palat
absenc
cataract
describ
context
ls
resultsanticip
result
ls
subject
mutat
patient
mutat
sought
sinc
renal
phenotyp
dent
diseas
indistinguish
ls
exon
fail
amplifi
standard
pcr
snp
genotyp
reveal
mb
delet
illumina
k
sequenc
across
delet
breakpoint
reveal
two
distant
direct
repeat
interven
invert
repeat
potenti
secondari
structur
deriv
repeat
suggest
slip
mispair
caus
gross
delet
discussionsignific
impact
besid
delet
interv
contain
gene
gene
variant
gene
associ
stocco
do
santo
syndrom
character
mental
retard
seizur
stunt
growth
propos
unusu
phenotyp
patient
due
novel
contigu
delet
syndrom
possibl
delet
hot
spot
current
investig
group
patient
larg
unmap
delet
genom
region
uddin
mn
jone
allen
zawieja
kuehl
health
scienc
center
templ
tx
usa
white
hospit
templ
tx
usa
objectivesspecif
aim
preeclampsia
pe
disord
pregnanc
marinobufagenin
mbg
ardioton
bufodienolid
increas
translat
research
aim
understand
pathogenesi
pe
methodsstudi
popul
evalu
bbb
function
plasma
urin
level
mbg
angiogen
factor
rat
model
pe
human
brain
microvascular
endotheli
cell
hbmec
util
examin
alter
monolay
permeabl
caus
mbg
hbmec
phosphoryl
jnk
src
evalu
mbg
apoptosi
evalu
effect
mbg
endotheli
tight
junction
protein
determin
urinari
mbg
angiogen
factor
determin
normal
pe
patient
resultsanticip
result
data
indic
increas
bbb
permeabl
pe
rat
urinari
excret
mbg
increas
mbg
induc
increas
monolay
hbmec
permeabl
mbg
caus
signific
decreas
phosphoryl
activ
phosphoryl
jnk
src
mbg
significantli
increas
express
caspas
indic
activ
apoptosi
mbg
caus
disrupt
endotheli
adheren
tight
junction
protein
urinari
excret
mbg
higher
pe
patient
compar
normal
angiogen
imbal
observ
pe
patient
compar
normal
discussionsignific
impact
propos
novel
hypothes
mbg
preced
pe
mbg
caus
disrupt
tight
junction
protein
lead
bbb
hyperperm
via
activ
mapk
trigger
apoptot
mechan
result
cerebr
edema
common
featur
pe
angiogen
factor
releas
process
serv
biomark
extent
vascular
imbal
howe
gw
fu
washington
univers
washington
dc
usa
objectivesspecif
aim
genet
research
behavior
outcom
hold
promis
enhanc
effect
prevent
intervent
pose
consider
challeng
given
dynam
interplay
gene
environ
introduc
novel
research
design
call
microtri
mean
translat
basic
genet
find
prevent
trial
microtri
defin
random
experi
test
effect
rel
brief
focus
manipul
design
suppress
specif
risk
mechan
bring
full
prevent
effect
find
microtri
use
develop
refin
target
prevent
intervent
present
three
specif
aim
present
find
risk
mechan
associ
depress
discuss
set
microtri
studi
design
test
malleabl
mechan
sampl
clarifi
find
microtri
use
refin
prevent
intervent
methodsstudi
popul
present
data
two
studi
depress
involv
nearli
recent
unemploy
adult
resultsanticip
result
find
implic
sever
phenotyp
genotyp
risk
factor
exacerb
effect
stressor
develop
sever
depress
anxieti
data
link
gener
risk
factor
specif
mediat
thought
malleabl
prevent
intervent
includ
cognit
variabl
concern
sens
strategi
cope
job
loss
discussionsignific
impact
describ
intervent
compon
design
influenc
mechan
plan
test
effect
seri
microtri
design
individu
greatest
risk
base
phenotyp
genotyp
data
discuss
use
result
microtri
build
prevent
intervent
specif
tailor
popul
cheung
wl
owe
avaritt
tackett
arkansa
medic
scienc
littl
rock
ar
usa
objectivesspecif
aim
uv
ultraviolet
radiat
link
increas
risk
skin
cancer
includ
melanoma
previous
determin
dna
dsb
detect
histon
phosphoryl
increas
human
melanoma
tissu
decid
determin
downstream
effector
dna
dsb
name
express
alter
human
primari
melanoma
cell
methodsstudi
popul
follow
case
retriev
archiv
melanoma
sever
dysplast
nevu
mild
dysplast
nevi
signific
differ
age
sex
locat
lesion
melanocyt
lesion
p
commerci
avail
antibodi
cell
signal
employ
routin
immunohistochemistri
perform
intens
multipli
percentag
follow
product
categor
analysi
use
determin
statist
signific
p
consid
signific
resultsanticip
result
melanoma
case
show
statist
signific
increas
stain
compar
case
mild
dysplast
nevi
sever
dysplast
nevi
posit
stain
nine
eleven
melanoma
case
two
seven
sever
dysplast
nevu
case
three
eleven
melanoct
nevu
case
p
interestingli
stain
local
cytoplasm
case
melanoma
case
local
nucleu
case
dysplast
melanocyt
nevi
p
discussionsignific
impact
first
studi
demonstr
activ
misregul
dna
repair
pathway
human
melanoma
cell
clearli
increas
melanoma
cell
cytoplasm
indic
aberr
local
least
one
dna
dsb
repair
protein
studi
need
determin
mechan
respons
aberr
local
human
melanoma
cell
bobo
ld
dubberk
haslam
univers
school
medicin
st
loui
mo
usa
objectivesspecif
aim
determin
c
difficil
toxin
b
induc
activ
protein
kinas
pathway
vitro
evalu
respons
human
infect
use
immunoassay
eia
develop
hous
purpos
methodsstudi
popul
vitro
interleukin
quantifi
eia
cytotox
test
toxin
intestin
cell
antitoxin
b
neutral
inhibit
patient
studi
comparison
fecal
lactoferrin
eia
pgml
presenc
c
difficil
studi
hospit
patient
yr
old
diarrhea
exclud
inflammatori
bowel
diseas
character
novel
c
difficil
studi
isol
resultsanticip
result
vitro
induc
time
dose
depend
fashion
correspond
cytotox
product
convers
antitoxin
b
inhibitor
markedli
decreas
respect
cytotox
patient
studi
fecal
biomark
c
difficil
posit
n
neg
n
p
valu
lactoferrin
u
sensit
specif
ppv
npv
lactoferrin
rocc
analysi
posit
cutoff
novel
phenotyp
patient
diarrhea
noncytotox
stool
undetect
fecal
toxin
b
posit
isol
pcr
eia
noncytotox
unabl
induc
discussionsignific
impact
c
difficil
toxin
diagnost
lack
specif
induc
biolog
activ
toxin
like
surrog
c
difficil
intestin
diseas
may
improv
specif
diagnosi
c
difficil
infect
higgin
j
maclean
hagman
colorado
denver
aurora
co
usa
objectivesspecif
aim
defin
dietari
characterist
lead
inpati
admiss
treatment
anorexia
nervosa
children
use
inform
refin
rat
model
modifi
rat
model
use
screen
novel
dietari
treatment
insur
efficaci
intervent
test
clinic
methodsstudi
popul
femal
year
administ
food
frequenc
questionnair
ffq
h
dietari
recal
assess
chang
diet
lead
inpati
admiss
data
diet
questionnair
use
refin
rat
model
close
mimic
human
condit
rat
model
subsequ
use
determin
effect
low
leucin
diet
recoveri
time
time
weigh
bodi
fat
content
assess
quantit
magnet
reson
resultsanticip
result
dietari
intak
pediatr
patient
kcal
mo
prior
admiss
ffq
drop
kcal
immedi
prior
admiss
h
recal
macronutri
content
diet
chang
time
carbohydr
fat
protein
induc
spragu
dawley
femal
rat
via
free
access
run
wheel
h
access
low
fat
diet
per
day
upon
reach
initi
bodi
weight
rat
refe
either
moder
fat
high
protein
diet
fat
protein
control
c
diet
low
leucin
content
loleu
c
rat
recov
initi
weight
refeed
total
bodi
fat
wherea
loleu
rat
took
recov
bodi
fat
discussionsignific
impact
loleu
diet
suitabl
treatment
howev
develop
good
rat
model
preclin
test
novel
dietari
treatment
stewart
pa
schmidt
lemck
wixom
peck
hyman
foley
clemon
rochest
ny
usa
emm
corpor
rockvil
md
usa
objectivesspecif
aim
examin
dietari
intak
supplement
use
children
autism
methodsstudi
popul
ndsr
softwar
use
analyz
nutrient
intak
supplement
use
three
day
diet
record
children
asd
age
multicent
studi
dietari
behavior
nutrit
statu
usual
intak
compar
iom
dietari
refer
intak
dri
percentag
children
meet
recommend
nutrient
intak
level
percentag
consum
nutrient
upper
limit
ul
food
alon
determin
nutrient
provid
dietari
supplement
assess
compar
nutrient
low
diet
ul
children
resultsanticip
result
dri
met
mani
particip
vitamin
cholin
potassium
fiber
ul
exceed
sodium
niacin
manganes
food
alon
children
take
dietari
supplement
multivitamin
common
dietari
supplement
consum
follow
fatti
acid
probiot
multivitamin
use
contain
vitamin
contain
cholin
vitamin
k
potassium
fiber
amount
potassium
cholin
provid
supplement
far
dri
folat
niacin
vitamin
nutrient
supplement
like
exceed
ul
even
includ
nutrient
food
discussionsignific
impact
mani
children
asd
meet
recommend
intak
nutrient
children
select
eater
may
better
serv
consult
dietitian
correct
nutrient
imbal
use
food
rather
gener
multivitamin
use
indic
target
supplement
may
avoid
exceed
ul
meet
child
nutrit
need
support
came
us
dhh
hrsa
mchr
mgh
mc
ncrr
gubin
calaluc
mage
hoffman
atasoy
missouri
columbia
mo
usa
truman
va
hospit
columbia
mo
usa
objectivesspecif
aim
breast
cancer
second
common
cancer
women
caus
death
peopl
worldwid
mani
cancer
gene
posttranscript
regul
protein
rbp
rbp
hur
bind
region
mrna
stabil
mrna
facilit
translat
protein
elev
level
cytoplasm
hur
directli
correl
increas
invas
poor
prognosi
mani
cancer
addit
hur
describ
control
gene
multipl
area
acquir
capabl
model
cancer
hypothes
gene
allow
cancer
prolifer
establish
investig
role
hur
aggress
difficult
treat
breast
cancer
methodsstudi
popul
na
resultsanticip
result
cell
higher
level
hur
alter
cell
cycl
kinet
faster
growth
unexpectedli
hur
overexpress
significantli
interf
tumor
growth
orthotop
mous
model
tumor
overexpress
hur
fewer
blood
vessel
control
tumor
microarray
analysi
reveal
sever
gene
overexpress
tumor
higher
level
hur
includ
antiangiogen
addit
found
downregul
mrna
protein
level
tumor
overexpress
hur
therefor
put
mechan
seem
antiangiogen
effect
increas
express
also
discussionsignific
impact
modul
hur
level
may
overcom
limit
associ
monotherapi
target
tumor
vessel
format
could
repres
potenti
theuraput
target
difficult
treat
aggress
breast
cancer
canter
rj
bori
davi
medic
center
sacramento
ca
usa
davi
medic
center
depart
patholog
sacramento
ca
usa
objectivesspecif
aim
although
patholog
respons
neoadjuv
chemotherapi
highli
correl
surviv
among
patient
osteosarcoma
os
current
molecular
marker
predict
respons
chemotherapi
object
studi
investig
relationship
express
os
tumor
patholog
respons
follow
neoadjuv
chemotherapi
methodsstudi
popul
tissu
microarray
creat
pretreat
biopsi
specimen
os
patient
immunohistochemistri
perform
commerci
avail
monoclon
mous
antibodi
express
defin
cytoplasm
stain
cell
percent
tumor
necrosi
measur
postchemotherapi
resect
specimen
per
establish
protocol
tumor
necrosi
consid
good
data
abstract
age
sex
tumor
site
histolog
subtyp
univari
multivari
analysi
perform
resultsanticip
result
median
age
femal
tumor
locat
femur
express
present
median
posttreat
tumor
necrosi
patient
experienc
good
chemotherapi
respons
express
correl
posit
median
percent
necrosi
good
chemotherapi
respons
p
respect
logist
regress
analysi
express
independ
associ
chemotherapi
respons
control
age
subtyp
sex
locat
ci
p
discussionsignific
impact
immunohistochem
express
significantli
correl
chemotherapi
respons
os
may
use
biomark
guid
os
treatment
select
lewelt
aj
krosschel
gappmaier
marcu
white
lope
stoddard
swoboda
utah
salt
lake
citi
ut
usa
univers
chicago
il
usa
pari
descart
pari
franc
objectivesspecif
aim
object
studi
obtain
preliminari
data
feasibl
safeti
effect
supervis
progress
strength
train
pst
exercis
program
children
adolesc
spinal
muscular
atrophi
sma
specif
aim
ascertain
feasibl
particip
adher
daysweek
week
pst
exercis
program
specif
aim
determin
safeti
toler
pst
studi
popul
specif
aim
determin
candid
outcom
measur
baselin
week
start
pst
methodsstudi
popul
method
nonblind
pilot
studi
studi
popul
children
age
year
sma
type
ii
iii
abl
cooper
physic
therapist
pt
live
within
mile
studi
center
resultsanticip
result
one
particip
complet
pst
program
without
advers
event
report
pain
loss
strength
progress
increas
weight
achiev
appropri
physic
exert
level
complet
outcom
measur
visit
success
two
addit
particip
enrol
start
pst
shortli
sever
famili
express
interest
studi
schedul
pend
avail
pt
discussionsignific
impact
supervis
daysweek
pst
exercis
program
appear
feasibl
first
particip
success
complet
pst
program
outcom
measur
addit
particip
start
pst
shortli
pt
avail
largest
obstacl
studi
first
provid
preliminari
data
pst
potenti
feasibl
safe
effect
intervent
children
adolesc
sma
hansel
de
orloff
elson
yang
eng
clinic
cleveland
oh
usa
objectivesspecif
aim
recent
identifi
mtor
pathway
activ
urotheli
carcinoma
uca
next
sought
determin
relationship
pten
upstream
neg
mediat
mtor
mtor
activ
outcom
uca
patient
methodsstudi
popul
patient
uca
n
examin
pten
express
includ
intens
express
predomin
subcellular
local
nuclearnonnuclear
result
correl
presenc
lymph
node
ln
metastas
surviv
rf
overal
surviv
univari
multivari
analysi
pten
intronexon
mutat
analysi
perform
dgge
mutat
statu
correl
pten
protein
express
specimen
resultsanticip
result
major
patient
demonstr
moder
intens
express
pten
pten
primarili
local
nucleu
patient
ln
metastas
reduc
pten
intens
associ
increas
percentag
cell
p
pten
mutat
analysi
identifi
variant
g
g
associ
absent
pten
protein
express
diffus
express
reduc
rf
correl
posit
surgic
margin
p
carcinoma
situ
p
nuclear
pten
p
reduc
overal
surviv
significantli
associ
metastas
p
nuclear
pten
express
p
stepwis
multivari
analysi
show
associ
reduc
rf
ln
metastas
p
carcinoma
situ
nuclear
pten
p
discussionsignific
impact
alter
pten
appear
mediat
mtor
pathway
activ
uca
although
mutat
result
reduc
pten
express
nuclear
local
pten
rel
new
find
function
mediat
cancer
behavior
investig
yang
b
yang
nelson
kelli
choi
laser
institut
medic
clinic
univers
california
irvin
irvin
ca
usa
dermatolog
univers
california
irvin
irvin
ca
usa
biomed
engin
univers
california
irvin
irvin
ca
usa
objectivesspecif
aim
improv
treatment
efficaci
port
wine
stain
birthmark
pw
use
laser
speckl
imag
lsi
mean
develop
laser
surgeri
methodsstudi
popul
pw
vascular
malform
seen
approxim
birth
year
lsi
techniqu
imag
coher
light
remit
object
result
speckl
pattern
spatiotempor
statist
pattern
relat
movement
optic
scatter
red
blood
cell
imag
process
algorithm
appli
produc
speckl
flow
index
sfi
map
repres
tissu
blood
flow
perform
real
time
lsi
play
import
role
surgeri
treatment
pw
continu
calcul
sfi
valu
treat
pw
region
well
surround
normal
tissu
look
see
treat
region
show
uniform
reduct
flow
exhibit
decreas
sfi
valu
treat
region
appear
high
nonuniform
sfi
valu
area
undergo
retreat
resultsanticip
result
gener
sfi
valu
within
treat
region
show
progress
decreas
treatment
pass
well
border
hyperemia
surround
treat
region
feedback
physician
case
abl
achiev
uniform
vascular
shutdown
region
interest
discussionsignific
impact
lsi
within
surgeri
provid
object
measur
determin
blood
flow
essenti
treatment
pw
furthermor
lsi
great
potenti
applic
wide
rang
disciplin
neurosurgeri
ophthalmolog
tsay
ia
haugen
colorado
denver
denver
co
usa
america
centenni
co
usa
objectivesspecif
aim
evalu
combin
telemedicin
smart
program
softwar
remov
cochlear
implant
program
improv
program
effici
without
impact
qualiti
clinic
outcom
subject
abil
hear
well
methodsstudi
popul
subject
adult
cochlear
implant
recipi
audiologist
locat
differ
room
subject
use
remot
desktop
technolog
control
monitor
local
comput
front
subject
audiologist
remot
supervis
interact
subject
smart
program
softwar
remot
program
result
compar
subject
tradit
program
result
resultsanticip
result
preliminari
data
show
clinic
signific
differ
remot
program
result
subject
tradit
program
result
discussionsignific
impact
cochlear
implant
ci
electron
hear
devic
design
help
peopl
suffer
moder
profound
hear
loss
surgic
implant
cochlea
ci
provid
electr
stimul
neuron
session
requir
audiologist
custom
program
devic
individu
base
patient
audibl
audiologist
adjust
current
level
deliv
electrod
order
achiev
appropri
loud
rural
area
ci
audiologist
avail
long
travel
distanc
may
caus
patient
arriv
tire
tens
increas
potenti
poor
program
session
although
previou
studi
demonstr
feasibl
remot
program
ci
local
repres
alway
present
subject
locat
order
facilit
process
studi
use
smart
program
softwar
elimin
local
repres
presenc
improv
effici
remot
program
procedur
wahezi
dm
rand
rajpathak
ilowit
hospit
montefior
albert
einstein
colleg
medicin
bronx
ny
usa
objectivesspecif
aim
annexin
potent
anticoagul
protein
shield
phospholipid
vascular
endotheli
cell
avail
coagul
reaction
disrupt
shield
antiphospholipid
apl
antibodi
may
play
role
pathogenesi
antiphospholipid
antibodi
syndrom
ap
studi
investig
associ
apl
antibodi
annexin
resist
children
rheumat
diseas
methodsstudi
popul
clinic
laboratori
data
collect
children
rheumat
diseas
patient
test
lupu
anticoagul
la
anticardiolipin
acl
glycoprotein
antibodi
novel
assay
perform
measur
coagul
time
presenc
absenc
annexin
resultsanticip
result
patient
persist
posit
apl
antibodi
significantli
lower
mean
level
compar
patient
apl
antibodi
persist
posit
one
apl
antibodi
mean
vs
patient
underli
diagnosi
primari
ap
sle
ss
mctd
significantli
higher
preval
persist
posit
apl
antibodi
p
thrombot
event
p
lower
mean
annexin
p
compar
remaind
group
patient
thrombot
event
also
significantli
lower
mean
level
p
discussionsignific
impact
assay
first
mechanist
assay
target
underli
pathogenesi
ap
first
report
demonstr
children
rheumat
diseas
persist
posit
apl
antibodi
demonstr
resist
annexin
anticoagul
activ
furthermor
patient
prior
histori
thrombosi
also
shown
reduc
kean
j
wang
west
mcdonald
mage
kronenberg
mathew
breier
saykin
univers
school
medicin
indianapoli
usa
objectivesspecif
aim
investig
differ
function
connect
patient
earli
stage
psychosi
healthi
control
subject
methodsstudi
popul
nine
male
patient
age
earli
stage
psychosi
healthi
control
match
age
handed
resultsanticip
result
quantit
comparison
rest
default
mode
network
activ
map
healthi
control
patient
earli
psychosi
show
significantli
greater
activ
later
right
dorsolater
prefront
cortex
dlpfc
right
posterior
pariet
cortex
p
k
similar
find
calhoun
colleagu
mask
display
dmn
network
compon
mask
hc
averag
dmn
p
discussionsignific
impact
increas
evid
anomal
function
connect
patient
psychosi
studi
report
decreas
connect
other
hyperconnect
result
indic
earli
stage
psychosi
associ
decreas
function
connect
consist
report
disrupt
white
matter
connect
kubicki
et
al
could
produc
hypoconnect
observ
patient
sampl
zeki
aa
bratt
filosto
ashfaq
tzipora
kenyon
california
davi
sacramento
ca
usa
objectivesspecif
aim
simvastatin
sim
inhibit
allerg
airway
inflamm
ovalbumin
ova
mous
model
transit
anim
human
investig
whether
system
treatment
sim
inhibit
mevalon
pathway
target
mous
lung
human
airway
epitheli
cell
hypothes
sim
treatment
mice
human
airway
epitheli
cell
inhibit
total
cholesterol
tc
synthesi
alter
reductas
hmgr
express
target
statin
methodsstudi
popul
balbc
mice
sensitizedexpos
ova
aerosol
wk
sim
mgkg
inject
intraperiton
min
ova
nebul
cell
treat
sim
hr
tc
content
whole
lung
homogen
whole
cell
lysat
determin
hmgr
protein
determin
cell
cytosol
membran
fraction
western
blot
resultsanticip
result
mice
tc
content
differ
ova
air
control
sim
alter
tc
content
cell
hr
sim
treatment
caus
decreas
tc
sim
caus
decreas
tc
mice
sim
decreas
hmgr
protein
express
kda
ova
group
chang
air
control
cell
sim
treatment
hr
decreas
hmgr
protein
express
kda
discussionsignific
impact
sim
alter
lung
tc
content
may
reduc
tc
airway
epithelium
via
hmgr
inhibit
airway
epitheli
chang
tc
hmgr
express
may
good
indic
statin
reach
airway
hmgr
enzym
activ
andor
statin
drug
level
may
better
indic
drug
reach
target
tissu
work
valid
result
yield
protocol
determin
whether
oral
ingest
statin
human
asthmat
reach
airway
epithelium
ghartey
j
chazott
einstein
herold
einstein
colleg
medicin
bronx
ny
usa
objectivesspecif
aim
compar
solubl
mucos
immun
mediat
endogen
antimicrobi
activ
genit
tract
secret
pregnant
women
colon
group
b
streptococcu
gb
methodsstudi
popul
seventi
pregnant
women
week
gestat
age
enrol
time
routin
gb
test
flock
vagin
swab
collect
dilut
ml
normal
salin
transport
laboratori
ice
clarifi
brief
centrifug
supernat
divid
aliquot
store
concentr
defensin
secretori
leuckocyt
proteas
inhibitor
slpi
measur
commerci
elisa
cytokin
identifi
multiplex
analysi
antibacteri
activ
determin
unit
assay
ecoli
gb
resultsanticip
result
interim
analysi
first
particip
colon
gb
significantli
lower
level
antimicrobi
human
neutrophil
peptid
hnp
compar
women
test
neg
gb
median
iqr
ngml
vs
ngml
p
trend
toward
lower
level
slpi
median
iqr
ngml
vs
ngml
p
concentr
mediat
endogen
activ
progress
discussionsignific
impact
colon
gb
associ
lower
level
protect
antimicrobi
peptid
genit
tract
slpi
result
research
serv
framework
prospect
longitudin
studi
differenti
whether
observ
reduct
protect
mediat
increas
risk
gb
colon
occur
respons
gb
colon
could
lead
novel
strategi
enhanc
mucos
defens
reduc
risk
preterm
birth
infect
charl
ed
orloff
rice
dustin
univers
new
york
ny
usa
objectivesspecif
aim
hepat
c
viru
hcv
caus
mix
cryoglobulinemia
mc
vascul
caus
rheumatoid
factor
rf
immun
complex
ic
mc
clonal
b
cell
lymphoprolif
disord
yet
antigen
stimulu
unknown
propos
ic
simul
b
cell
expans
somat
hypermut
shm
affin
matur
shm
essenti
rf
activ
assess
reactiv
hcv
mc
patient
clonal
ig
test
whether
depend
upon
shm
methodsstudi
popul
ig
variabl
v
region
perform
three
hcv
mc
patient
clonal
b
cell
select
ig
also
revert
germlin
pcr
ligat
express
vector
ig
transfect
j
cell
secret
pentamer
igm
purifi
rf
activ
determin
elisa
resultsanticip
result
ig
clone
express
vh
util
gene
segment
respect
nonsynonym
mutat
rang
vh
ig
contain
shm
rf
activ
prefer
contrast
revert
germlin
ig
markedli
diminish
activ
competit
ngml
protein
abrog
rf
activ
suggest
specif
igg
fc
swap
mutat
heavi
light
chain
pair
also
abrog
rf
activ
suggest
pair
appropri
igh
igk
addit
shm
necessari
ig
rf
activ
discussionsignific
impact
shm
essenti
rf
activ
hcv
mc
patient
suggest
autoreact
aris
shm
oppos
nondelet
autoreact
germlin
ig
expans
polyreact
natur
antibodi
ford
al
power
lin
lee
univers
st
loui
mo
usa
north
carolina
chapel
hill
nc
usa
objectivesspecif
aim
statin
pretreat
associ
improv
neurolog
outcom
ischem
stroke
although
sever
mechan
examin
anim
studi
human
hypothes
earli
reperfus
enhanc
ischem
stroke
patient
take
statin
stroke
onset
methodsstudi
popul
acut
ischem
stroke
patient
underw
two
mri
hr
onset
mean
transit
time
mtt
map
show
perfus
deficit
region
reperfus
defin
perfus
deficit
normal
threshold
defin
perfus
deficit
mtt
sec
ensur
result
base
arbitrari
threshold
baselin
data
reperfus
nih
stroke
scale
chang
mo
compar
patient
take
statin
admiss
multivari
regress
model
identifi
clinic
variabl
predict
reperfus
nihss
resultsanticip
result
acut
ischem
stroke
patient
statin
prospect
enrol
baselin
data
differ
group
statin
pretreat
result
greater
reperfus
compar
untreat
group
across
mtt
threshold
mtt
sec
reperfus
iqr
statin
group
vs
untreat
group
p
clinic
variabl
predict
model
reperfus
includ
statin
pretreat
volum
perfus
deficit
admiss
blood
pressur
patient
take
statin
greater
pt
mo
compar
untreat
patient
pt
p
predict
model
nihss
includ
statin
pretreat
age
discussionsignific
impact
statin
use
prior
ischem
stroke
onset
associ
earli
reperfus
improv
outcom
juth
v
cohen
silver
sender
ocampo
california
irvin
costa
mesa
ca
usa
objectivesspecif
aim
understand
treatment
cancer
continu
improv
popul
adolesc
young
adult
aya
survivor
continu
grow
result
aya
patient
famili
healthcar
provid
face
potenti
long
stress
share
ill
experi
methodsstudi
popul
phase
current
studi
focus
interact
aya
patient
primari
caregiv
famili
unit
relationship
particularli
import
major
influenc
aya
psycholog
physic
serv
primari
support
system
deal
treatment
procedur
cope
gener
uniqu
development
life
stage
phase
explor
interact
pediatr
patient
primari
caregiv
physician
healthcar
set
phase
consist
intervent
healthcar
provid
base
find
phase
resultsanticip
result
phase
identifi
common
cancer
care
stressor
experienc
within
famili
unit
ie
aya
patient
hisher
primari
caregiv
healthcar
set
ie
aya
patient
hisher
primari
caregiv
healthcar
provid
respect
phase
use
assess
intervent
design
healthcar
provid
intend
lessen
stressor
within
pediatr
cancer
care
discussionsignific
impact
find
program
research
potenti
guid
futur
polici
promot
health
cancer
survivor
caregiv
well
ensur
effici
util
healthcar
resourc
lindman
br
arnold
madrazo
zajaria
johnson
perez
mann
univers
school
medicin
st
loui
mo
usa
objectivesspecif
aim
diabet
heart
exhibit
increas
left
ventricular
lv
mass
reduc
ventricular
function
howev
relationship
studi
patient
aortic
stenosi
object
determin
diabet
mellitu
dm
impact
lv
remodel
function
patient
sever
methodsstudi
popul
echocardiogram
perform
patient
sever
symptomat
mean
age
year
femal
mean
aortic
valv
area
ava
mean
lv
eject
fraction
ef
diabet
includ
measur
lv
remodel
lv
function
multivari
linear
regress
model
investig
independ
effect
dm
aspect
lv
structur
function
resultsanticip
result
compar
nondiabet
n
diabet
n
increas
lv
mass
lv
dimens
lv
dimens
decreas
lvef
longitudin
systol
strain
p
multivari
analys
adjust
age
sex
systol
bp
ava
bsa
cad
dm
independ
predictor
increas
lv
mass
g
p
lv
dimens
cm
p
lv
dimens
cm
p
addit
adjust
lv
mass
dm
associ
reduc
systol
strain
p
trend
toward
reduc
ef
p
discussionsignific
impact
dm
addit
advers
effect
hypertroph
lv
mass
larger
caviti
associ
reduc
systol
function
patient
beyond
known
factor
pressur
overload
given
advers
effect
lv
hypertrophi
dysfunct
patient
find
may
import
clinic
implic
pileggi
gs
malardo
clemencio
donadi
medicin
preto
paulo
univers
ribeirao
preto
sp
brazil
objectivesspecif
aim
aim
studi
evalu
role
sequenc
plasmid
dna
control
autoimmun
diabet
methodsstudi
popul
mice
induc
develop
diabet
daili
applic
streptozotocin
stz
group
receiv
plasmid
stz
dna
group
stz
treatment
pancreat
lymph
node
cell
cultiv
stimul
insulin
cell
analyz
flow
cytometri
fac
pancrea
anim
remov
histolog
analysi
resultsanticip
result
fac
analysi
show
reduct
number
cell
group
treat
dna
cell
show
memori
phenotyp
label
cell
exhibit
signific
reduct
group
pancreat
histolog
possibl
observ
reduc
inflammatori
infiltr
better
preserv
islet
group
treat
dna
group
treat
stz
discussionsignific
impact
treatment
plasmid
dna
sequenc
reduc
number
infiltr
cell
pancrea
enhanc
preserv
islet
data
show
treatment
dna
sequenc
capabl
reduc
inflammatori
injuri
pancrea
suggest
strategi
could
effici
treatment
patholog
guptil
v
cui
middleton
quezado
bethesda
md
usa
nation
medic
center
washington
dc
usa
objectivesspecif
aim
transient
receptor
potenti
vanilloid
nonselect
cation
channel
express
sensori
neuron
pivot
role
nocicept
therapi
target
test
human
anim
treat
pain
syndrom
studi
show
role
sepsi
purpos
studi
determin
whether
effect
surviv
immun
respons
benefici
harm
methodsstudi
popul
studi
effect
genet
ko
vs
wt
mice
pharmacolog
disrupt
resiniferatoxin
rtx
agonist
capsazepin
cpz
antagonist
mortal
bacteri
clearanc
cytokin
express
lp
cecal
ligat
punctur
clp
sepsi
resultsanticip
result
clp
increas
mortal
risk
hazard
ratio
ci
p
compar
wt
intrathec
rtx
vs
vehicl
increas
mortal
risk
ci
p
wt
mice
lp
neither
genet
disrupt
pharmacolog
activ
rtx
signific
effect
surviv
compar
control
contrast
lp
pharmacolog
disrupt
cpz
compar
vehicl
increas
mortal
risk
ci
p
wt
anim
clp
increas
mortal
anim
associ
higher
blood
bacteri
count
p
nitratenitrit
level
regul
express
p
compar
control
discussionsignific
impact
disrupt
affect
mortal
blood
bacteria
clearanc
cytokin
respons
sepsi
relev
disrupt
investig
pain
therapi
human
zhang
z
mackensen
podgoreanu
univers
durham
nc
usa
objectivesspecif
aim
myocardi
ischemiareperfus
ir
injuri
remain
major
caus
cardiovascular
morbid
mortal
follow
cardiac
surgeri
use
sever
preclin
model
myocardi
ir
test
cardioprotect
efficaci
novel
tripeptid
deriv
protein
methodsstudi
popul
vitro
simul
ir
adult
rat
ventricular
cardiomyocyt
arvc
incub
normal
high
glucos
mm
without
h
subject
h
depriv
follow
h
reoxygen
either
hyperglycem
medium
rat
ir
rat
underw
min
mild
hypotherm
cardiopulmonari
bypass
cpb
min
cardiopleg
arrest
ca
group
hyperglycem
mm
ca
treat
mgkg
vehicl
pig
ir
yorkshir
pig
subject
min
mild
hypotherm
cpb
min
ca
receiv
mgkg
vehicl
efficaci
end
point
assess
h
arvc
h
rat
h
pig
postreperfus
includ
marker
myonecrosi
apoptosi
leukocyt
extravas
pump
function
resultsanticip
result
attenu
myocardi
ir
injuri
hyperglycem
condit
confirm
decreas
myocardi
necrosi
activ
apoptosi
peptid
treat
pig
demonstr
improv
myocardi
energet
hemodynam
none
requir
inotrop
vasopressor
support
discussionsignific
impact
use
translat
approach
robust
efficaci
end
point
report
elicit
cardioprotect
vitro
small
larg
anim
model
surgic
ir
effect
blunt
hyperglycemia
believ
repres
novel
therapeut
target
cardiac
surgic
patient
cheung
wl
munkberg
smoller
byrum
tackett
arkansa
medic
scienc
littl
rock
ar
usa
objectivesspecif
aim
incid
melanoma
continu
rise
everi
year
yet
abil
treat
advanc
diseas
chang
previou
current
studi
aim
identifi
melanoma
marker
ffpe
section
compar
metastat
melanoma
sampl
benign
nevu
improv
protein
extract
gel
separ
mass
spectrometri
analys
method
valid
addit
protein
identifi
signific
melanoma
case
use
mass
spectrometri
analyz
larg
scale
basi
futur
studi
methodsstudi
popul
melanoma
cell
melanocyt
harvest
laser
microdissect
protein
extract
analyz
spectromet
data
mass
spectrometri
studi
show
protein
differenti
express
metastat
melanoma
nevi
high
signific
protein
found
two
publish
possibl
melanoma
marker
includ
silv
fatti
acid
synthas
fa
top
signific
protein
valid
mass
spectrometri
result
use
immunohistochem
stain
formalin
fix
paraffin
embed
section
retriev
archiv
includ
benign
nevi
dysplast
nevi
melanoma
case
stain
pattern
score
base
extent
intens
resultsanticip
result
higher
immunoreact
silver
fa
detect
melanoma
case
benign
dysplast
nevi
case
statist
signific
p
p
respect
discussionsignific
impact
studi
show
identifi
least
two
melanoma
marker
silv
fa
mass
spectrometri
formalin
fix
paraffin
embed
section
compar
metastat
melanoma
benign
nevu
addit
protein
found
signific
mass
spectrometri
analyz
method
larg
scale
basi
futur
studi
hamidi
szema
lyubski
said
stoni
brook
stoni
brook
ny
usa
va
medic
center
northport
ny
usa
objectivesspecif
aim
despit
consider
advanc
treatment
pulmonari
arteri
hypertens
pah
condit
remain
highli
fatal
consider
appeal
combin
multipl
drug
object
answer
question
combin
vasoact
intestin
peptid
vip
endothelin
receptor
antagonist
bosentan
effect
either
drug
alon
treatment
experiment
ph
methodsstudi
popul
singl
inject
monocrotalin
mct
sc
rat
result
ph
rv
hypertrophi
rvh
pulmonari
vascular
remodel
lung
inflamm
week
patholog
uniformli
fatal
within
week
three
week
mct
inject
rat
receiv
either
placebo
treat
bosentan
po
vip
ip
togeth
hemodynam
measur
rat
euthan
examin
patholog
evid
pulmonari
vascular
thicken
lung
section
degre
rvh
sever
lung
inflamm
assess
inflammatori
cell
infiltr
score
surviv
monitor
day
mct
inject
resultsanticip
result
mct
caus
signific
elev
rv
pressur
thicken
smaller
pulmonari
arteri
perivascular
inflamm
rvh
treatment
either
vip
bosentan
significantli
attenu
measur
pah
except
rvh
rat
receiv
vip
bosentan
lowest
rv
pressur
least
vascular
thicken
rvh
lung
inflamm
rat
dead
within
week
inject
bosentan
vip
alon
significantli
reduc
mortal
surviv
p
rat
receiv
drug
remain
aliv
surviv
p
discussionsignific
impact
combin
therapi
bosentan
vip
improv
likelihood
success
revers
patholog
featur
ph
thu
improv
outlook
patient
pah
moreau
j
hartman
fink
angu
bell
watson
pittsburgh
critic
care
medicin
crisma
center
pittsburgh
pa
usa
pittsburgh
critic
care
medicin
safar
center
pittsburgh
pa
usa
univers
st
loui
divis
pediatr
critic
care
st
loui
mo
usa
associ
perkasi
pa
usa
objectivesspecif
aim
aim
determin
whether
children
acut
cn
disord
use
hospit
resourc
children
hospit
condit
methodsstudi
popul
studi
nonfeder
hospit
children
day
year
old
state
includ
us
pediatr
popul
use
code
identifi
patient
acut
cn
disord
dichotom
treatment
gener
versu
children
hospit
use
icu
resourc
length
stay
lo
cost
stay
dollar
calcul
resultsanticip
result
children
acut
cn
disord
nearli
greater
icu
use
hospit
children
p
much
like
hospit
children
hospit
vs
p
admiss
icu
admiss
children
hospit
associ
greater
resourc
use
regardless
diseas
statu
overal
mean
lo
day
cn
patient
day
patient
mean
cost
nearli
twice
high
cn
patient
patient
vs
p
discussionsignific
impact
children
acut
cn
disord
receiv
critic
care
often
admit
children
hospit
children
hospit
reason
also
use
resourc
acut
set
origin
greater
resourc
use
cn
patient
explor
hope
identifi
potenti
system
improv
lower
healthcar
cost
maintain
improv
outcom
moreau
j
fink
hartman
angu
bell
watson
pittsburgh
critic
care
medicin
crisma
center
pittsburgh
pa
usa
pittsburgh
critic
care
medicin
safar
center
pittsburgh
pa
usa
univers
st
loui
divis
pediatr
critic
care
saint
loui
mo
usa
associ
perkasi
pa
usa
objectivesspecif
aim
aim
determin
whether
children
acut
cn
disord
receiv
critic
care
higher
mortal
children
hospit
condit
methodsstudi
popul
studi
nonfeder
hospit
children
day
year
old
state
compris
us
pediatr
popul
use
code
identifi
patient
admit
acut
cn
disord
classifi
traumat
nontraumat
gener
nation
hospit
estim
use
censu
data
cdc
resultsanticip
result
nation
children
hospit
acut
cn
disord
epilepsi
mild
tbi
common
children
acut
cn
disord
nearli
greater
icu
use
hospit
children
vs
p
made
quarter
patient
receiv
icu
care
although
account
hospit
admiss
acut
cn
disord
account
nearli
half
death
nation
among
icu
patient
children
cn
disord
higher
mortal
p
made
death
discussionsignific
impact
account
minor
hospit
admiss
children
acut
cn
disord
often
receiv
critic
care
higher
mortal
children
hospit
reason
focu
popul
potenti
greatli
benefit
outcom
critic
ill
children
foster
e
univers
school
medicin
st
loui
mo
usa
objectivesspecif
aim
prospect
memori
abil
rememb
carri
previous
form
intent
essenti
function
independ
individu
parkinson
diseas
pd
prospect
memori
deficit
associ
reduc
qualiti
life
implement
intent
mnemon
strategi
design
improv
prospect
memori
purpos
pilot
studi
test
feasibl
potenti
efficaci
implement
intent
individu
pd
methodsstudi
popul
volunt
pd
n
age
sd
perform
computer
prospect
memori
test
two
separ
occas
month
apart
baselin
test
session
particip
perform
test
gener
instruct
test
session
four
particip
repeat
test
gener
instruct
control
group
four
particip
receiv
implement
intent
train
repeat
test
intervent
group
prospect
memori
accuraci
proport
correct
task
compar
across
group
test
session
resultsanticip
result
group
similar
prospect
memori
perform
baselin
control
sd
intervent
sd
intervent
group
accuraci
improv
sd
control
group
remain
rel
stabl
sd
intervent
particip
improv
baselin
compar
control
particip
discussionsignific
impact
prospect
memori
cognit
problem
pd
howev
current
rehabilit
effort
aim
address
result
suggest
implement
intent
train
feasibl
efficaci
intervent
prospect
memori
impair
pd
rigor
control
test
effect
implement
intent
warrant
garonzik
wang
j
berger
ro
kucirka
deshpand
boyarski
segev
hopkin
baltimor
md
usa
objectivesspecif
aim
report
barrier
identif
live
donor
includ
inadequ
educ
lack
resourc
reluct
initi
convers
donat
gener
patient
esrd
hesist
discuss
ill
difficulti
associ
dialysi
howev
friend
famili
member
often
eager
spread
awar
love
one
plight
empow
advoc
hypothes
separ
advoc
patient
help
allevi
commun
barrier
experienc
esrd
patient
lead
increas
live
donor
transplant
methodsstudi
popul
conduct
pilot
studi
adult
kidney
transplant
candid
least
month
lack
potenti
live
donor
recipi
select
live
donor
champion
ldc
friend
famili
member
will
advoc
spread
awar
esrd
live
donor
transplant
candid
ldc
attend
monthli
meet
address
topic
rang
basic
transplant
educ
method
initi
convers
outcom
includ
comfort
level
initi
convers
live
donor
recruit
transplant
resultsanticip
result
comfort
initi
convers
kidney
transplant
increas
throughout
program
six
potenti
donor
initi
workup
four
reach
phase
evalu
four
program
particip
accept
deceas
donor
organ
offer
despit
fact
three
repeatedli
declin
previou
offer
attribut
accept
increas
knowledg
gain
program
two
patient
receiv
live
donor
transplant
discussionsignific
impact
transplant
candid
seek
live
donor
separ
advoc
patient
understand
concern
initi
convers
reduc
sgarlat
cm
miller
ruthaz
parson
medic
center
float
hospit
children
boston
usa
univers
sackler
school
graduat
biomed
scienc
boston
usa
clinic
translat
scienc
institut
boston
usa
objectivesspecif
aim
purpos
studi
solicit
inform
cam
usag
parent
seek
care
children
pediatr
subspecialti
clinic
methodsstudi
popul
previous
survey
cam
usag
adapt
clinic
popul
survey
consist
gener
demograph
question
specif
question
cam
use
parent
patient
follow
pediatr
rheumatolog
divis
academ
medic
center
invit
complet
survey
resultsanticip
result
consecut
parent
complet
survey
major
mother
mean
age
year
respond
behalf
children
predominantli
femal
mean
age
year
major
respond
white
asian
african
american
patient
juvenil
arthriti
although
children
chronic
condit
also
includ
overal
patient
current
cam
user
taken
form
cam
past
cam
user
parent
famili
member
histori
cam
use
compar
user
multivari
logist
regress
use
explor
factor
significantli
differ
cam
user
versu
nonus
discussionsignific
impact
found
cam
use
extens
patient
chronic
diseas
follow
pediatr
subspecialti
clinic
famili
use
cam
may
associ
patient
cam
use
great
import
littl
known
benefit
potenti
harm
cam
despit
widespread
use
import
physician
understand
factor
influenc
decis
use
cam
children
benefit
parent
seek
cam
use
leutwyl
h
california
san
francisco
san
francisco
ca
usa
objectivesspecif
aim
introduct
adult
struggl
schizophrenia
live
longer
time
data
suggest
older
adult
live
schizophrenia
poor
physic
health
purpos
abstract
present
find
qualit
studi
explor
understand
physic
health
among
older
adult
schizophrenia
gather
individu
perspect
particip
describ
deal
care
transit
impact
physic
health
methodsstudi
popul
method
ground
theori
studi
conduct
among
older
adult
schizophrenia
live
varieti
set
use
semistructur
interview
particip
observ
resultsanticip
result
result
deal
care
transit
process
evolv
data
particip
describ
live
independ
particip
describ
would
never
prepar
live
independ
particip
also
describ
process
deal
care
transit
could
impact
physic
health
discussionsignific
impact
conclus
older
adult
schizophrenia
deal
care
transit
impact
neurocognit
issu
symptom
schizophrenia
medic
system
level
prepar
independ
live
find
provid
insight
design
futur
research
intervent
clinic
practic
promot
optim
physic
health
outcom
older
adult
schizophrenia
bearss
k
scahil
univers
new
ct
usa
objectivesspecif
aim
autism
spectrum
disord
asd
character
deficit
social
interact
commun
presenc
repetit
behavior
addit
children
asd
behavior
problem
tantrum
aggress
noncompli
show
defici
adapt
function
parent
train
receiv
much
interest
due
central
role
parent
promot
develop
children
autism
studi
aim
develop
parent
train
manual
children
asd
behavior
problem
evalu
feasibl
preliminari
efficaci
methodsstudi
popul
investig
initi
made
modif
research
unit
pediatr
train
manual
insur
appropri
preschool
age
children
newli
develop
pt
program
pilot
test
sampl
famili
preschool
asd
disrupt
behavior
famili
complet
intervent
subject
includ
children
autism
caucasian
latino
special
educ
mainstream
classroom
iq
none
medic
resultsanticip
result
chang
noncompli
hyperact
irrit
behavior
baselin
week
signific
produc
robust
effect
size
es
home
situat
questionnair
es
aberr
behavior
checklist
abc
es
es
age
equival
gain
vineland
month
daili
live
skill
month
commun
month
social
final
parent
attend
core
session
discussionsignific
impact
preliminari
data
provid
support
effect
accept
structur
parent
train
manual
young
children
asd
stebbin
vukotich
pittsburgh
pittsburgh
pa
usa
objectivesspecif
aim
univers
pittsburgh
school
base
research
practic
network
network
establish
juli
bring
togeth
research
investig
public
privat
parochi
school
grade
purpos
creat
research
school
improv
school
environ
outreach
educ
methodsstudi
popul
network
staff
met
superintend
key
administr
school
district
allegheni
counti
pa
million
peopl
establish
commun
identifi
research
interest
prioriti
addit
network
staff
outreach
research
univers
pittsburgh
carnegi
mellon
univers
univers
pittsburgh
medic
center
identifi
project
appropri
school
environ
resultsanticip
result
date
research
complet
network
novel
train
help
understand
advantag
pitfal
research
school
addit
network
facilit
placement
research
activ
interest
school
total
investig
research
project
public
privat
parochi
school
discussionsignific
impact
research
school
essenti
part
research
translat
work
network
facilit
translat
method
result
research
school
commun
network
methodolog
function
easili
emul
region
state
benefit
particip
mcpartland
j
perszyk
crowley
napl
may
child
studi
center
new
ct
usa
objectivesspecif
aim
face
percept
impact
autism
spectrum
disord
asd
potenti
erp
studi
reveal
signific
delay
basic
stage
face
process
index
compon
current
studi
examin
relationship
attent
face
brain
respons
asd
specif
investig
whether
latenc
normal
point
gaze
control
b
slow
process
evid
irrespect
point
gaze
predict
children
asd
would
exhibit
longer
latenc
irrespect
facial
featur
attend
methodsstudi
popul
children
asd
typic
develop
children
match
age
sex
iq
handed
particip
studi
particip
view
neutral
face
eeg
record
continu
hz
manipul
visual
attent
posit
fixat
crosshair
preced
face
direct
attent
either
eye
b
nose
c
mouth
fourth
present
condit
use
fixat
crosshair
latenc
amplitud
extract
across
six
electrod
left
right
later
posterior
scalp
resultsanticip
result
repeat
measur
anova
reveal
shorter
latenc
face
right
hemispher
irrespect
group
fixat
posit
b
longer
latenc
asd
group
irrespect
hemispher
fixat
posit
c
group
shorter
latenc
eye
rel
nose
mouth
crosshair
equival
discussionsignific
impact
children
asd
show
delay
latenc
brain
respons
independ
visual
attent
find
emphas
import
understand
tempor
dynam
social
brain
function
asd
offer
insight
therapeut
strategi
young
bishop
graham
clinic
cleveland
oh
usa
objectivesspecif
aim
endovascular
stent
superfici
femor
arteri
sfa
sweep
world
promis
stent
therapi
rel
high
rate
stent
fractur
observ
patient
research
propos
studi
influenc
arteri
calcif
stent
fractur
model
sfa
develop
uncalcifi
sever
calcifi
averag
calcifi
sfa
patient
peripher
arteri
diseas
pad
stent
fatigu
condit
studi
compar
methodsstudi
popul
detail
examin
clinic
patient
data
intravascular
ultrasound
imag
measur
obtain
peripher
vascular
core
laboratori
cleveland
clinic
subject
studi
age
gender
racial
mix
characterist
popul
pad
includ
cleveland
clinic
vascular
surgeri
registri
resultsanticip
result
test
hypothesi
arteri
calcif
advers
affect
stent
durabl
increas
stent
fractur
discussionsignific
impact
stent
fractur
seriou
problem
could
lead
vascular
complic
restenosi
stent
occlus
howev
littl
inform
avail
interplay
vessel
patholog
stent
function
specif
effect
arteri
calcif
stent
function
calcifi
environ
chang
arteri
mechan
properti
vessel
dynam
advers
affect
stent
function
calcium
caus
higher
compress
stress
uneven
load
condit
lead
higher
incid
stent
failur
identifi
mechan
factor
allow
design
stent
withstand
forc
